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Although the anterior pituitary secretes three hormones that affect metabolism and 
body fat stores, a comprehensive analysis of pituitary gene expression associated with 
body fat has not been performed.  This research used cDNA microarrays to investigate 
pituitary gene expression in two chicken lines that were selected for low and high body 
fat (Lean and Fat). RNA was extracted from pituitaries at 1, 3, 5, and 7 weeks of age. 386 
genes that showed significant differences in expression levels by line or in the line-by-
age interaction were analyzed further.  Differentially expressed genes between lines are 
potential candidates as genetic markers for high and low potential for body fat 
accumulation. One such candidate, the lysophosphatidic acid (LPA) receptor-1 (LPAR1), 
was identified as a potential marker, being differentially expressed between the 2 lines at 
the early ages.  Genomic DNA from the Fat and Lean F0 generation was sequenced 
upstream of the LPAR1 coding region.  A SNP consisting of a T to C transversion that 
introduces a GATA-1 transcription factor binding site was identified in the Lean line 
(Fisher’s Exact Test, p ≤ 0.001).  The fattest and leanest animals of both sexes in the 
back-crossed F2 generation (n=48 each) were genotyped by allele-specific PCR, and an 
association was present between the genotype and phenotype (generalized linear model, p 
≤ 0.05).  Expression of GATA transcription factors in mice inhibits differentiation of 
preadipocytes into mature adipocytes.  LPAR1 also inhibits differentiation of 
preadipocytes in mice, and LPAR1 knock-out mice become significantly fatter than wild-
type mice.  A SNP that introduces a GATA site in the promoter of LPAR1 could up-
regulate its expression in the Lean line, and increased LPA signaling could then inhibit 
preadipocyte differentiation.  Conversely, loss of the GATA binding site could explain 
decreased levels of LPAR1 expression and attenuated inhibition of adipocyte maturation 
in the Fat line.
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Chapter 1: Introduction
The aim of this research was to identify genes expressed in neuroendocrine tissues 
that regulate body fat composition in domestic chickens using cDNA microarrays. 
Specifically, the research focused on the identification of differentially expressed genes 
in the anterior pituitary gland of fat and lean chicken lines and analysis of candidate 
genes to be used for marker-assisted selection of leaner chickens in the future.
Protein is a major class of nutrient and the primary source of amino acids.  
Chicken meat provides a high quality complete source of protein.  Commercial broiler 
chickens have been selected for increased body mass (i.e. muscle) and rapid growth rate 
(Havenstein, Ferket et al. 2003).  Unfortunately, this selection has also increased body fat 
deposition (Deeb and Lamont 2002), along with other undesirable traits like decreased 
reproductive performance, increased skeletal muscle abnormalities, ascites, and fatty liver 
and kidney syndrome (Griffin and Goddard 1994; Julian 2005).  Excessive fat deposition
is an undesirable from a production and consumer standpoint, but traditionally 
commercial selection against this highly heritable trait has not been practiced, due to the 
cost and labor involved in slaughtering and dissecting animals in breeding assays 
(Lagarrigue, Pitel et al. 2006).  A means of genetically selecting for leanness would be of 
great commercial value.
In addition, it is likely that any genes involved in body composition phenotype in 
the chicken have human orthologs, and so may play a role in understanding obesity—a 
major health concern in humans, now and in the future.  Obesity has been described as a 
rising epidemic in the developed world, especially in the United States, where the 
prevalence of overweight and obese individuals is increasing.  Approximately 60 % of 
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the population in the United States is considered overweight or obese [body mass index 
(BMI, body weight in kilograms over the square of height in meters) greater than 25.0 
and 30.0, respectively] (Hedley, Ogden et al. 2004).  With this increase in the prevalence 
of obesity, there has been a concomitant increase in the incidence of other diseases, such 
as diabetes, hypertension, and cardiovascular disease (Muoio and Newgard 2006).
The fact that the chicken is a warm-blooded vertebrate species that can produce 
large numbers of offspring quickly, which allows generation of fairly large pedigrees of 
animals in a relatively short time, makes it a valuable genetic resource and experimental 
model.  Most domestic farm animals take months to years to reach reproductive age and 
produce relatively small numbers of offspring.  The chicken also offers the advantage, 
after egg deposition, of being free of maternal-fetal nutritional and hormonal interactions, 
which can affect body composition in mammals later in life (Oken and Gillman 2003).
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Chapter 2: Literature Review
Overview of involvement of pituitary hormonse in regulating body composition
Body composition is determined by a complex interaction between 
environmental, hormonal, genetic, behavioral, and nutritional factors.  The pituitary 
produces (at least) three hormones that exert major effects on growth, body composition, 
and metabolism: growth hormone (GH), pro-opiomelanacortin (POMC), and thyroid-
stimulating hormone (TSH).  These hormones are produced by somatotrophs, 
corticotrophs, and thyrotrophs, respectively.  Genes involved in the expression and 
regulation of these hormones, especially during the developmental period during which 
adipocytes undergo differentiation, will be of particular interest with regard to 
understanding neuroendocrine regulation of adiposity.
Overview of regulation of pituitary hormone secretion
The endocrine system, along with the nervous system, regulates and integrates the 
functions of the various tissues and cells that make up multicellular organisms.  The heart 
of this system is comprised of the hypothalamus-pituitary-target tissue axes.   The classic 
model of the endocrine system involves the production of hypophysiotrophic factors by 
neurons in the hypothalamus whose axons project to the median eminence (ME), where 
the released factors enter the capillaries of the hypophysial-portal system and are 
transported to the anterior pituitary, integrating the central nervous system with the 
endocrine system.  Hypothalamic factors generally either stimulate the biosynthesis and 
release of pituitary hormones, or inhibit their synthesis or release.  The hormones travel 
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through the systemic circulation to reach their target organs, where they initiate the 
physiological effects, such as the secretion of the target organ’s own hormones, which 
then can travel back through the circulation to the hypothalamus or pituitary to down-
regulate the trophic factors and hormones in a negative feedback loop.  The 
hypothalamus-pituitary-target axes and their feedback loops provide mechanisms by 
which an organism maintains homeostasis.
Hypothalamic factors
There are several peptides produced by the hypothalamus that exert trophic 
effects on the pituitary gland.  The chicken GH-releasing hormone (GHRH) gene has 
been cloned (McRory, Parker et al. 1997).  Three different transcripts were isolated, 
GHRH 1-46, GHRH 1-43, and GHRH 33-46.  The full length chicken GHRH peptide is 
less than 50% identical to mouse and human GHRH.  Interestingly, the GHRH gene also 
encodes for pituitary adenylate cyclase-activating polypeptide (PACAP) whereas GHRH 
and PACAP are encoded by different genes in mammals.  It has been posited that, like 
mammals, the GHRH-producing neurons are located in the arcuate nucleus, since lesions 
in this area reduced GH secretion (Harvey, Fraser et al. 1991). 
 The  preprothyrotropin-releasing hormone (TRH) cDNA has been recently 
cloned (Vandenborne, Roelens et al. 2005); TRH is a three amino acid peptide (pyro-Glu-
His-Pro amine) produced in the paraventricular nucleus  (PVN) and in the lateral 
hypothalamus (Geris, D'Hondt et al. 1999; Vandenborne, Roelens et al. 2005) as a 26 
kDa prohormone and is processed into active TRH by the actions of prohormone 
convertase (PC) 1/3 and PC2 (Perello, Friedman et al. 2006).  
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Chicken ghrelin is a recently described 26-amino acid protein that acts as a GH-
secretagoue in vivo (Kaiya, Van Der Geyten et al. 2002).  In the hypothalamus, ghrelin 
immunoreactivity was not found in the arcuate nucleus as in mammals, but in the anterior 
medial hypothalamus (Ahmed and Harvey 2002).
Somatotropin-release inhibitory factor (SRIF) has been found in the 
hypothalamus of chickens (Geris, Meeussen et al. 2000).  It is also found in other 
hypothalamic nuclei that do not project to the ME, and in the brainstem and other 
peripheral tissues (gonads, thyroid, and intestine).
Corticotropin-releasing hormone (CRH) has been cloned in the chicken 
(Vandenborne, De Groef et al. 2005).  Like mammalian CRH, it is a 41 amino acid
peptide found in the paraventricular nucleus (Jozsa, Vigh et al. 1984).
Growth hormone
GH is necessary for normal growth after hatching (King and Scanes 1986).  GH is 
a 22 kDa glycoprotein hormone synthesized by somatotrophs in the caudal lobe of the 
chicken anterior pituitary.  A cDNA for chicken GH has been sequenced (Lamb, 
Galehouse et al. 1988).  GH expression and secretion are stimulated by GH-releasing 
hormone (GHRH) (Scanes and Harvey 1984), thyrotropin-releasing hormone (TRH) in 
embryos and  young birds (Van As, Careghi et al. 2004), and ghrelin (Baudet and Harvey 
2003), and inhibited by somatotropin-release inhibiting factor (SRIF) (Spencer, Harvey et 
al. 1986).  These hypothalamic factors exert their effects by binding to receptors on the 
cell surface of the somatotrophs.  Receptor binding and activation initiates signaling 
cascades of second messenger molecules that mediate changes in enzyme activity and 
gene expression.  
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The GHRH receptor (GHRH-R) is a member of the G protein-coupled receptor 
superfamily.  Ligand binding causes the exchange of guanosine diphosphate (GDP) for 
guanosine triphosphte (GTP) and the disassociation of the cytoplasmic Gαs subunit, 
which activates adenylyl cyclase, causing an increase of cAMP levels (Gaylinn 2002). 
The increase in cAMP in turn activates protein kinase A (PKA), whose catalytic subunits, 
after dissociation from their regulatory subunits, travel to the nucleus to phosphorylate 
their target proteins (e.g. cAMP response element binding protein) which mediate 
genomic responses.  The Gαs subunit has a GTPase activity and signaling stops when 
GTP is hydrolyzed to GDP. There is also evidence that GHRH can activate the mitogen-
activated protein kinase (MAPK) pathway independently of PKA signaling and that this 
is mediated by the Gβγ subunits of the receptor (Pombo, Zalvide et al. 2000).  In 
mammals, the major effect of GHRH is the stimulation of the synthesis and release of GH 
(Mayo, Miller et al. 2000).  The GHRH receptor has recently been cloned in chickens that 
binds to human GHRH and increases cAMP accumulation, but only weakly responds to 
recombinant chicken GHRH, suggesting that GHRH may not be the endogenous ligand 
for this receptor (Porter, Ellestad et al. 2006; Toogood, Harvey et al. 2006; Wang, Wang 
et al. 2006).  Chicken GHRH has been cloned and has less than 50% amino acid identity 
with rat and human GHRH (McRory, Parker et al. 1997).
The TRH receptor has been cloned in chickens (Sun, Millar et al. 1998).  Ligand 
binding to the TRH receptor causes the activation of membrane-bound phospholipase C 
(PLC) via the GTP-bound Gq/11 subunit; PLC in turn catalyzes the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messenger molecules 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (Song and Hinkle 2005).  IP3
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binds to an endoplasmic receptor and causes the release of Ca++ from the endoplasmic 
reticulum (ER) in the cytosol.  Free cytosolic Ca++ binds to the kinase calmodulin, which 
then can phosphorylate its targets, elicting its celluar effects. DAG also acts as a second 
messenger in that it activates protein kinase C (PKC), a phospholipid- and Ca++-
dependent serine/threonine kinase (Kiley, Parker et al. 1991).  TRH receptor signaling 
can also activate the MAPK pathway (Ohmichi, Sawada et al. 1994). 
The ghrelin receptor also belongs to the G protein-coupled receptor family 
(Tanaka, Miyazaki et al. 2003).   As with TRH receptor, ligand binding to the ghrelin 
receptor results in the activation of the PLC and PKC signaling pathways (Richards, Poch 
et al. 2006).  Ghrelin receptor mRNA expression has been detected in the pituitary 
(Tanaka, Miyazaki et al. 2003).
There are 5 SRIF receptor subtypes that are members of the G protein-coupled 
receptor family.  SRIF receptor inhibits the activity of adenylyl cyclase via its Gαi
subunit; it also stimulates the activity of phosphotyrosine phosphatase, and interacts with 
the MAPK pathway (Patel 1999).  Inhibition of GH-release in birds by SRIF is mediated 
primarily through the SRIF receptor subtype 2, and to a lesser extent the subtype 5 
(Bossis and Porter 2001).  SRIF-binding sites are present on the membranes of pituitary 
cells (Harvey, Attardo et al. 1990).  There are 2 forms of biologically active SRIF that 
have been described in birds, a 14-amino acid peptide that is identical to SRIF-14 in 
mammals, and a 28-amino acid peptide that differs by one residue (Hasegawa, Miyamoto 
et al. 1984). 
GH secretion is pulsatile in nature and exerts its effect through the GH receptor 
(Vasilatos-Younken, Cravener et al. 1988).    A sex-linked dwarf strain of chickens, 
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which have a truncated GH receptor that does not bind GH, have a phenotype of adult 
weight that is 30-40 % lower than normal (Burnside, Liou et al. 1992).  The chicken GH 
receptor has been cloned (Burnside, Liou et al. 1991).  The GH receptor is a member of 
the cytokine receptor superfamily.  Upon ligand binding, the GH receptor dimerizes and 
recruits the intracellular tyrosine kinase, Janus 2 (JAK2).  Two JAK2 molecules bind to 
the membrane proximal cytoplasmic domains of the dimerized GH receptors and undergo 
autophosphorylation; they then phosphorylate tyrosine residues on the GH receptor.  
These phosphorylated tyrosines serve as docking sites for protein with src homology 2 
(SH2) domains.  The classic proteins that are phosphorylated by the activated JAK2-
receptor complexes are the signal transducers and activators of transcription (STAT) 
transcription factors.  Phosphorylated STATs form dimers, translocate to the nucleus, and 
bind to regulatory regions in responsive genes.  Activated GH receptor also has been 
shown to phosphorylate other proteins such as insulin receptor substrate-1 (IRS-1), src
homology- containing protein (SHC), phosphidylinositol 3’ phosphate kinase (PI-3), and 
MAPKs (Zhou, Wang et al. 2005).
GH exerts its effects throughout the body, but it mediates most of its actions 
through production of insulin-like growth factors (IGFs) by the liver.  IGFs are 
structurally related to insulin and play a role in a variety of anabolic and metabolic 
processes (reviewed in McMurtry, Francis et al. 1997).  GH has been shown to increase 
release of IGF-1 from chicken hepatocytes in vitro (Houston and O'Neill 1991).  When 
GH is administered to birds in a pusatile fashion that mimics endogenous release, 
circulating IGF-1 levels are much greater than in birds administered GH continuously 
(Vasilatos-Younken, Cravener et al. 1988).  The IGF-1 levels in the sex-linked dwarf 
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chicken that lack a functional GH receptor are lower than normal chickens despite having 
higher levels of circulating GH (Vasilatos-Younken, Dunnington et al. 1997).  
Circulating levels of IGF-1 were significantly higher in a line of chickens selected for 
increased breast muscle and decreased fatness than in a control line (Tesseraud, Pym et 
al. 2003).  Injection of IGF-1 increases lean growth and feed efficiency and decreases 
carcass fat (Tomas, Pym et al. 1998).  The chicken IGF-1 gene maps to 165.5 cM on 
chromosome 1; interestingly, this is near a QTL for body weight (160 cM, confidence 
interval 114 to 180 cM; (Sewalem, Morrice et al. 2002) and a QTL for abdominal fat 
weight (150 cM, confidence interval 100 to 182 cM; (Ikeobi, Woolliams et al. 2002).  A 
SNP in the IGF-1 promoter has recently been described that is associated with significant 
differences in percentage of abdominal fat weight in chickens (broiler-Leghorn and 
broiler-Fayoumi crosses) (Zhou, Mitchell et al. 2005).  IGF-I exerts a negative feedback 
effect on the pituitary, decreasing synthesis of GH (Buonomo, Lauterio et al. 1987; 
Scanes, Proudman et al. 1999).
GH also has metabolic effects.  GH increases lipolysis in vitro in adipose tissue 
(Harvey, Scanes et al. 1977) and this effect can be blocked with a GH antagonist 
(Campbell, Chen et al. 1993).  In vivo, injection with recombinant chicken GH increases 
free fatty acid levels in the blood (Hall, Cheung et al. 1987).  A week-long pulsatile 
administration of GH decreased fat pad size and lipogenesis in young birds (Rosebrough, 
McMurtry et al. 1991).   
GH also affects levels of circulating thyroid hormones (TH), which are essential 
in the development of the embryo, hatchability, thermoregulation, growth, and 
metabolism (reviewed in (McNabb 2000)).  The thyroid gland secretes thyroxine (T4) 
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into the circulation, which is then deiodinated at the outer ring via Type I 5’-deiodinase, 
primarily in the chicken liver, to the active metabolite 3,5,3’-triiodothyronine (T3), which 
is the preferred ligand of the 2 major isoforms of thyroid hormone receptor (TRα and 
TRβ) (Decuypere, Van As et al. 2005).   Inner ring deiodination of T4 and T3 by Type III 
5-deiodinases leads to the formation of the inactive metabolites reverse 3,3’,5’-
triiodothyronine (rT3) and 3,3’-diiodothyronine (T2), respectively.   Chicken GH does not 
affect Type I 5’-deiodinase activity but does inhibit Type III 5-deiodinase activity, which 
leads to higher levels of circulating T3 (Darras, Rudas et al. 1993).
T3 in turn feeds back to inhibit secretion of TRH-stimulated growth hormone 
(Harvey 1990).  T3 has also been shown to down regulate TRH-binding sites on pituitary 
membranes (Harvey and Baidwan 1990). GH synthesis is increased in birds made 
hypothyroid by methimazole (MMI) injection, indicating that TH inhibit the production 
of GH (Denver and Harvey 1991).  In the same study, treatment with T3 inhibited the 
release of GH in response to TRH.
Thyroid-stimulating hormone
TSH stimulates the production of thyroid hormones, which are important for 
normal growth, development, and metabolism.  Thyrotrophs produce TSH, a heterodimer 
of two glycoproteins, an α-subunit which is shared with follicle stimulating hormone 
(FSH) and luteinizing hormone (LH), and a hormone specific β-subunit. Chicken TSHβ
has been cloned (Gregory and Porter 1997).   Although there is no chicken TSHβ
antibody available--and therefore no direct measurements of TSH in plasma, the report 
that TRH administration increases levels of T4 in the blood (Thommes and Hylka 1978), 
and a subtractive assay (where LH and FSH specific β-subunit levels were subtracted 
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from total levels of α-subunit to obtain an estimate of TSHβ) (Berghman, Darras et al. 
1993) that indicated increase of TSHβ in response to TRH administration, support that 
TSH is upregulated and secreted in response to TRH.   TSH has also been shown to be 
released by ovine corticotrophin-releasing hormone (CRH) (Geris, Kotanen et al. 1996), 
and to be inhibited by SRIF (Lam, Harvey et al. 1986) (Lam, Harvey et al. 1986), as 
inferred by alterations in levels of thyroid hormones.  
CRH receptor types I (Yu, Xie et al. 1996) and II (DeGroef, Grommen et al. 
2004) have been cloned in chickens. The CRH receptors are members of the G protein-
coupled receptor family and activate adenylyl cyclase, presumably through their Gαs
subunit.  However, in chickens the Type I receptor mRNA and TSHβ peptide do not 
colocalize (DeGroef, Geris et al. 2003), indicating the involvement of the Type II 
receptor in TSH secretion.  Treatment with Type II receptor-specific agonists and 
antagonist indicates that it is the Type II receptor that mediates CRF-induced TSH 
secretion (De Groef, Goris et al. 2003). The target organ of TSH action is the thyroid 
gland, where it stimulates the growth of the gland and the production and release of 
thyroxine (T4).  The general mechanism of T4 action is conversion into active 
triiodothyronine (T3) by peripheral deiodinases in thyroid hormone target tissues (e.g.
liver, see above).
TSH mediates its effects through its receptor, which has recently been cloned 
(Grommen, Taniuchi et al. 2006).  TSH receptor in a G protein-coupled receptor and 
treatment with bovine TSH increases intracellular cAMP levels in transfected HEK cells, 
suggesting the presence of a Gαs subunit.  TSH receptor mRNA is found in the thyroid, 
and in several other tissues, including brain, pineal gland, and retina.
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Thyroid hormones are required for normal growth.  In a study involving an 
induction of either a hyperthyroid or hypothyroid state by feeding TH or MMI, 
respectively, an increase in fatness and a decrease in growth was seen with MMI 
treatment, and TH decreased both fatness and growth (Decuypere, Buyse et al. 1987).  
Thyroid hormone receptors are members of the nuclear receptor superfamily.  Receptors 
in the family share structural similarities; they possess an amino-terminal domain, a 
DNA-binding domain, a hinge region, and a hormone binding domain.  The nuclear 
receptor superfamily is made up of 3 classes: Type I receptors bind steroid hormones, 
Type II bind THs, retinoic acids, and vitamin D3, and Type III receptors are orphan
receptors (Mendelson 2004).  TRs, in general, bind to DNA in an unliganded state and 
repress transcription at positively regulated thyroid hormone response elements (TREs); 
at negatively regulated TREs, THs activate or derepress gene transcription (Decuypere, 
Van As et al. 2005).
Thyroid hormones exert negative feedback on thyrotrophs, as goitrogens—
substances that inhibit thyroid hormone production—increase thyrotroph number and 
pituitary TSH content (Sharp, Chiasson et al. 1979; Thommes, Martens et al. 1983; 
Decuypere, Buyse et al. 1987), and TSHβ mRNA (Muchow, Bossis et al. 2005).  
Pro-opiomelanocortin
The pituitary also regulates adrenocortical function and the production of 
glucocorticoids.  Chicken POMC has been cloned; it is a 251 amino acid peptide with 9 
proteolytic cleavage sites (Takeuchi, Teshigawara et al. 1999).  POMC is a precursor 
protein that is produced by corticotrophs, and through proteolytic cleavage produces 
many peptide hormones—most notably adrenocorticotropic hormone (ACTH), β-
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endorphin, and α- and β-melanocyte- stimulating hormone (MSH).  ACTH is the major 
hormone produced by the avian pituitary corticotrophs and has been localized to the 
cephalic lobe of the anterior pituitary (Hayashi, Imai et al. 1991).  
Not much is known about the regulation of the hypothalamic-pituitary-adrenal 
(HPA) axis in birds.  In mammals, CRH stimulates secretion of ACTH from the pituitary, 
which in turn stimulates the production of glucocorticoids and mineralocorticoids in the 
adrenal gland.  Glucocorticoids then feed back to the hypothalamus to down regulate 
CRH transcription and mRNA stability (Ma, Camacho et al. 2001).  Adrenalectomy 
increased ACTH synthesis and secretion in rats (Spinedi, Giacomini et al. 1991).
In chickens, corticosterone (CORT) is the major glucocorticoid.  Dexamethasone 
(DEX) has been shown to suppress secretion of ACTH in vivo (Herold, Brezinschek et al. 
1992). Ovine CRH has been shown to stimulate the release of ACTH in chicken pituitary 
cells, and DEX inhibited basal and stimulated ACTH release (Carsia, Weber et al. 1986).  
Glucocorticoid negative feedback is also suggested by the lower levels of circulating 
ACTH and higher levels of CORT in chickens fed protein-restricted diets (Carsia, Weber 
et al. 1988).  CORT injection decreases levels of CRH precursor mRNA and CORT 
plasma levels in embryonic and 9-day old chicks (Vandenborne, De Groef et al. 2005).  
Levels of CRH peptide in the hypothalamus, and levels of CRH receptor-1 and POMC 
mRNA levels in the pituitary were not affected.  However, culture of pituitary cells with 
CORT decreased levels of POMC mRNA.
Glucocorticoids and mineralocorticoids are steroids that exert their effects 
through Type I nuclear hormone receptors.   In general, steroid hormone receptors are not 
bound to DNA in their unliganded state.  Glucocorticoid receptor is localized in the 
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cytoplasm bound to heat shock proteins.  Upon ligand binding, the heat shock proteins 
dissociate and the receptor localizes to the nucleus, where it dimerizes and binds DNA to 
exert transcriptional effects.
Daily injections of CORT in 26-day old broilers increases abdominal fat pad size, 
liver size, and liver fat content (Bartov, Jensen et al. 1980).  This same effect  (injections 
starting on day 28) was seen (Buyse, Decuypere et al. 1987) in 2 lines of chickens 
selected for abdominal fat weight based on selection for levels of very low density 
lipoproptein (VLDL) (Whitehead and Griffin 1984).
Deposition of body fat in birds
Adipose tissue, the main fat depot in the body, functions to store excess energy in 
the form of triglycerides and to release fatty acids during energy deficit.  In birds a major 
storage depot of adipose tissue is the abdominal fat pad (Hood 1982).  The abdominal fat 
pad provides a good estimator of overall body fat in adipose tissues, since they are highly 
correlated (Cahaner, Nitsan et al. 1986).  Unlike mammals, adipocytes contribute little to 
the synthesis of new fatty acids found in adipose tissue in birds (Griffin, Guo et al. 1992).  
The source of the majority of the fatty acids found in adipose tissue come from lipids in 
the plasma (Griffin 1993).  Since commercial chickens are fed diets low in lipids, the 
liver synthesizes most of the lipids that are utilized by the body (Hermier 1997).  Adipose 
tissue growth can occur by formation of new adipocytes from clonal expansion of 
differentiating preadipocytes derived from mesenchymal stem cells (hyperplasia) and/or 
an increase in adipocyte size via the uptake of lipids (hypertrophy) (Kacsoh 2000).  In 
young broilers (up to 14 weeks) adipose tissue growth mainly occurs via hyperplasia, 
after that further growth chiefly occurs by hypertrophy of the adipocytes (Hood 1982).  
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The major processes that regulate growth of adipose tissue are: 1) hepatic lipogenesis, 2) 
transport of lipids from the liver to the adipose tissue, and 3) uptake of triglycerides by 
the adipocytes (Hermier 1997).
As reviewed in (Nir, Nitzan et al. 1988; Nelson and Cox 2000); the diet is a 
source of carbohydrate that provides the substrate for the formation of acetyl-CoA.  
Acetyl-CoA is converted into malonyl-CoA by acetyl-CoA carboxylase. After a meal, 
insulin stimulates the activity of the enzyme fatty acid synthase (FAS), which 
incorporates acetyl-CoA and malonyl Co-A into palmitate.  Palmitate is a 16-carbon fatty 
acid that is incorporated into triglycerides (although other fatty acids formed by 
elongation and desaturation are used, too).  In the liver triglycerides are assembled, along 
with apolipoproteins apoB-100 (the major protein), apoC-I, apoC-II, apoC-III, and apo-E 
and cholesterol into VLDLs and secreted into the circulation.  When the VLDL come in 
contact with lipoprotein lipase associated with the cell surface of the adipocytes, the 
enzyme is activated by apoC-II, and free fatty acids are hydrolyzed from triglycerides and 
are taken up into the adipocytes where they are reesterified back into triglycerides for 
storage.
Fat and Lean lines of chickens
Two lines of chickens have been genetically selected that exhibit significant 
differences in body fat accumulation.    The lean and fat chicken lines (LL and FL, 
respectively) were created at the Institute Nationale Reserches Agrinomique (INRA), 
Nouzilly, France, and the F0-F2 generations were first described in 1980 (Leclercq, Blum 
et al. 1980). The selection criterion was based on the proportion of body fat in males at 9 
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weeks of age. Generation of the fat and lean broiler strains until the end of selection (F7) 
was as described previously (Leclercq, Blum et al. 1980; Leclercq 1988). 
The F-1 generation consisted of a blending of 6 different strains of broiler 
chickens with 23 males bred with 68 females.  Six strains were used to capture as many 
broiler-type alleles as possible.  Four sons per hen were sacrificed at 9 weeks of age and 
abdominal fat pad weights were measured.  Birds have little intramuscular fat compared 
to mammals but maintain a large abdominal fat pad depot.  Each of the F0 families was 
classified as fat line or lean line depending on the deviation (positive or negative) from 
the linear regression between ratio of abdominal fat:body weight with body weight 
(Figure 1).  
Progeny from the 20 hens whose sacrificed sons had the highest deviations from 
the regression line (above line for fat line, under for lean line) were used to breed the F1
generation.  Since deviations from the regression line were used for selection, the body 
fat:body weight ratio was not correlated with body weight, and mean body weights of the 
two lines were similar. After F0, the proportion of abdominal fat was not correlated with 
body weight within each line and so selection was based on abdominal fat proportion and 
not the deviation between the fat proportion and body weight.  Four sons per hen were 
sacrificed and from the 15 hens whose progeny had the highest or lowest ratios the sires 
and dams of the F2 generation were selected.  The progeny of 14-15 dams per line (4 
sacrificed males per dam at 9 weeks) that had the highest or lowest ratios of abdominal 
fat: body weight were used to produce the subsequent generations with care taken not to 
cross full or half sibs.  Selection was continued for 7 generations, with 14 sires and 5 
hens per sire in each line for the F0 and F1 generations and then 15 sires and 5 dams per 
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sire in each line for generations F2 through F7.  Realized heritabilities were calculated for 
proportion of abdominal fat from F0 to F1 and F0 to F2 and although heritabilities were 
reduced over three generations, they still were considered high (h2 = 0.67 and 0.57, 
respectively) by Leclercq (1988). Selection was stopped after F7, and representative birds 
(one son per male and one daughter per hen) were kept for the continuance of the two 
lines.  
The difference between lines in fat pad:body weight ratio at nine weeks remained 
constant through F10, the last generation examined (Leclercq 1988).  Differences in 
abdominal fat ratio between the two lines were seen as early as 4 weeks of age by the F2
generation, and by the end of selection (F7) the fat line had a ratio of abdominal fat:body 
weight that was more than three times greater than the lean line. Metabolizable energy 
intake was not significantly different between the lines (Leclercq and Saadoun 1982).  
These two strains have now been sustained for more than twenty-five years after 
selection was discontinued and still maintain the difference in abdominal body fat.
Since the creation of the LL and FL, several differences between the two lines 
have been noted.  For example, in vivo fatty acid synthesis is greater in the FL than the 
LL, and FL livers are heavier (Saadoun and Leclercq 1983).   The LL is more susceptible 
to depressed growth when fed a low protein diet (Leclercq 1983). The FL birds always 
have lower blood glucose levels than the LL, whether they are fed or fasted; conversely, 
the LL always have lower levels of triglycerides, especially in a fed state (Leclercq, 
Hermier et al. 1984).  There are no significant differences in levels of cholesterol or free 
fatty acids.  The FL hens are lighter than LL hens at the onset of the laying phase and 
produce lighter eggs but the yolk percentage of the egg is higher in FL hens, indicating 
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that yolk production may be superior in the FL (Leclercq, Kouassi-Kouakou et al. 1985).   
The effect of CORT injection on various metabolic parameters was tested, and differing 
sensitivity to CORT does not seem to be involved in fattening (Saadoun, Simon et al. 
1987).  When the birds are fed a diet with high enough fat to suppress liver lipogenesis, 
there are still differences in body composition (Saadoun and Leclercq 1987; Griffin 
1993).  The activity of delta 9-desaturase, the rate-limiting enzyme in the synthesis of 
unsaturated fatty acids, was 45% higher in the FL (Legrand, Mallard et al. 1987).  The 
differences between the lines are not due to differing lipolytic activity of the abdominal 
adipose tissue (Lemarchal, Beaunez et al. 1988).  In a fasted state, the FL has lower blood 
glucose than LL, but levels of insulin, T3, T4, and CORT are not different (Saadoun, 
Simon et al. 1988).  When fed, insulin and T4 are increased in the FL, and T3 is slightly 
higher in the LL.  After refeeding, glucose and insulin were lower in the FL; T3 was 
lower and T4 was higher in the FL.  To see if thyroid hormone differences were involved, 
T3 was added to the diet of the FL to bring T3 levels up to LL levels and only a small 
change in body composition was observed, suggesting that the higher T3 levels in the LL 
only account for a small difference in the phenotype (Leclercq, Guy et al. 1988).   The FL 
has higher LPL activity in their adipose tissue, but this is due to hyperplasia and 
hypertrophy of the adipocytes and not increased intrinsic LPL activity (Hermier, 
Quignard-Boulange et al. 1989).  The difference in fatness is not accounted for by an 
increase in the number or kinase activity of insulin receptors (Simon, Chevalier et al. 
1991).  Utilization of dietary protein is more efficient in the LL (Leclercq and Guy 1991).  
mRNA levels of apoAI [a major component of high density lipoprotein (HDL)] were 
found to be significantly different between lines and correlated with abdominal tissue 
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weight (Douaire, Fur et al. 1992).  GH levels are slightly higher in LL with no difference 
in GH binding to liver membranes (Buyse, Vanderpooten et al. 1994).  Increased 
activation of insulin receptor pathways after feeding could be responsible for increased 
liver lipogenesis in the FL (Dupont, Chen et al. 1999).  The FL has higher levels of IGF-I 
and IGF-II in both fed and fasted states (Beccavin, Chevalier et al. 2001).  Malic enzyme, 
ATP citrate-lyase, and (as previously shown) ApoAI genes, which are involved in 
lipogenesis in the liver, have greater mRNA levels and transcription rates in the FL 
(Daval, Lagarrigue et al. 2000).  In short, much work has been done with the FL and LL 
birds.  However, the underlying genetic basis for the differences in abdominal fat is not 
known.  A summary of metabolic differences between LL and FL is presented in Table 1 
(Leclercq 1988).
14K cDNA Microarrays
DNA microarrays allow the quantification of expression levels for thousands of 
genes simultaneously. The construction of the cDNA libraries and the production of the 
Del-Mar 14K Chicken Integrated Systems Microarray have been described in detail 
(Cogburn, Wang et al. 2003; Cogburn, Wang et al. 2004; Carre, Wang et al. 2006).  The 
Del-Mar 14K Chicken Integrated Systems Microarrays were printed from cDNA libraries 
created from metabolic tissues (liver and fat), somatic tissues (skeletal muscle and growth 
plate), reproductive tissues (oviduct, ovaries, and testes), and neuroendocrine tissues 
(pituitary, hypothalamus, and pineal).  These tissues were chosen for their agricultural 
and biological importance.  All of the publicly available (as of March 1, 2003) chicken 
expressed sequence tags (ESTs; ~407000) were assembled into 33949 contigs using the 
CAP3 software program (Huang and Madan 1999).  The ESTs from the tissue specific 
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libraries were incorporated into these contigs.  Contigs were then identified by their 
highest scoring BLASTX and BLASTN returns.  cDNA clones from the libraries were 
amplified by PCR and printed onto glass slides.  The Del-Mar 14K Chicken Integrated 
Systems Microarray contains 19200 spots and 14053 of these represent unique cDNA.  In 
addition to the cDNAs from the tissue specific libraries, 387 60-mer oliogonucleotide 
probes for specific genes were printed, along with 72 quality control spots.  The quality 
control spots are salmon sperm DNA, which has been included for an estimation of 
background hybridization, and 8 housekeeping genes: β-tubulin, TEF1α, β-actin, pre-
mRNA splicing factor, GAPDH, dynactin, Na+/K+ ATPase, and sodium pump 3 (printed 
in 8 replicate spots each).  The composition of the microarray is summarized in Table 2.
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Chapter 3: Identification of a single nucleotide polymorphism associated with adiposity 
following transcriptional profiling of gene expression in the anterior pituitary gland
Introduction
Body composition is determined by complex interactions between environmental, 
hormonal, genetic, behavioral, and nutritional factors.  Commercial broiler chickens have 
been selected for increased muscle mass and rapid growth (Havenstein, Ferket et al. 
2003).  Unfortunately, selection for these desirable commercial traits has also led to a 
concomitant increase of undesirable traits such as ascites, decreased reproductive 
performance, increased skeletal muscle abnormalities, and fatty liver syndrome (Griffin 
and Goddard 1994; Havenstein, Ferket et al. 2003; Julian 2005).  Excessive fat deposition 
is an undesirable trait from a production standpoint due to inefficient feed conversion and 
from a consumer viewpoint due to the increasing demand for leaner meats.  In 
commercial industry it is not economically feasible to select against this highly heritable 
trait due to the high cost and labor involved in slaughtering and dissecting animals in 
breeding assays (Lagarrigue, Pitel et al. 2006).  Identification of genetic markers for the 
quantitative trait would be of great commercial value.  Additionally, with the incidence of 
obesity in humans reaching epidemic proportions—approximately 60% of Americans are 
considered overweight or obese (Hedley, Ogden et al. 2004)—identification of genes 
involved in development of adiposity in chickens will likely implicate their human 
orthologs in obesity.  This could be especially helpful, considering the relationship of 
obesity with other diseases that are on the rise, such as diabetes, hypertension, and heart 
disease (Muoio and Newgard 2006). 
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Experimental strains of chickens have been developed by genetic selection for 
body fat that allow for investigation into the genetic and metabolic mechanisms involved 
in adiposity.  Lines of lean and fat chickens (LL and FL, respectively) were developed by 
selection for abdominal fat pad weight in males at 9 weeks of age (Leclercq, Blum et al. 
1980).  The FL has a ratio of abdominal fat weight: body weight that is almost 4-fold 
higher than the LL.  The difference in adiposity between the two lines appears by four 
weeks of age and can not be accounted for by differences in feed consumption or use of 
metabolizable energy (Leclercq 1988).  
The adenohypophysis, or anterior pituitary gland, is comprised of five major cell 
types characterized by the hormones they synthesize and secrete.  Three of these cell 
types: somatotrophs, corticotrophs, and thyrotrophs, produce hormones—growth 
hormone (GH), pro-opiomelanocortin [POMC and its derivative adrenocorticotropin 
(ACTH)], and thyrotropin (TSH), respectively—that exert major effects on growth, body 
composition, and metabolism.  Differences in the production and secretion of these 
hormones may be involved in the difference in adiposity that is manifested between the 
Lean and Fat lines of chickens.
DNA microarrays now allow the simultaneous analysis of expression levels of 
thousands of genes in a single assay (Duggan, Bittner et al. 1999), and  DNA microarrays 
have been used to identify differentially expressed genes involved in signaling pathways 
in the pituitary (Ma, Qi et al. 2005).  The Del-Mar 14K Chicken Integrated Systems 
Microarray (GEO accession no. GPL1731) contains 14053 unique cDNAs from multiple 
tissue specific cDNA libraries (Cogburn, Wang et al. 2003; Cogburn, Wang et al. 2004; 
Carre, Wang et al. 2006).  Of the cDNAs contained in the microarray, the neuroendocrine 
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cDNA library contributed 5929 of these cDNAs, and these neuroendocrine cDNAs have 
already been used in our laboratory to profile gene expression patterns during pituitary 
development by microarray analysis (Porter and Ellestad 2005; Ellestad, Carre et al. 
2006).   In recent years, there has been a dramatic increase in the available tools for 
chicken genomics, including the completion of the draft of the chicken genome (Hillier, 
Miller et al. 2004). The chicken genome is about 1 billion base pairs in sequence 
containing 20000-23000 genes. Most genetic markers are polymorphic sequences of 
DNA that have a known locus. Examples of markers are known genes (first generation 
Type I markers) and much shorter polymorphic segments like microsatellites or variable 
number tandem repeats (second generation Type II markers) (Emara and Kim 2003).  The 
most common genetic marker is the single nucleotide polymorphism (SNP) and they are 
considered the basis of third generation genetic maps (Wang, Fan et al. 1998).  It is 
estimated that the chicken genome contains 2.8 million SNPs (Wong, Liu et al. 2004).  
SNPs can be found anywhere in the genome, but SNPs that are located in the promoter 
regions of differentially expressed genes will be of particular interest due to the fact that 
they may alter transcriptional machinery binding sites. 
A combined functional genomic and bioinformatic approach was taken in the 
present study to analyze differential gene expression in the anterior pituitary between the 
LL and FL at 1-, 3-, 5-, and 7-weeks of age (the time frame during which adiposity 
becomes significantly different) and to identify polymorphisms such as SNPs in the 
flanking regions of differentially expressed genes that could be used as genetic markers 
for adiposity.  The objective of this research was to identify a genetic marker that could 




The Fat line and Lean line chickens were produced by inseminating hens with 
pooled semen from each line (eight pools; seven hens per semen pool).  Each hen’s eggs 
were marked and incubated; chicks were sexed, wing-banded, and vaccinated against 
Marek’s disease at hatch.  Males (87 Fat, and 102 Lean) were reared together in 4.4 x 3.9 
meter floor pens under a standard heat program.  The birds were fed ad libitum a mashed 
diet for the first few days, a pelleted starter diet for the first three weeks and then a 
growing diet up to week 11; water was freely available. Light cycles were 24 hours for 
the first two days and then 14 hours light/10 hours dark.
Pituitary glands from 8 birds in each line (1 bird per semen pool/ different hen) 
were extracted at weeks 1, 3, 5, and 7, snap-frozen in liquid nitrogen, and stored at -75°C.  
Birds were weighed and blood was drawn before sacrifice by cervical dislocation.  Fat 
pad was excised and weighed, and other tissues were collected (hypothalamus, breast 
muscle, liver, and abdominal fat) for use in other studies. 
The F0 generation used to produce the F2 intercross consisted of thirty animals: 
four males and thirteen females from the Lean line, and five males and eight females 
from the Fat line.  Fat males were bred to Lean females and vice versa to produce the F1
generation.  Five males and fifty females of the F1 generation animals were kept to 
produce the F2 generation.  Three of the F1 males had Fat sires and Lean dams; two had 
Lean sires and Fat dams.  Thirty of the F1 females were from Fat sires and Lean dams; 
twenty females were from Lean sires and Fat dams.  Six hundred thirty-seven F2 animals 
(332 females and 305 males) were able to provide biometric data. The F0 and the F2
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intercross generations were reared under the same conditions and sacrificed at 9 weeks of 
age.  Blood was drawn and body weight and abdominal fat pad weight were measured.
RNA extraction and amplification
Total RNA was extracted from individual chicken pituitaries using Qiagen 
RNeasy mini-prep kits according to the manufacturer’s protocols and quantified by 
absorbance at 260 nm.  RNA quality was assessed using the Agilent Bioanalyzer (Agilent 
Technologies, Palo Alto, CA) at the University of Maryland Microarray Core Facility and 
replacement samples were extracted if the RNA was of low quality.  A drawback of using 
the chicken pituitary as the tissue of interest for microarray analysis is its small size and 
therefore low content of RNA.  To ensure sufficient quantities of RNA for microarray 
analysis, a variation of the Eberwine procedure was used to generate amplified RNA 
(aRNA) (Van Gelder, von Zastrow et al. 1990; Luo, Salunga et al. 1999; Porter and 
Ellestad 2005).  A reverse transcriptase (Superscript II, Invitrogen, Carlsbad, CA) was 




Santa Clara, CA) to transcribe 0.5 µg of total RNA into first strand cDNA.  After 
RNaseH digestion, DNA polymerase I synthesized the second strand using the digested 
RNA as primers and the first strand as template; DNA ligase joined the second strand 
fragments together, and T4 polymerase polished any single stranded overhangs to form 
blunt-ended double-stranded cDNA.  The cDNA was then extracted with phenol-
chloroform in a phase-lock centrifuge tube (Eppendorf, Westbury, NY), washed in a 
Microcon-30 (Millipore, Billerica, MA) spin column, and dried down in a vacuum 
centrifuge.
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In vitro transcription of aRNA off of the cDNA was performed using Ambion’s 
(Austin, TX) T7 MEGAscript kit as per the manufacturer’s directions.  Amplified RNA 
was then phenol-chloroform extracted using a phase-lock centrifuge tube (Eppendorf) 
and purified by centrifugation through a Spin Column-30 (Sigma, St. Louis, MO).  The 
aRNA was then quantified by absorbance at 260 nm and with the RiboGreen RNA 
Quantification kit (Molecular Probes), and visualized by ethidium bromide staining after 
electrophoresis in an agarose-formaldehyde gel.  
Note:  The RNA amplification procedure has been previously validated in our 
laboratory.  Pooled total RNA and RNA amplified from that pool were hybridized in 
replicate to 5K Chicken Neuroendocrine System microarrays (GEO accession no. 1744), 
and the mean log2-transformed raw pixel intensities from each spot were found to be 
highly correlated (r2=0.96) between the total RNA and the aRNA (Ellestad and Porter 
2005).
Labeling and hybridization of microarrays
The labeling and hybridization of 1µg of target aRNA to the Del-Mar 14K 
Chicken Integrated Systems microarrays (GEO accession no. 1731) was performed by the 
Microarray Core Facility, Center for Biosystems Research at the University of Maryland, 
College Park.  Target aRNA (1µg) was reversed transcribed using random primers into 
cDNA containing a dTTP analog that has a reactive amino allyl group [5-(3-aminoallyl)-
dUTP] (Ambion).  After purification, cDNA was labeled with the ester form of the 
fluorophores Cy3 and Cy5 (Amersham, Piscataway, NJ), which link to the amino allyl 
group. 
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cDNA from each of the pituitaries was labeled with Cy3, and a pooled reference 
sample was labeled with Cy5.  The pooled reference sample was created from equal 
amounts of all of the aRNA samples from the experiment.  The labeling reactions were 
purified to remove unincorporated dye, hybridized to the microarrays overnight at 42 °C, 
and then washed with increasingly stringent sodium citrate saline solutions.  After 
washing, slides were scanned by the Facility’s 418 confocal laser (Affymetrix) at 550 nm 
for Cy3 and 650 nm for Cy5.  For each slide, a TIFF image file was generated for each 
fluorophore and saved.  
Analysis of microarrays
The Institute for Genomic Research (TIGR) makes available a suite of free 
software for the analysis of microarray data (Saeed, Sharov et al. 2003).  The TIFF files 
were loaded into Spotfinder (version 2.2.4), an image processing program, to visualize 
the overlaid hybridization scans and to quantify pixel intensities of the spots.  The 
software creates a grid that overlays each spot on the slide within a square cell.  The grid 
for the 14K slides consists of forty-eight 20x20-cell blocks arranged in 4 columns by 12 
rows; this grid arrangement matches the printing pattern of the spots.  For each 
hybridization, the Cy3 scan was loaded into channel A and the Cy5 scan into channel B. 
The slides were analyzed using the Otsu thresholding algorithm option with the spot size 
parameters set at a minimum of 3 and a maximum of 22.5.  The quality control filter was 
used and the flagged values and raw data were kept.  The data generated by Spotfinder 
analysis were saved as MEV files and exported into Microarray data Analysis System 
(MIDAS; version 2.18), TIGR’s data normalization software, using the data directory
mode.  This allowed normalization of all the data in a single processing step.  Parameters 
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that were applied were using flags and background checking for both channels; signal-to-
noise ratio threshold was set to 3.0.  These parameters rejected flagged spots that were 
saturated, not detected, malformed, or had a background greater than the spot intensity; 
the background checking parameter keeps only the spots whose intensities are 3 times the 
background for both channels.  Spots that failed to pass these criteria were excluded from 
downstream analysis.  Cy3 spot intensities were normalized by block with the LOWESS
algorithm using a smoothing parameter of 0.33, and normalization was followed by 
standard deviation regularization by block and then by slide using Cy 5 (pooled aRNA) 
as the reference channel. The output was saved as MEV files.
Statistical analysis
Two-way analysis of variance of the normalized data using Statistical Analysis 
System software version 8.02 (SAS Institute, Cary, NC) was used to identify 
differentially expressed spots and to trim spots that did not exhibit sufficient changes to 
be of proximate interest.  Only spots with at least 2 replicates for all ages in both lines 
were examined.  The log2 ratio of normalized Cy3: raw Cy5 was analyzed to detect 
significant differences (p<0.05) between lines, among ages, and interactions between 
lines and ages.  Spots that did not show any significant differences were excluded from 
further analysis. The next criterion for further analysis was that the fold-spread of the 
least squares means of a spot across all ages and lines must be ≥ 0.68 (log2 ratio).  The 
final trimming step excluded any spots that did not have intensities greater than the 8 
salmon sperm DNA control spots on each array for both Cy3 and Cy5.  Three hundred 
and eighty-six genes were kept for further analysis. 
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Cluster analysis
GeneCluster 2 software (http://www.broad.mit.edu/cancer/software/genecluster2/ 
gc2.html) was used to cluster and visualize genes with similar expression patterns by self-
organizing maps (SOMs) analysis.  SOMs use a clustering algorithm that imposes partial 
structure on a dataset while also reflecting some of the natural structure of the dataset by 
an iterative classification of data points into nodes, or clusters, which are easy to visually 
interpret (Tamayo, Slonim et al. 1999).  The fat and lean lines were analyzed separately. 
Genes were classified into 30 clusters with the geometry of the nodes being a 6x5 grid 
using the default parameters with the exception that the number of iterations was 
increased to 500,000.  To simplify confirmation of gene expression patterns by qRT-
PCR, 7 expression profiles were defined as follows: 1) gene expression always greater in 
the Fat line than Lean line, 2) gene expression always greater in the Lean line than Fat 
line, 3) early age gene expression (weeks 1 and 3) greater in Lean line than Fat line, 4) 
late age gene expression (weeks 5 and 7) greater in Lean line than Fat line, 5) early age 
gene expression greater in Fat line than Lean line, 6) late age gene expression greater in 
Fat line than Lean line, and 7) no difference in gene expression between the 2 lines.
Marker analysis
GeneCluster 2 software was also used to identify “marker” genes whose up or 
down regulation is most correlated with the Fat or Lean lines. Twenty-five markers per 
line were determined at 1-, 3-, and 5-weeks of age using both the signal to noise ratio 
[(µa-µb)/ (σa+σb)] and the t-test statistic [(µa-µb)/ √ (σa2+σb2)] as the distance metric (µ is 
the mean per class and σ is the standard deviation per class).  Genes with missing 
replicates were not included in the analysis.
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Verification of gene expression
Expression profiles of microarray gene expression were confirmed by 2-step 
quantitative reverse transcription PCR (qRT-PCR).  Before qRT-PCR, the gel picture of 
the PCR product that was spotted on the microarray was inspected to ascertain whether 
PCR amplification of the cDNA library clone produced a clean, single band.  Since a 
DNAse digestion was not performed on the RNA extracted from the pituitaries, genomic 
contamination in the qRT- PCR reaction was a concern.  To design PCR primers, the 
sequence of the EST clone that was printed on the microarray 
(http://www.chickest.udel.edu/Cogburn_CAP3_DB) was BLASTed against the chicken 
genome using ENSEMBL.  After confirming that the sequence was within an EST or 
mRNA, the entire expressed sequence was used to design primer pairs that spanned at 
least one intron.   The lack of a single sharp melting peak of the PCR product indicates 
probable genomic contamination (although it could be due to alternatively spliced 
cDNAs).  Two genes from each of the 7 expression profiles were verified by qRT-PCR.   
qRT-PCR for the 14 genes on each of the 32 total RNA samples and a no reverse 
transcriptase negative control reaction were performed in duplicate. The RNA for the no 
enzyme control was from the pooled reference total RNA sample. The first step of the 
qRT-PCR was performed as for the first step of the RNA amplification procedure above 
except that oligo-dT primer (5’-CGGAATTCTTTTTTTTTTTTTTTTTTTTV-3’, Sigma 
Genosys, Houston, TX) was used. The cDNA from these reactions, along with a water 
negative control, were quantified by real time-PCR using Qiagen’s Quantitect SYBR 
Green PCR kits.  This required 28 specific primer pairs that were designed using Primer 
Express software (version 2.0, Applied BioSystems).  The parameters for primer design 
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were a primer length of 18-30 nucleotides spaced 115-130 base pairs apart, a G/C content 
of 40-60%, and a melting temperature of 58-60 °C.  The primers were generally targeted 
to the 3’ end of the gene sequence due to the fact that dT-primed reverse transcription 
preferentially transcribes mRNA sequences localized in the 3' end.  The real-time 2-step 
PCR was done in an iCycler thermocycler (BioRad).  One microliter of cDNA was used 
as template, and primers were at a final concentration of 300nM. Thermocycler 
parameters were an initial enzyme activation incubation for 15 minutes at 95 °C, 40 
cycles of denaturation at 95 °C for 10 seconds then annealing and extension for 45 
seconds at 55 °C, and a final denaturation at 95 °C and extension step at 55 °C for one 
minute each. Primer sequences used are given in Table 1 in the appendix. 
Identification of markers for genes of interest
Twelve genes whose expression patterns were confirmed by qRT-PCR were 
chosen for further analysis.  The DNA sequences of the microarray clones for each of the 
12 genes were BLASTed against the chicken genome to determine genomic location 
using ENSEMBL.  ENSEMBL GeneSeqView was used to display SNPs in the genomic 
sequence within 5000 base pairs (bp) upstream of the first exon.  Primers were designed 
that would generate PCR products of about 1000 bp in length containing as many SNPs 
as possible.  Genomic DNA was phenol-chloroform extracted from ~100 µl of blood 
taken from F0 animals. Seventeen primer pairs were designed for the 12 genes.  The 
parameters for primer design were a primer length of 18-30 nucleotides spaced 500-1000
base pairs apart, a G/C content of 40-60%, and a melting temperature of 58-60 °C.  One 
microliter of genomic DNA (not quantified) was used as starting template, and primers 
were at a concentration of 200 nM in the reaction. Thermocycler parameters were initial 
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denaturation of 3 minutes at 95 °C; 35 cycles of denaturation at 95 °C for 1 minute, 
annealing at 55 °C for 1 minute, and then extension for 1 minute at 72 °C; and a final 
extension step at 72 °C for 7 minutes each.  PCR was used to amplify genomic DNA 
from 22 F0 animals (4 males and 7 females from each line).  Primer sequences used are 
given in Table 2 in the appendix.
Genomic sequencing
PCR products from the 17 reactions per 22 F0 animals were submitted in 96-well 
format to the High-Throughput Genomics Unit (HTGU), Department of Genome 
Sciences, University of Washington for sequencing using the forward primers.  The PCR 
reactions were subjected to clean-up using exonuclease/ shrimp alkaline phosphatase by 
HTGU and sequenced using Applied Biosystems’ (Foster City, CA) BigDye terminator 
v3.1 Cycle sequencing kit and a 3730xl DNA analyzer (Applied Biosystems).  SNPs 
were identified by assembling the sequences into contigs using the ContigExpress feature 
in the Vector NTI software package (Invitrogen).
Locked nucleic acid primer genotyping
Allele specific primers were designed with a locked nucleic acid nucleotide at the 
3’ end that was specific for a T/C SNP found 718 bp upstream of the first exon of 
lysophosphatidic acid receptor-1 at position 32846318 on the Z chromosome. The 
antisense primer sequence For the T SNP was TCTAAGATTTGAACTGGGAA, and the 
antisense primer sequence for the C SNP was TCTAAGATTTGAACTGGGAG; the 
sense primer sequence for both reactions was 
GGCAATGAAACACAACTGAGTGAAA.  PCR was performed using Promega 
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(Madison, WI) Green GoTaq master mix; 1µl of PCR product from genomic DNA 
diluted 1:100 was used as a template, and primers were at a final concentration of 
200nM. Thermocycler parameters were an initial denaturation step at 95 °C for 3 
minutes; 35 cycles (32 cycles for the C-specific primer) of denaturation at 95 °C for 40 
seconds, annealing at 52.5 °C (55 °C for the C-specific primer) for 20 seconds, and then 
extension for 40 seconds at 72 °C; and a final extension step at 72 °C for 7 minutes each.  
Genotype was determined by the presence or absence of SNP specific PCR amplicons 
after electrophoresis in an agarose gel.  Forty-eight of the leanest and fattest F2 animals of 
both sexes were genotyped (final n=189) and a generalized mixed model (PROC 
GLIMMIX, SAS) was used to test whether an association between genotype and the 
phenotypic tails of the population was present.
Results
Microarray analysis
Gene expression profiles in the anterior pituitary were characterized using cDNA 
microarrays representing greater than 14,000 genes.  Pituitaries were extracted from Fat 
and Lean birds at 1-, 3-, 5-, and 7- weeks of age and total RNA isolated and amplified.  
Four replicate samples for each strain and age were labeled and hybridized to the Del-
Mar 14K Chicken Integrated Systems microarrays (GEO accession no. GPL1731) for a 
total of 32 samples.  The raw data was first subjected to LOWESS normalization using 
MIDAS and then each slide was subjected to standard deviation regularization by block 
within slide and the across all slides.  Two-way ANOVA (SAS) of log2 ratios was used to 
detect significant (p<0.05) differences by line, age, and the line-by- age interaction.  There 
were 1150 significantly different genes between the 2 lines and 339 of these genes 
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exhibited greater than 0.68-fold differences in their log2 ratios (highest group mean at 
least 160% of the lowest group mean). One thousand four hundred twenty nine genes 
were significantly different by age and of these, 583 exhibited fold changes greater than 
0.68 in the log2 ratio.  There were 145 genes that significantly differed in their line-by-
age interaction, and 62 of these exhibited greater than 0.68-fold differences. Since it is 
known that gene expression changes with age, only the 386 genes with significant 
differences by line or for line-by-age interaction with at least a 0.68-fold change in log2
ratio and n ≥ 2 for each experimental group were kept for further analysis (Tables 3 and 
4).
At 1 week of age, mRNA levels of 59 genes were up-regulated in the Lean line 
(Table 5) and 58 genes were up-regulated in the Fat line (Table 6).  At 3 weeks of age, 41 
genes were up-regulated in the Lean line (Table 7) and 61 genes up-regulated in the Fat 
line (Table 8).  At 5 weeks of age, 60 genes were up-regulated in the Lean line (Table 9) 
and 64 genes up-regulated in the Fat line (Table 10).
Cluster analysis
GeneCluster 2 software was used to cluster and visualize genes with similar 
expression patterns by self-organizing maps (SOMs) analysis.  Genes were classified into 
30 clusters with the geometry of the nodes being a 6x5 grid.  The Lean and Fat lines were 
analyzed separately.  Three genes which represent different expression patterns between 
the Lean and Fat lines have been identified by microarray spot number (Figure 2).
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Redundancy was apparent in the clusters.  To simplify confirmation of gene 
expression patterns by qRT-PCR, 7 expression profiles were defined using genes that had 
differences in gene expression between the 2 lines as follows: 1) gene expression always 
greater in the Fat line than Lean line (Figure 3); 2) gene expression always greater in the 
Lean line than Fat line (Figure 4); 3) early age gene expression (weeks 1 and 3) greater in 
Lean line than Fat line (Figure 5); 4) late age gene expression (weeks 5 and 7) greater in 
Lean line than Fat line (Figure 6); 5) early age gene expression greater in Fat line than 
Lean line (Figure 7); 6) late age gene expression greater in Fat line than Lean line (Figure 
8); and 7) no difference in gene expression between the 2 lines (Figure 9).
Although GH, POMC, and TSH were not significantly different in the microarray 
analysis, qRT-PCR was performed for those genes (Figure 10).
Identification of marker genes
Genecluster 2 software was used to identify the 25 genes most correlated with 
each strain at 1-, 3- , and 5-weeks of age using both the signal-to-noise ratio and the t-test 
as the distance metric between the means of the genes in the 2 classes (Lean and Fat).  
Results are present in Tables 11-16.
A total of 12 genes were chosen as candidate genes (Table 17).  The 12 genes 
were either up-regulated (0.68-fold log2 ratios) or were identified in the marker analysis 
at weeks 1 and 3.  The sole exception was Ubiquinone biosynthesis monooxgenase 
COQ6 (GEO no. 44.3.14), which looked to be highly up-regulated in the Lean line as 
determined by qRT-PCR.  Gene expression levels for eight of the candidate genes were 
already verified by qRT-PCR (see figures above).  In addition to Ubiquinone biosynthesis 









overlapping transcript (GEO no. 15.3.6), and Clusterin (GEO no. 20.8.17) were chosen as 
candidates and expression profiles for these candidates were also verified by qRT-PCR 
(Figure 11).
Identification and genotyping of SNPs
 Genomic sequences of the candidate genes were located within the chicken 
genome using the online database ENSEMBL 
(http://www.ensembl.org/Gallus_gallus/index.html), which also shows the location of 
known SNPs (Figure 12).
Regions of up to a 1000 bp containing known SNPs located within 5000 bp 
upstream of the first exon of 12 genes whose expression patterns were verified by qRT-
PCR were chosen for sequencing to identify polymorphisms (e.g. SNPs).  Although 
regulatory elements may be located throughout a gene, the upstream region was chosen 
as a systematic approach to identifying polymorphisms.  The sole exception was Leptin 
receptor overlapping transcript, which was sequenced in the 3’ untranslated region of the 
mRNA that contained numerous SNPs.
Seventeen genomic regions of the 12 candidate genes were amplified by PCR 
performed on genomic DNA from the F0 generation (4 males and 7 females from each 
line), and the products were sequenced by the High-Throughput Genomics Unit (HTGU), 
Department of Genome Sciences, Univ. of Washington. The sequences that were 
obtained were assembled into contigs using Vector NTI software and examined for SNPs 





animals within a line to be considered for further analysis.  There were 11 SNPs in 5 
genes identified that met this criterion (Table 18).
Confirmation of sequencing results
LPAR-1 was chosen to be further investigated as a candidate marker due to the 
fact that it had a large difference in SNP frequency in the F0 generation between the two 
lines and it is involved with cell differentiation, including that of adipocytes (Pages, 
Girard et al. 2000).  The frequency of the T/C SNP was significantly different between 
the 2 lines (p≤0.001, Fisher’s Exact Test).  To confirm that the sequencing results were 
accurate, PCR using allele-specific locked nucleic acid (LNA) primers was performed.  
PCR primers with LNA at their 3’-ends are highly specific and can be used to 
discriminate between two SNPs (Johnson, Haupt et al. 2004).  Genotype was determined 
by the presence or absence of an allele-specific PCR band using the SNP-specific LNA 
primers (Figure 14).
The allele-specific PCR confirmed the results of the sequencing performed by 
HTGU.  The Genotypes of the 22 F0 birds are presented in Table 19.  The sequence 
chromatograms indicated that birds 472 and 712 were heterozygous for the T/C SNP, and 
this was confirmed by PCR.
Identification of potential transcription factor binding sites
The SNP-specific consensus sequences returned for the LPAR-1 were searched 
for vertebrate transcription factor binding sites using the TRANSFAC (version 1.3) 
website (http://mbs.cbrc.jp/research/db/TFSEARCH.html; default score threshold = 
85.0).  TRANSFAC is a searchable database that identifies cis-acting elements and their 
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trans-acting factors (Heinemeyer, Wingender et al. 1998). The T-SNP consensus 
sequence did not return any transcription factor binding sites in the location of the SNP; 
however the C-SNP introduced a putative GATA-1 binding site (score = 87.3) (Figure 
15).  When the search score threshold cutoff is lowered to 75.0, an additional putative 
GATA-2 binding site is introduced in the same sequence (score = 79.4) (data not shown).
Genotyping the F2 generation for the T/C SNP
The F0 Lean and Fat lines were intercrossed to produce a F2 generation, and 
abdominal fat percentage was measured at 9 weeks (n=637).  The F2 generation has a 
normal distribution of abdominal body fat percentage (data not shown).  The animals in 
the tails of the abdominal body percentage distribution (48 leanest males, 48 leanest 
females, 48 fattest males, and 48 fattest females) were genotyped by LNA PCR (Figure 
16; Table 20). Since the C-SNP introduces a putative GATA transcription factor binding 
site, animals were categorized into C-SNP positive (C/C and C/T) or negative (TT) 
genotypes (Table 21).  
A binomial generalized linear mixed model with a logit link function (PROC 
GLIMMIX; SAS) was used to test the association of genotypes with the tails of the 
distributions.  PROC GLIMMIX “fits statistical models to data with correlations or 
nonconstant variability and where the response is not necessarily normally distributed” 
(SAS Institute 2005).  There was a significant association between the C-SNP negative 





The goal of this research was to identify polymorphisms in the chicken genome 
that were associated with adiposity.  The Del-Mar 14K Chicken Integrated Systems 
microarrays were used to identify differentially expressed genes in the anterior pituitary 
gland of two lines of chickens that have been genetically selected for low and high 
adiposity.  Over a thousand genes were identified as being significantly different by 
microarray analysis and nearly four hundred of these exhibited large enough fold changes 
in expression that they were examined further. Since microarrays measure relative gene 
expression, a bioinformatics approach was taken to identify polymorphisms in regions 
upstream of the first exon (potential cis-regulatory sites) that might affect transcription of 
differentially expressed genes.  It is known that there are SNPs which are significantly 
different in frequency between the FL and LL (Fotouhi, Karatzas et al. 1993).  DNA 
sequences of differentially expressed genes were BLASTed against the chicken genome 
to determine their genomic location and to identify known SNPs within 5000 bp of their 
first exon.  Genomic DNA that contained putative SNPs upstream of twelve differentially 
expressed candidate genes was amplified by PCR and sequenced.   Eleven SNPs in five 
genes were identified as potential candidate markers.  The frequency of a SNP in the 
LPAR-1 upstream region was significantly different between the LL and FL, and this 
SNP introduced a potential GATA transcription factor binding site.  The phenotypic tails 
of a F2 generation created by intercrossing the LL and FL lines were genotyped for the 
SNP, and a significant association was found between the genotype and phenotypic tails.
The first objective of this project was to identify genes that were differentially 
expressed between the Lean and Fat lines.  Gene expression profiles were obtained by 
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analyzing levels of mRNA in the pituitary gland over a time course during which 
adiposity becomes significantly different between the two lines.  The difference in 
adiposity appears by 4 weeks of age (Leclercq, Blum et al. 1980), so pituitaries were 
collected on ages before, during, and after this divergence in adiposity in order to identify 
differentially expressed genes that may be involved in the development of body 
composition.  After gene expression levels were quantified, ANOVA was used to identify 
genes which had significant differences in expression.  Over a thousand genes were 
significantly different by line, and more than three hundred were different in their line-
by-age interaction (many genes were significant by both line and line-by- age interaction.  
Almost fifteen hundred genes were significantly different by age, but since our primary 
goal was to identify differences between the lines, we did not explore these further.  
ANOVA uses the variances about means to determine significant differences. Two means 
might be very similar in magnitude, but if the variance about the mean is small enough, 
the means can be statistical different; conversely, two means may be quite different in 
magnitude but not be significant if their variances are large.  To narrow down the list of 
genes to be investigated further, genes that did not exhibit greater than 0.68-fold 
differences in their mean log2 ratios were filtered out.  This cut-off value was chosen so 
that there were not an overwhelming number of genes to analyze, but not to be so 
stringent that potentially important genes were lost.   Each gene also had to have at least 
two replicates per age as to limit the influence of any outliers.  Three hundred eighty six 
genes fulfilled these prerequisites for further analysis.
Next, genes were classified according to whether they were up or down regulated 
in a line at 1-, 3-, and 5-weeks of age.  Week seven was not examined because the 
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difference in adiposity has already occurred by that time.  Disappointingly, none of the 
expression levels of the three major pituitary hormones—GH, POMC, and TSH—
involved in body composition was significantly different between the LL and FL in the 
microarray analysis. 
All 386 genes were organized in 30 clusters of expression patterns in a 6x5 
configuration using SOMs analysis.  The 6x5 configuration was chosen (after evaluation 
of all geometric node configurations of 12 to 36 clusters) to minimize within cluster 
variation and between cluster redundancy.   However, redundancy was still apparent 
among the clusters, so instead 7 simpler expression profiles were chosen to verify 
microarray results.  Six profiles with different patterns were chosen, along with a seventh 
profile that exhibited no difference between lines.  Genes were classified into the seven 
profiles based on their microarray expression patterns.  To verify expressions patterns of 
genes within these profiles, qRT-PCR was performed and relative gene expression was 
quantified and compared to the microarray results.  Following the primer design 
procedures used in the present study resulted in single melt curves in at least 85% of the 
qRT-PCR performed, indicating a single PCR product.  Approximately 70% of the 
microarray expression profiles were verified by qRT-PCR.
The GeneCluster2 software allowed for the identification of markers for the LL 
and FL.  The marker identification program has been used to classify cancer types using 
gene expression levels as determined by microarray (Golub, Slonim et al. 1999).  The 
same approach was used to classify genes as markers of the FL or LL.   A problematic 
drawback of this approach was the fact that replicates with missing values were not able 
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to be analyzed by the software.  Still, it was useful to identify which of the genes that had 
full replicates were potential markers for each line.  
In order to expedite the verification of the 7 different microarray expression 
patterns and verification of candidate gene profiles, genes were chosen that were 
differentially expressed or were identified as markers and that also fit into one of the six 
changing profiles.  This allowed the process of verifying general microarray expression 
profiles and confirming expression patterns of candidate genes to be consolidated into 
one step.  Eight candidate marker genes were also used to verify microarray expression 
profiles.  With the goal of examining 12 genes as candidates, three more genes were 
chosen that were either differentially expressed or identified as markers.  GEO no. 32.2.5 
and GEO no. 5.17.9 are both aldo-keto reductase ESTs that were assembled into the same 
contig by the CAP3 program.  As an internal control for the microarray, the expression 
profiles of aldo-keto reductase [GEO no. 32.2.5; Figure 4 and GEO no. 5.17.9; Figure 11] 
were confirmed by qRT-PCR using different primer pairs.  The one gene that was not 
differentially expressed or a marker was putative ubiquinone biosynthesis monooxgenase 
COQ6 (GEO no. 44.3.14).  This gene was chosen as a candidate based on its qRT-PCR 
profile, which indicated it was highly expressed in the LL compared to FL.  It turns out 
that the DNA printed in the spot is not COQ6 (the clone was amplified from the library 
and sequenced).  The primers were designed for COQ6 and so, although the microarray 
profile was not verified, this appeared to be an interesting gene.
The 12 candidate genes are listed in Table 16, and their functions are briefly 
summarized below.  Immunoglobulin (Ig) J polypeptide (GEO no. 3.1.3; microarray 43; 
Accession no. BAA83785) encodes the peptide that links polymeric IgG molecules 
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together (Takahashi, Iwase et al. 2000).  Aldo-keto reductase (GEO no. 5.17.9; 
microarray no. 2889; Accession no. CAC40811) is an enzyme that functions to oxidize 
alcohols and reduce retinoids (Crosas, Cederlund et al. 2001).  This is a potentially 
interesting gene because Crosas et al. speculate that the enzyme functions as a metabolic 
barrier to alcohols and aldehydes present in foodstuffs.  Extracellular superoxide 
dismutase 3 (SOD3) (GEO no. 12.2.1; microarray no. 3341; Accession no. NP_003093) 
is a secreted enzyme that eliminates oxygen radicals in the plasma.  SOD3 has been 
shown to provide protection from oxidative stress in birds (Altan, Pabuccuoglu et al. 
2003).  Regulator of G-protein signaling 5 (GEO no. 16.1.20; microarray no. 4880; 
O15539) is a member of a family of proteins that modulate G protein-coupled receptor 
signaling by increasing the rate of GTP hydrolysis (Zhong and Neubig 2001).  This 
protein is interesting considering that most of the hypothalamic trophic factors bind to G 
protein-coupled receptors in the pituitary.  Lysophosphatidic acid receptor-1 (GEO no. 
14.3.9; microarray no. 4989; NP_446388) is an especially promising candidate gene 
given that signaling through the receptor inhibits adipocyte differentiation (Pages, 
Daviaud et al. 2001; Simon, Daviaud et al. 2005).  Leptin receptor overlapping transcript 
(GEO no. 15.3.6; microarray no. 5006; Accession no. AAF63411) is an alternate 
transcript of the leptin promoter that encodes for a protein structurally unrelated to the 
leptin  receptor isoforms (Bailleul, Akerblom et al. 1997).  Leptin is an important 
regulator of energy homeostasis; leptin deficient ob/ob mice and leptin receptor deficient 
db/db rats exhibit hyperphagia, decreased energy expenditure, insulin resistance, and 
obesity (Jazet, Pijl et al. 2003).  It is possible that leptin receptor expression, and 
therefore response to leptin, is regulated by transcription of the alternate transcript.  
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Clusterin (GEO no. 20.8.17; microarray no. 7037; Accession no. AAD17257) is also 
know as apolipoprotein J, and as a apolipoprotein it is involved in lipid transport in the 
plasma and it is a marker for HDL (de Silva, Stuart et al. 1990).  A gene that expresses a 
protein involved in lipid transport is interesting, since the triglycerides in the adipose 
tissue in chickens are synthesized in the liver and transported in the plasma.  Early 
activation antigen CD69 (GEO no. 18.10.7; microarray 7147; gene 17.5; Accession no. 
M88072) is a transmembrane protein belonging to the major histocompatability (MHC) 
family (Bernot, Zoorob et al. 1994).  Syndecan-1 (GEO no. 24.11.6; microarray 8866; 
Accession no. AAA60605) and glypican-3 (GEO no. 28.6.10; microarray 10070; 
Accession no. 004475) are both heparan sulfate proteoglycans that are  involved in 
lipoprotein clearance and metabolism (Kolset and Salmivirta 1999).  Again, genes that 
encode proteins that are involved in the transport and uptake of triglycerides would be of 
interest in adipocyte hypertrophy.  Blood plamsa glutamate carboxypeptidase (GEO no. 
41.3.17; microarray no. 16177; Accession no. AAD31418) is a circulating enzyme that 
may be involved in the hydrolysis of circulating peptides (Gingras, Richard et al. 1999).  
Similar to Putative ubiquinone biosynthesis monooxgenase COQ6 (GEO no. 44.3.14; 
microarray no. 16234; Accession no. XP_126972) is a peripheral membrane protein 
associated with the matrix of the mitochondria that is involved in the biosynthesis of 
coenzyme Q in yeast (Gin, Hsu et al. 2003).   COQ6 is potentially interesting as a 
candidate gene due to its role in aerobic respiration.
Seventeen genomic regions of the 12 genes were sequenced; sixteen regions were 
upstream of the first exon, with 2 upstream regions for aldo-keto reductase, LPAR-1, 
COQ6, SOD 3, and syndecan-1 sequenced.  Leptin receptor gene related-protein was 
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sequenced in the 3’ untranslated region as that contained numerous SNPs that may affect 
mRNA stability.  Not all of the sequencing was successful, but the contigs that were 
assembled demonstrated 11 SNPs in 5 genes showing promising differences in SNP 
frequencies between the lines: SOD3, LPAR-1, aldo-keto reductase, glypican, and 
syndecan (Table 17).  Glypican and syndecan are interesting because they are involved in 
lipoprotein transport.  Aldo-keto reductase may be involved in regulating the expression 
of GH, TSH, and ACTH in the pituitary (Angioni, Lania et al. 2005).  SOD3 and LPAR-1 
contained SNPs upstream that were highly significant in association between the lines (p 
< 0.001).  SOD3 (genomic location: chromosome 4; 73,901,427-73,902,577) is an 
especially interesting candidate because it is located within a known Quantitative Trait 
Loci (QTL) for abdominal body fat on chromosome 4 (flanking markers MCW240-
LEI073, position 201-243 cM, genomic location 68517805-80227860) (Lagarrigue, Pitel 
et al. 2006).   However, LPAR-1 was chosen for further investigation due to the fact that 
it is directly involved in regulating adipocyte differentiation (Pages, Daviaud et al. 2001; 
Simon, Daviaud et al. 2005).  LPA is a phospholipid found in the serum and is produced 
by the hydrolysis of cell surface phosphatidic acid by phospholipase A2 or 
lysophosphatidylcholine by autotaxin/lysophospholipase D (Guo, Kasbohm et al. 2006).  
Many biological effects are mediated by LPA through multiple G-protein coupled 
receptor pathways which include stimulation of PLC, inhibition of adenyly cyclase, and 
Ras-MAPK (Moolenaar, van Meeteren et al. 2004).  For example, LPA reduces 
triglyceride uptake and expression of lipogenesis genes in preadipocytes; removal of LPA 
from culture medium induces preadipocytes to differentiate.  LPAR-1 knockout mice 
become significantly fatter than wild-type mice but without any difference in food 
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intake—a similar situation to what is seen in the FL and LL.  LPAR-1 is close to, but not 
included within a known QTL for abdominal fat on chromosome Z (flanking markers 
LEI0111-LEI0075, position 127 cM, genomic location 22950349-31399653) (Ikeobi, 
Woolliams et al. 2002). The C-SNP at genomic position 32846269 on chromosome Z 
introduces a GATA transcription factor binding site.  The highest TRANSFAC score was 
for GATA-1 (87.3), an overlapping GATA-2 site was identified when the threshold score 
was lowered (79.4), and there is also an adjacent GATA-3 site (77.8).  GATA 
transcription factors are involved in cellular differentiation.  GATA-1 is best known for 
its role in erythropoiesis (Leonard, Lim et al. 1993).  GATA transcription factors are 
know regulators of adipocyte differentiation (Tong, Dalgin et al. 2000).  Defective 
GATA-2 and GATA-3 expression is associated with obesity.  GATA-2 and GATA-3 
expression inhibits preadipocyte terminal differentiation through suppression of 
peroxisome proliferator-activated receptor γ (PPARγ).  PPARγ is a member of the 
nuclear receptor superfamily and plays an important role in adipogenesis and lipogenesis, 
upregulating genes involved in fat uptake and lipogenesis (Kersten 2002).  The fattest and 
leanest animals were genotyped by allele-specific PCR for the T/C SNP in the upstream 
region of the LPAR-1, and a significant (p <0.05) association was found between the 
GATA negative genotype (TT) and the fattest animals.  
It has not been shown that the LPAR-1 is regulated by GATA transcription 
factors, but it is tempting to speculate that it might be.  GATA-2 and GATA-3 transcripts 
are expressed in the mouse pituitary and presumably in the chicken also (Charles, 
Saunders et al. 2006).  Although the LPAR-1 SNP was found in an analysis of pituitary 
gene expression, the same SNP may regulate differential expression in adipocytes or 
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hepatocytes.  It is unknown at the present time whether this is true.  A GATA 
transcription factor binding site might upregulate the expression of LPAR-1, and 
increased signaling through the receptor may inhibit the maturation of preadipocytes into 
adipocytes.
An analysis of the differentially expressed genes by Gene Ontology annotation 
[BioRag (Bioresource for array genes) at www.biorag.org] indicated that the two largest 
categories of biological functions were signal transduction and DNA-dependent 
regulation of transcription.  This is not surprising considering the pituitary’s central role 
in integrating the hypothalamus and the target tissue axes.  The pituitary must respond to 
hypothalamic trophic factors and then regulate the production and release its own 
hormones.  Although there were no significant differences between the lines in 
expression of GH, TSHβ, and POMC message, this does not mean these hormones do not 
play a role in the differences in adiposity between the lines.  On a physiological level, 
quantities of message produced are not necessarily indicative of amount of protein.   For 
example, in the bacterium Desulfovibrio vulgaris mRNA abundance accounts for less 
than 30% of the variation in protein abundance (Nie, Wu et al. 2006).  There are many 
processes that affect the amount of hormone that would actually be secreted into systemic 
circulation.  Even after secretion into the blood, the availability and uptake of hormones 
are affected by binding proteins and metabolism and/or clearance by the liver or kidneys.  
GH levels in the blood are hard to interpet due to its pulsatile secretion.   There is no 
direct assay for chicken TSHβ because there is no homologous antibody.   Chicken 
ACTH is measureable, but it has not been measured in the FL and LL.  Thus, a lack of 
significant differences in expression levels of GH, TSHβ, and POMC does not mean that 
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there are no differences with regard to the physiological effects of these hormones in the 
FL and LL.  The genes on the Del-Mar 14K Integrated Systems microarrays represent 
about half the genes in the chicken genome.  It is possible that there are non-represented 
genes differentially expressed in the pituitary that play roles in regulating adiposity.
Quantitative traits, such as adiposity, are caused by an unknown number of 
known and unknown genes exerting known and unknown effects.  It is possible that the 
SNP that introduces the GATA factor binding site upstream of the LPAR-1 gene may 
increase its expression, which in turn makes the preadipocyte more resistant to 
differentiation; conversely, loss of the binding site may make preadipocytes more 
susceptible to differentiation.  This difference in differentiation disposition may be one 
factor regulating body composition in chickens.  LPAR-1 therefore may be useful as one 
marker to be used in marker-assisted selection against adiposity.
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Chapter 4: Future directions
The approach taken was successful in identifying a polymorphism upstream of the 
first exon of the LPAR-1 gene that was significantly associated with adiposity.   The 
entire F2 generation of chickens should be genotyped for the T/C SNP by allele-specific 
PCR.  Knowing the genotypes of all the animals would allow for more powerful 
statistical tests for associations between phenotype and genotype. 
The higher levels of LPAR-1 mRNA in the pituitary do not necessarily mean a 
higher numbers of cell surface receptors.  Since the pituitary is an endocrine gland that 
secretes hormones, the physiological effects of LPA treatment on hormonal gene 
expression, production, and secretion could be investigated by qRT-PCR, 
immunocytochemistry, and radioimmunoassay, respectively, in each chicken line.  
Chicken pituitaries could be cultured with differing doses of LPA to determine what 
effects it has on global gene expression using microarrays.  LPA could also be injected in 
ovo and its effects investigated.
To investigate the function of LPAR-1 in vivo, tissue-specific LPAR-1 Floxed 
mice could be created.  The LPAR-1 gene could be flanked by LoxP sites using 
homologous recombination.  CRE expression could be placed under control of tissue-
specific promoters.  To investigate LPA-1 conditional knockout in the pituitary, CRE 
could be expressed behind the α-glycoprotein subunit.  In muscle or liver, CRE could be 
expressed behind creatine kinase promoter or albumin promoter, respectively.  There are 
a substantial number of tissue and developmental stage CRE mice available; a searchable 
online database is available (CreXMice; 
http://nagy.mshri.on.ca/PubLinks/indexmain.php#).  Once the LPAR-1 gene or any other 
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gene of interest is Floxed, it can be conditionally knocked out in a variety of tissues and 
developmental stages by crossing with the CRE mouse strain of interest.
The T/C SNP introduced a high scoring GATA-1 binding site according to the 
TRANSFAC analysis, but the same site also binds to GATA-2 in silico, which is 
expressed in the pituitary.  On a molecular level, does GATA-2 bind to the upstream 
transcription factor site?  Chromatin immunoprecipitation assays could be performed, and 
if there is no antibody against chicken GATA-2, one could be produced.  This would test 
whether GATA-2 binds to that region of the genomic DNA.  If GATA-2 does bind, its 
effects on transcription could be investigated by cloning the upstream region into a 
luciferase expression vector and treating transfected cells with LPA.  LPAR agonists and 
antagonists exist, and their effects could be tested on pituitary cell function in vitro or in 
vivo (Gududuru, Zeng et al. 2006).  Consequently, these types of experiments could be 
performed for other candidate genes that are later identified.
The upstream region of superoxide dismutase contains three SNPs that have 
different frequencies between the FL and LL, one of which is highly significant (p<0.001, 
Fisher’s Exact Test).  SOD3 is especially interesting since it is located in a known QTL 
for abdominal body fat.  Allele-specific PCR should be performed to confirm the F0
genotyping for all three SNPs, and then the tails of the F2 generation should be 
genotyped.  If there are significant associations between the genotypes and the tails, the 
entire generation should be genotyped.  This genotyping also can be done for the other 
genes that have upstream SNPs that differ significantly between the two lines.
Since these chicken genes have mammalian orthologs, the same genes in mouse, 
rat, and human can be investigated to see if there are similar SNPs in the upstream 
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regions.  Approximately 1700 bp upstream of the human LPAR-1 first exon is a known 
SNP that introduces a GATA-3 binding site.  The upstream regions of the other genes can 
be examined similarly for SNPs that introduce or remove transcription factor binding 
sites.  Other potential regulatory regions can also be examined.  Are there variations 
present in the 3’ untranslated regions of the mRNAs that might affect message stability?  
Since microarrays reflect steady state mRNA levels, the levels of actual proteins for 
genes identified can be examined.  This may provide a more accurate picture of the 
physiological processes that are actually occurring in the cell.
The LPAR-1 marker could be used for animal selection in commercial breeding 
programs.  But complex traits such as adiposity are influenced by many genes.  Making 
the dissection of the genetic architecture of a complex trait like adiposity difficult is the 
fact that genes do not exert their effects in isolation.  Genes interact with other genes in 
complex networks.  Multiple loci that affect a trait can have different effects on that trait 
depending on epistatic interactions of combinations of alleles at those loci (Carlborg, 
Jacobsson et al. 2006).  Not only do alleles that could be markers for adiposity need to be 
identified, their relationships with the genetic architecture need to be elucidated in order 
to more fully understand the regulation of a complex trait like adiposity.  As more genes 
that affect adiposity, and their relationships with other alleles that are involved in 
adiposity, are identified, the further marker-assisted selection is advanced.  A panel of 
genes known to be involved in regulating adiposity could be developed for easy assay.  
PCR could be used to genotype potential breeders for a number of genes that are markers 
for adiposity and be selected against in breeding stocks.
67
The identification of novel markers for adiposity will provide a means to 
genetically select and produce leaner chickens, which is beneficial to both to the producer 
and to the consumer.  In addition, genetic markers for adiposity in the chicken may lead 
to new insight into human obesity.
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Appendix
Table1. Primer sequences for qRT-PCR (GEO platform GPL1731 no., gene name, 
forward sequence, reverse sequence).
GEO 
no.













































































































Table 2. Primer sequences for the amplification of F0 genomic DNA. (GEO 
platform GPL1731 no., gene name, forward sequence, reverse sequence).







































































































Table 3. Differences of metabolism between FL and LL chickens. 0, no difference; +, fat 
superior to lean; -, fat inferior to lean. (Leclercq 1988).
Energy metabolism Diff
Basal metabolic rate 0
Maintenance requirement 0
Efficiency of fat and protein gain 0
Body temperature 0
Energy gain as lipids/energy gain +
Carbohydrate metabolism
Plasma glucose (fed or starved state) -
Glucose tolerance test 0+
Liver glycogen 0
Lipid metabolism
De novo lipogenesis (liver) +
Plasma free fatty acids (fed or starved) 0+
Plasma VLDL (starved or fed states) +
Plasma triglyceride (fed state) +
Plasma HDL +
Plasma phospholipid +
LPL per abdominal pad (AF) +
LPL per adipocytes (AF) 0
Volume per adipocytes (AF) +
Number of adipocytes (AF) +
Protein metabolism
Protein gain/protein ingested -
Plasma free amino acids -
Plasma uric acid 0+
Uric acid excretion +
Hormonal profile
Insulin (fed state) 0+
Insulin (glucose tolerance test) +




Corticosterone (fed or fasted) 0
GH 0+
Glucagon 0
Sensitivity to exogenous corticosterone 0
Sensitivity to exogenous insulin 0+
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Table 4. Composition of Del-Mar 14K Chicken Integrated Systems Microarray.  Spot 
category represents category; No. of spots is the number of spots in that category.










Salmon sperm DNA 8






Sodium pump 3 8
β-actin 8
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Table 5. Log2 ratios of 386 significantly different genes with greater than 0.68-fold 
differences in log2 ratios between the highest and lowest mean.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number; GEO no. is the GEO 
accession no. GPL1731 ID; Lean 1 through Fat 7 are the normalized log2 ratios for each 
line at 1-, 3-, 5-, and 7-weeks of age.
Spot
GEO 
no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
35 2.1.15 -1.470 -0.502 -1.002 -0.524 -1.019 0.421 0.039 0.011
43 3.1.3 -1.083 -0.475 -0.755 -0.588 -0.970 0.352 0.113 -0.037
159 4.2.19 -0.021 -0.180 -0.307 -0.286 0.323 0.459 0.688 0.196
224 4.3.4 0.003 0.084 -0.300 0.273 -0.172 0.153 0.394 0.036
238 4.3.18 0.892 0.412 0.555 0.430 0.139 -0.130 0.098 0.240
264 2.4.4 -0.099 0.294 0.431 0.200 -0.934 -0.048 -0.187 -0.350
284 3.4.4 -0.340 -0.039 0.374 0.082 -0.722 -0.495 -0.033 -0.059
292 3.4.12 0.856 0.031 -0.098 0.026 -0.046 -0.142 0.085 -0.328
310 4.4.10 -0.193 -0.139 0.202 0.000 -0.592 -0.350 -0.124 -0.068
321 1.5.1 0.942 0.664 0.284 -0.048 0.360 0.371 -0.197 0.021
333 1.5.13 -0.932 -0.414 -0.193 -0.407 -0.449 0.802 0.876 0.282
343 2.5.3 0.906 1.117 1.294 0.673 0.624 0.881 0.577 0.487
408 1.6.8 -0.300 0.325 0.005 -0.776 -0.995 -0.176 -0.362 -0.756
413 1.6.13 0.769 0.439 1.353 0.869 -0.391 -0.226 0.190 0.286
422 2.6.2 0.689 0.029 0.951 0.041 0.478 0.263 -0.221 0.020
455 3.6.15 -0.042 0.348 0.533 0.038 -0.596 -0.949 -0.197 -0.695
501 2.7.1 0.581 0.526 0.394 -0.143 0.231 0.167 0.020 -0.366
608 3.8.8 0.485 0.458 0.922 0.571 0.276 0.427 0.088 0.134
650 1.9.10 -0.301 0.224 0.268 0.310 0.205 0.357 0.316 0.682
689 3.9.9 0.571 0.558 -0.165 -0.247 0.680 1.458 0.658 0.704
701 4.9.1 0.875 1.422 1.355 1.574 0.448 0.382 0.251 0.425
730 1.10.10 0.492 0.701 1.190 0.382 -1.444 -0.345 -0.486 -0.144
744 2.10.4 -0.260 -0.427 -0.211 -0.310 0.165 0.321 -0.247 -0.213
746 2.10.6 -0.608 -0.384 -0.174 0.145 0.033 0.254 0.325 -0.064
771 3.10.11 -0.810 -0.992 -0.387 -0.212 0.201 0.021 -0.234 -0.154
887 1.12.7 0.468 0.651 0.597 0.591 0.510 1.090 0.621 -0.056
1017 3.13.17 0.717 1.342 0.969 0.949 1.473 0.404 1.681 0.524
1018 3.13.18 0.642 0.880 0.441 0.890 -0.303 0.628 0.178 0.161
1037 4.13.17 0.382 0.871 0.487 0.481 0.175 0.354 0.302 0.394
1089 3.14.9 -0.360 0.294 0.301 0.069 -0.102 0.178 0.595 0.690
1123 1.15.3 0.677 0.633 0.324 0.207 0.459 0.240 0.090 -0.063
1185 4.15.5 0.600 0.879 0.872 0.253 -0.104 -0.149 -0.087 0.168
1187 4.15.7 0.956 0.467 0.456 0.482 0.625 0.316 0.168 0.012
1319 2.17.19 -0.945 -0.376 -0.473 -0.172 -0.554 0.392 0.227 0.225
1337 3.17.17 -0.974 -1.337 -0.795 -0.388 -0.448 -0.376 -0.192 -0.336
1507 4.19.7 -0.650 -0.536 -0.562 -0.543 0.236 -0.264 -0.307 -0.250
1602 5.1.2 -0.371 0.007 -0.281 -0.665 -0.998 -0.369 -0.421 -0.855
1639 6.1.19 -0.280 0.321 -0.062 -0.844 -0.978 -0.183 -0.412 -1.027




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
1652 7.1.12 0.059 0.707 0.697 0.342 -0.673 -0.263 -0.114 0.171
1666 8.1.6 1.197 1.033 1.066 0.611 0.399 0.537 0.211 0.158
1687 5.2.7 0.379 0.390 -0.340 0.824 0.940 1.165 0.824 0.535
1696 5.2.16 0.296 0.444 0.448 0.237 -0.588 -0.595 -0.094 -0.324
1712 6.2.12 -0.213 -0.285 -0.494 -0.300 -0.155 0.226 -0.041 -0.236
1757 8.2.17 -0.181 0.165 -0.020 -0.252 -0.559 -0.245 -0.188 -0.406
1764 5.3.4 0.028 0.288 0.004 -0.776 -0.985 -0.297 -0.444 -0.920
1806 7.3.6 -0.201 0.436 0.004 -0.901 -1.198 -0.213 -0.468 -0.969
1832 8.3.12 0.935 0.715 1.719 0.322 0.144 0.272 -0.157 0.451
1846 5.4.6 0.107 0.259 0.382 0.615 0.107 0.073 -0.126 0.280
1900 7.4.20 0.215 0.001 0.562 0.080 0.025 -0.052 -0.098 0.848
1977 7.5.17 0.330 0.668 0.565 0.108 0.091 0.422 0.249 -0.115
2035 6.6.15 -0.159 0.071 -0.159 -0.884 -1.316 -0.339 -0.290 -1.181
2054 7.6.14 0.988 0.278 -0.044 0.357 0.580 -0.006 -0.260 -0.391
2101 6.7.1 0.528 0.224 0.223 -0.460 -0.214 -0.125 -0.058 -0.982
2141 8.7.1 0.429 0.401 1.417 -0.032 -0.386 -0.033 -0.286 0.568
2145 8.7.5 -0.322 -0.130 -0.359 0.173 0.189 0.162 0.964 -0.161
2296 7.9.16 0.566 0.246 0.868 0.136 0.201 0.383 0.220 0.216
2350 6.10.10 1.795 0.750 1.739 -0.320 0.553 0.943 -0.224 -0.033
2368 7.10.8 -0.337 -0.432 -0.863 -0.522 -0.297 -0.282 -0.041 -0.285
2413 5.11.13 0.573 0.904 0.865 0.864 2.020 0.381 0.840 0.843
2533 7.12.13 0.089 0.267 0.485 0.007 0.226 0.087 -0.830 0.205
2567 5.13.7 0.388 0.751 0.420 2.305 1.752 3.500 1.595 0.762
2569 5.13.9 0.392 0.783 0.826 0.798 0.823 1.274 1.077 0.858
2600 6.13.20 -0.479 -0.249 -0.125 0.036 0.251 0.220 -0.039 0.315
2621 8.13.1 0.205 0.346 0.242 0.409 0.807 -0.045 0.137 0.169
2694 7.14.14 -0.560 -0.515 -0.435 -0.010 -0.187 -0.233 0.039 0.157
2706 8.14.6 1.386 0.314 1.085 -0.264 -1.220 -0.975 -0.798 -0.685
2745 6.15.5 1.053 0.324 0.574 0.154 0.185 -0.022 -0.007 -0.251
2815 5.16.15 0.328 0.267 0.038 0.354 0.086 -0.310 -0.138 -0.365
2851 7.16.11 0.474 0.521 0.971 0.646 0.386 -0.175 0.234 0.122
2854 7.16.14 -0.040 0.236 2.191 0.629 -0.513 -0.973 0.111 -0.253
2858 7.16.18 -0.502 -0.439 -0.216 0.572 -0.502 0.068 0.455 0.692
2889 5.17.9 0.568 0.671 0.466 0.024 -0.221 -0.314 0.075 -0.105
2968 5.18.8 1.108 1.238 2.038 0.543 -0.504 -0.612 0.005 -0.325
3033 8.18.13 0.623 0.892 3.684 0.641 1.509 3.610 1.115 0.614
3221 10.1.1 -3.625 -1.127 -0.637 -0.831 -1.963 1.114 0.369 0.204
3236 10.1.16 0.217 0.144 -0.201 0.091 -0.087 -0.520 -0.316 -0.679
3241 11.1.1 -1.285 -0.758 -0.798 -0.182 -0.174 -0.322 -0.147 -0.093
3242 11.1.2 -0.281 0.338 -0.078 -0.900 -1.032 -0.253 -0.360 -1.066
3260 11.1.20 -0.061 -0.170 -0.274 0.204 -0.337 -0.512 -0.301 -0.322
3270 12.1.10 0.521 0.404 0.219 0.185 0.095 -0.191 0.117 -0.186
3274 12.1.14 0.225 0.177 -0.127 0.149 -0.008 -0.408 -0.344 -0.581
3280 12.1.20 -0.268 0.300 -0.112 -0.881 -0.885 -0.234 -0.414 -0.907
3284 9.2.4 -0.147 0.127 -0.149 -0.599 -0.665 -0.193 -0.353 -0.764
3291 9.2.11 -0.156 0.329 0.081 -0.774 -0.778 -0.105 -0.323 -0.772
3293 9.2.13 -0.133 0.297 0.082 -0.640 -0.609 -0.128 -0.265 -0.658
3341 12.2.1 0.413 0.281 -0.012 -0.179 1.079 0.777 0.738 -0.148
3399 10.3.19 0.327 0.210 -0.216 0.413 0.026 -0.342 -0.381 -0.775
3404 11.3.4 -0.215 0.464 -0.019 -0.930 -1.033 -0.206 -0.403 -1.105
3413 11.3.13 -0.146 0.004 -0.001 0.429 -0.254 -0.263 -0.091 -0.064




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
3441 9.4.1 -0.644 -0.938 -1.092 -0.349 -0.259 -0.528 -0.301 -0.584
3451 9.4.11 -0.430 0.022 -0.157 0.037 -0.163 0.196 0.163 0.432
3549 10.5.9 0.615 0.682 0.923 0.477 -0.220 0.204 0.011 0.166
3550 10.5.10 1.389 -0.137 0.922 1.072 0.719 0.213 -0.177 0.070
3623 10.6.3 0.633 0.610 0.462 0.178 0.312 0.241 0.101 -0.093
3642 11.6.2 0.268 0.210 -0.113 0.163 0.034 -0.280 -0.078 -0.451
3645 11.6.5 -0.643 -0.732 -0.064 0.207 -2.594 -1.249 0.066 0.243
3677 12.6.17 -0.632 -0.248 0.476 0.087 -1.628 -1.137 -0.437 -0.060
3759 12.7.19 0.746 0.549 0.567 0.383 0.436 0.215 -0.016 0.314
3818 11.8.18 0.927 0.475 0.579 0.429 0.383 0.580 0.116 0.053
3831 12.8.11 0.057 0.227 0.527 0.697 -0.037 0.140 0.189 0.510
3869 10.9.9 -0.319 -0.124 -0.109 0.038 0.184 0.308 0.385 0.718
3883 11.9.3 0.825 0.478 0.451 0.507 0.454 0.043 0.313 0.107
3940 9.10.20 -0.110 0.240 -0.050 0.299 0.569 0.770 0.395 0.627
4127 11.12.7 -0.223 0.300 -0.227 0.236 0.513 0.686 0.358 0.522
4170 9.13.10 0.093 0.760 0.745 0.922 0.892 0.940 0.912 1.019
4200 10.13.20 0.277 0.600 0.451 1.003 1.130 0.454 0.751 0.697
4247 9.14.7 1.080 0.792 0.848 0.141 0.051 0.714 -0.440 -0.104
4311 12.14.11 -0.955 -0.118 -0.043 0.038 0.243 0.211 1.063 0.102
4352 10.15.12 0.894 -0.041 -0.148 -0.261 -0.169 0.033 0.260 0.023
4354 10.15.14 0.382 0.246 0.825 0.174 0.374 -0.018 -0.129 -0.326
4413 9.16.13 -0.306 -0.416 -0.129 0.579 -0.506 0.228 0.663 0.612
4433 10.16.13 0.316 0.261 -0.017 0.304 0.167 -0.184 -0.177 -0.446
4481 9.17.1 -0.242 -0.200 0.381 0.590 0.215 0.437 0.604 0.650
4649 9.19.9 1.081 0.400 1.266 0.469 0.628 0.374 0.164 0.291
4713 12.19.13 -0.346 -0.704 -0.564 -0.154 -0.011 -0.220 -0.194 -0.028
4811 13.1.11 -0.460 -0.561 -0.031 0.745 0.287 0.560 1.326 0.187
4817 13.1.17 0.366 0.267 0.041 0.235 0.028 -0.297 -0.261 -0.373
4849 15.1.9 0.145 -0.041 -0.581 -0.049 -0.314 -0.086 0.151 -0.286
4880 16.1.20 -0.658 -0.226 -0.104 0.378 0.362 0.117 0.507 0.620
4938 15.2.18 -0.328 0.348 -0.055 -0.173 -0.977 -0.261 -0.433 -0.960
4989 14.3.9 0.947 0.209 0.971 0.290 -0.102 -0.066 -0.090 0.488
5005 15.3.5 -0.208 -0.105 -0.056 0.360 -0.310 -0.544 -0.180 -0.173
5006 15.3.6 0.335 0.361 0.057 0.279 0.138 -0.336 -0.198 -0.522
5007 15.3.7 0.871 1.207 0.843 0.637 0.522 0.669 0.401 0.430
5050 13.4.10 0.971 -0.293 -1.967 0.548 1.496 0.305 0.076 0.869
5073 14.4.13 0.448 0.605 0.440 0.234 0.971 1.945 1.584 0.436
5114 16.4.14 0.471 -0.035 0.052 0.152 -0.080 -0.242 -0.258 0.098
5132 13.5.12 0.405 0.450 0.939 0.503 0.190 0.127 0.177 0.644
5140 13.5.20 0.130 0.255 0.834 0.082 0.381 0.266 0.453 0.318
5155 14.5.15 -0.146 0.397 1.729 1.189 1.653 1.378 4.125 1.094
5193 16.5.13 -2.091 -0.577 -0.674 -0.027 -1.899 1.049 0.465 0.174
5208 13.6.8 0.187 -0.208 0.231 0.458 -0.291 -0.150 -0.100 0.048
5283 13.7.3 0.162 0.289 0.377 0.121 -0.673 -0.689 -0.415 -0.407
5285 13.7.5 0.217 1.345 -0.262 1.172 -0.326 -0.858 -0.213 0.129
5331 15.7.11 1.574 1.807 1.148 0.986 0.702 0.980 0.673 0.853
5353 16.7.13 0.597 0.920 1.645 0.572 0.520 0.750 -0.155 0.589
5430 16.8.10 1.171 1.018 2.544 3.338 0.151 0.910 0.709 0.803
5456 13.9.16 0.144 0.376 0.595 0.333 -0.343 -0.732 0.539 -0.098
5479 14.9.19 -0.452 -0.430 -0.736 -0.414 -0.613 0.232 0.067 0.065
5495 15.9.15 -0.130 0.271 0.276 0.531 0.243 0.482 0.538 0.816




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
5532 13.10.12 -0.090 -0.511 -0.287 -0.295 0.405 -0.266 -0.062 0.154
5579 15.10.19 0.932 0.231 0.283 -0.005 0.083 -0.023 -0.139 -0.031
5691 13.12.11 -0.592 -0.268 -0.152 0.277 0.202 0.375 0.496 0.167
5732 15.12.12 0.072 0.955 0.184 0.944 1.840 1.526 1.160 0.968
5781 14.13.1 0.305 0.595 0.760 0.885 -0.161 0.154 0.207 0.643
5845 13.14.5 0.239 0.698 1.229 0.696 0.000 0.576 0.427 0.288
5846 13.14.6 0.724 0.585 1.116 0.702 0.367 0.493 0.288 0.389
5855 13.14.15 -0.568 -1.358 -0.790 -0.381 -0.489 -0.372 0.104 0.298
5862 14.14.2 0.131 0.345 0.510 0.837 0.508 0.755 0.859 0.830
6021 14.16.1 0.617 0.398 0.485 0.379 0.212 0.085 0.268 -0.156
6074 16.16.14 0.311 0.122 -0.219 0.054 0.045 -0.643 -0.869 -0.621
6401 17.1.1 0.252 0.821 0.593 0.537 0.370 0.316 0.116 -0.441
6438 18.1.18 -0.065 0.449 0.495 0.385 0.595 0.162 0.221 0.649
6447 19.1.7 -0.504 0.621 0.175 -1.335 -1.381 -0.357 -0.420 -1.878
6480 20.1.20 0.883 0.622 0.130 -0.180 0.629 0.311 0.121 -0.378
6495 17.2.15 0.530 0.710 0.853 0.858 -0.018 0.495 0.037 0.687
6503 18.2.3 -0.156 0.124 0.414 0.869 0.187 0.383 0.858 0.713
6507 18.2.7 -0.373 -0.273 -0.233 0.095 0.191 0.232 0.309 -0.145
6511 18.2.11 -0.241 0.562 0.505 -0.343 -0.414 0.067 0.012 -0.759
6533 19.2.13 -0.774 -0.314 -0.024 0.400 0.191 0.491 0.640 0.241
6545 20.2.5 0.288 0.266 -0.037 0.148 0.001 -0.411 -0.307 -0.477
6629 20.3.9 -0.793 -0.801 0.092 0.070 -0.327 0.548 -0.113 -0.408
6690 19.4.10 -0.177 -0.070 0.453 0.159 -0.526 -0.239 0.040 0.022
6745 18.5.5 0.344 0.069 -0.075 -0.171 0.564 0.462 0.149 -0.010
6768 19.5.8 0.827 0.702 0.878 0.702 1.144 2.390 1.279 1.073
6794 20.5.14 -0.230 0.298 0.354 0.423 0.213 0.561 0.712 0.502
6840 18.6.20 0.218 0.278 0.444 0.222 -0.622 -0.691 -0.131 -0.234
6849 19.6.9 0.469 0.327 1.265 0.472 0.613 0.554 0.301 0.559
6947 20.7.7 0.062 0.877 0.862 0.114 -0.219 0.466 0.168 -0.198
7037 20.8.17 0.299 -0.064 -0.019 -0.271 -0.918 -0.641 -0.295 -0.102
7110 20.9.10 0.833 0.621 0.593 0.397 0.423 0.163 0.211 0.113
7147 18.10.7 1.437 0.951 1.411 0.843 -0.986 0.245 -0.559 0.033
7157 18.10.17 0.984 1.375 0.945 1.060 0.501 -0.717 -0.269 0.418
7333 19.12.13 0.648 0.554 0.628 -0.003 1.216 2.337 2.284 1.406
7349 20.12.9 -0.457 -1.368 -0.716 -0.106 -0.055 -0.498 0.002 -0.403
7376 17.13.16 0.267 1.054 0.752 0.645 0.627 0.553 0.251 0.568
7388 18.13.8 -0.291 -0.078 0.051 0.379 0.254 0.334 0.483 0.135
7423 20.13.3 -0.020 0.735 0.674 0.679 0.137 0.358 -0.284 0.034
7428 20.13.8 0.442 0.664 1.164 0.663 0.280 0.609 0.384 0.513
7501 20.14.1 0.588 0.714 0.800 0.237 0.426 0.274 0.277 0.028
7517 20.14.17 -0.634 -0.113 -0.245 -0.184 -0.261 -0.130 -0.074 0.191
7570 19.15.10 0.520 0.722 0.631 0.238 0.278 0.292 0.016 0.190
7639 18.16.19 0.256 0.771 0.465 1.050 0.984 0.606 0.871 0.604
7702 18.17.2 0.476 0.891 0.895 1.071 0.062 0.485 0.120 0.906
8048 23.1.8 -0.430 -0.094 0.090 0.060 -0.124 0.461 0.137 0.532
8138 23.2.18 0.436 0.152 -0.092 0.295 0.005 -0.495 -0.209 -0.689
8169 21.3.9 -0.341 0.344 -0.040 -1.172 -1.278 -0.333 -0.538 -1.341
8207 23.3.7 -0.116 -0.132 -0.024 0.397 -0.336 0.157 0.213 0.112
8257 21.4.17 -0.300 -0.211 -0.053 0.319 -0.132 0.224 0.347 0.449
8418 21.6.18 0.693 0.458 0.151 0.064 -0.320 -0.205 -0.016 -0.119
8433 22.6.13 0.019 0.454 0.084 -0.890 -1.075 -0.067 -0.404 -1.054




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
8479 24.6.19 -1.871 -0.943 0.537 0.882 -0.169 1.221 0.352 2.344
8555 24.7.15 -0.230 0.034 0.169 0.460 0.465 0.639 0.790 0.410
8655 21.9.15 -1.092 -1.167 -0.428 0.347 -0.034 0.352 -0.960 -0.601
8673 22.9.13 -0.535 -0.339 -0.864 -0.094 0.550 0.610 0.311 0.092
8703 24.9.3 0.701 0.655 0.923 0.434 0.804 0.236 0.203 0.610
8851 23.11.11 1.040 0.688 0.619 0.323 2.510 1.201 1.592 0.487
8866 24.11.6 0.723 0.743 2.250 0.784 -0.207 -0.239 0.328 1.043
8876 24.11.16 -0.270 -0.474 -0.604 0.077 -0.221 -0.198 0.090 -0.135
8919 22.12.19 0.307 0.700 0.781 0.613 0.305 -0.035 0.049 1.091
8961 21.13.1 -0.403 -0.307 -0.230 -0.361 0.253 0.113 0.120 0.325
8984 22.13.4 0.176 -0.069 0.049 0.464 0.255 0.340 1.057 0.676
8989 22.13.9 0.972 0.328 0.144 0.315 0.023 -0.238 -0.366 -0.178
9001 23.13.1 0.048 0.774 0.695 0.844 0.987 1.260 1.648 1.418
9071 22.14.11 0.408 0.746 1.665 1.134 1.480 3.187 1.022 1.452
9090 23.14.10 0.220 0.691 1.165 1.130 -0.800 -0.500 0.432 0.972
9447 21.19.7 0.307 0.377 0.306 0.525 -0.099 -1.178 -0.534 0.658
9635 26.1.15 -0.049 0.759 0.150 -0.335 -0.683 -0.068 -0.132 -0.434
9659 27.1.19 -0.637 -0.224 0.416 0.127 0.060 0.815 1.068 0.599
9713 26.2.13 0.350 0.197 -0.067 0.157 0.016 -0.399 -0.218 -0.503
9743 28.2.3 -0.142 -0.198 -0.066 0.292 -0.057 -0.100 0.316 -0.439
9781 26.3.1 -0.206 0.350 0.254 -0.414 -0.748 -0.056 -0.198 -0.569
9843 25.4.3 -1.732 -0.727 -0.922 -0.776 -1.302 0.724 0.148 0.046
9878 26.4.18 0.271 0.203 0.918 0.408 0.992 0.731 1.214 0.529
10038 26.6.18 0.510 0.912 -0.273 1.066 -0.406 -0.161 -0.193 0.146
10040 26.6.20 -0.329 0.375 0.071 -0.914 -1.166 -0.244 -0.410 -0.914
10070 28.6.10 -1.396 -1.429 0.170 -0.037 -0.886 -0.543 0.030 0.991
10098 25.7.18 0.708 0.477 0.839 0.223 -0.637 -0.967 -0.220 -0.387
10099 25.7.19 2.382 1.272 1.702 1.294 1.901 1.314 -0.061 0.255
10168 25.8.8 0.665 1.042 1.171 0.873 0.536 0.643 0.344 0.785
10231 28.8.11 0.441 0.163 0.265 0.246 0.982 0.380 0.383 0.481
10287 27.9.7 0.903 0.535 0.494 0.806 0.536 0.334 0.141 0.690
10322 25.10.2 1.310 0.945 0.919 0.751 0.823 0.688 0.613 0.452
10345 26.10.5 1.193 0.772 0.496 0.575 0.762 0.063 -0.090 -0.095
10348 26.10.8 0.773 0.997 2.768 0.723 0.672 1.174 0.694 0.989
10350 26.10.10 -0.255 -0.047 0.220 0.809 0.526 0.754 0.563 0.950
10438 26.11.18 0.959 1.001 1.677 1.855 3.850 0.665 1.060 0.622
10551 28.12.11 0.890 0.880 0.503 1.102 0.827 0.750 0.150 -0.169
10633 28.13.13 0.645 0.557 0.636 0.315 0.323 -0.265 -0.342 -0.156
10667 26.14.7 -0.075 -0.260 0.140 0.493 -0.761 -0.322 0.291 0.040
10675 26.14.15 -0.455 -0.582 -1.928 -0.274 0.237 -0.557 -0.155 -0.023
10702 28.14.2 -0.696 -0.344 -0.161 0.372 0.112 0.334 0.552 0.166
10767 27.15.7 0.351 0.362 0.378 0.340 0.962 0.272 0.384 0.315
10888 25.17.8 -0.162 -0.487 -0.623 -1.430 0.363 0.355 -0.063 0.079
10937 27.17.17 -1.549 -0.489 -0.393 -0.338 -0.951 0.991 0.401 0.589
10954 28.17.14 0.145 0.584 0.441 0.258 -0.126 0.491 0.103 0.184
11262 32.1.2 0.033 0.240 0.522 0.599 -0.226 -0.075 0.196 0.336
11265 32.1.5 -0.133 0.306 0.558 0.455 -0.377 -0.135 0.163 0.397
11292 29.2.12 -0.249 -0.448 -0.332 0.365 -0.404 0.116 0.406 -0.077
11305 30.2.5 -0.038 0.375 0.233 -0.231 -0.420 -0.039 0.116 -0.318
11309 30.2.9 -0.018 0.093 -0.033 0.312 1.036 0.866 0.680 0.876
11313 30.2.13 -0.629 0.311 0.055 -0.973 -2.536 -0.477 -0.541 -1.205




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
11363 29.3.3 -0.885 -0.388 -0.527 -0.351 -1.462 -0.559 -0.523 -0.700
11494 31.4.14 -0.128 0.040 0.301 0.093 -0.392 -0.175 -0.004 0.128
11515 32.4.15 0.393 0.028 0.034 -0.125 -0.125 -0.233 -0.193 -0.421
11523 29.5.3 0.150 0.199 0.304 0.093 -0.427 -0.469 -0.038 -0.162
11530 29.5.10 -0.229 -0.097 -0.115 -0.078 0.225 0.092 0.278 0.550
11560 30.5.20 -0.085 0.600 0.909 0.204 0.587 0.845 -0.047 0.555
11610 29.6.10 -0.042 -0.396 -0.744 0.017 -0.754 -0.766 0.308 -0.554
11622 30.6.2 -0.624 -0.034 0.357 -0.028 -0.474 0.810 0.468 0.389
11649 31.6.9 0.285 -0.097 -0.393 -0.360 0.378 0.063 0.001 -0.211
11797 30.8.17 0.799 0.471 0.477 0.035 0.361 0.025 -0.144 -0.106
11963 31.10.3 1.359 0.840 0.894 0.404 0.575 0.488 0.697 0.517
12097 29.12.17 0.739 0.612 1.082 0.759 0.085 0.373 0.479 0.883
12199 30.13.19 0.803 0.496 0.952 0.788 -0.061 0.911 0.077 -0.328
12217 31.13.17 -0.093 0.068 0.354 0.480 0.622 0.436 0.344 0.873
12255 29.14.15 -0.372 -0.602 -0.060 0.012 -0.308 -0.444 -0.028 0.729
12314 32.14.14 -0.427 -0.394 -0.358 -0.852 0.110 -0.065 -0.275 -0.429
12350 30.15.10 -0.545 -0.171 0.597 0.419 0.295 0.947 0.563 0.752
12915 34.2.15 0.060 0.546 0.303 -0.073 -0.231 0.182 0.064 -0.099
12945 36.2.5 -0.171 0.400 0.089 -0.445 -0.663 -0.039 -0.186 -0.501
12970 33.3.10 -0.289 0.271 0.035 -0.793 -0.924 -0.221 -0.311 -0.873
12975 33.3.15 -0.387 0.026 0.246 0.524 0.098 0.248 0.784 0.790
12976 33.3.16 -0.243 0.238 -0.093 -0.697 -0.915 -0.237 -0.360 -0.846
13006 35.3.6 -0.346 0.183 0.079 -0.599 -1.045 -0.226 -0.404 -0.468
13019 35.3.19 0.256 0.398 0.323 -0.209 0.149 -0.272 -0.398 -0.281
13057 33.4.17 0.471 0.149 0.405 0.314 0.451 0.161 0.569 1.513
13108 36.4.8 -0.490 -0.237 -0.296 -0.019 0.266 0.339 0.134 0.068
13203 33.6.3 0.233 0.341 1.212 0.614 0.486 0.858 1.282 1.115
13212 33.6.12 -0.512 -0.319 -0.324 0.079 -0.033 0.028 0.469 -0.073
13227 34.6.7 0.312 0.217 0.007 0.245 0.044 -0.117 -0.053 -0.388
13304 34.7.4 0.676 0.259 -0.056 0.099 0.118 -0.150 0.426 1.633
13578 35.10.18 1.068 1.203 0.954 1.014 0.863 0.439 0.335 0.923
13779 33.13.19 0.812 0.863 0.860 0.592 0.427 0.297 0.356 -0.004
13876 34.14.16 -0.124 -0.064 -0.127 -0.043 0.695 0.326 -0.310 -0.093
14002 33.16.2 0.107 -0.030 -0.315 -0.017 -0.097 -0.423 -0.473 -0.646
14052 35.16.12 0.474 0.392 0.036 0.382 0.265 -0.265 -0.159 -0.335
14080 36.16.20 0.041 -0.116 -0.211 -0.024 -0.304 -0.759 -0.728 -0.775
14091 33.17.11 0.089 -0.069 0.241 0.124 0.388 0.310 -0.514 0.196
14109 34.17.9 1.126 0.326 0.481 0.269 0.564 0.183 -0.077 0.497
14157 36.17.17 -0.575 -0.144 -0.509 -0.096 -0.262 0.386 0.217 0.195
14236 36.18.16 0.585 0.304 0.735 0.488 0.960 0.836 1.202 0.924
14275 34.19.15 0.641 -0.257 0.095 -0.088 0.526 0.387 0.432 0.865
14490 37.2.10 -0.279 0.238 -0.022 -0.695 -0.887 -0.205 -0.215 -0.824
14515 38.2.15 -0.805 -0.649 -0.251 0.277 -0.021 0.582 -0.116 -0.383
14541 40.2.1 0.361 0.030 -0.081 0.100 0.029 -0.418 -0.306 -0.380
14563 37.3.3 -0.240 0.130 -0.193 -0.425 -0.691 -0.229 -0.306 -0.699
14571 37.3.11 0.438 0.368 0.604 -0.037 0.434 0.693 2.083 0.989
14589 38.3.9 0.749 0.470 0.132 -0.081 0.507 0.276 0.119 -0.320
14596 38.3.16 -0.183 0.224 0.027 -0.549 -0.815 -0.212 -0.313 -0.690
14623 40.3.3 -0.252 -0.444 -0.756 0.311 -0.151 0.081 1.117 0.016
14625 40.3.5 -0.554 -0.246 -0.110 0.211 0.029 0.197 0.298 0.094
14643 37.4.3 -0.172 0.171 -0.164 -0.510 -0.659 -0.177 -0.289 -0.775




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
14690 39.4.10 -0.517 -0.343 -0.405 0.180 -0.081 0.133 0.004 0.082
14816 37.6.16 0.438 0.249 0.090 0.057 -0.001 0.021 -0.061 -0.346
14839 38.6.19 0.423 0.097 -0.807 0.073 -0.010 -0.857 0.378 0.255
14871 40.6.11 0.842 0.611 1.458 1.494 1.171 1.678 2.339 1.744
14944 40.7.4 -0.250 0.281 0.462 0.388 -0.267 0.012 0.026 0.040
14955 40.7.15 1.431 1.533 1.954 1.386 3.412 2.425 4.907 2.605
15001 39.8.1 0.703 1.283 1.242 0.901 0.343 0.914 0.692 0.248
15027 40.8.7 0.538 0.633 0.936 0.934 2.534 1.636 0.926 0.533
15125 37.10.5 0.174 0.035 0.028 0.110 0.383 -0.467 -0.521 -0.459
15165 39.10.5 0.414 0.461 0.505 0.701 -0.063 -0.170 0.203 0.261
15188 40.10.8 0.097 0.034 0.808 0.232 0.541 0.632 0.708 0.610
15228 38.11.8 -0.370 -0.052 -0.120 0.457 0.652 0.995 0.615 0.437
15285 37.12.5 0.641 1.316 1.447 0.676 0.564 0.661 0.661 0.790
15370 37.13.10 -0.259 -0.264 -0.176 0.052 -0.060 0.844 0.334 0.668
15379 37.13.19 0.272 0.228 -0.510 0.135 0.702 0.442 0.755 0.040
15429 40.13.9 0.400 0.620 0.920 0.938 0.880 1.674 0.763 0.935
15432 40.13.12 0.020 0.424 0.182 0.057 0.846 0.862 1.576 0.382
15436 40.13.16 -0.341 0.038 0.096 0.527 0.502 0.709 0.687 0.885
15439 40.13.19 0.712 0.731 0.581 0.437 0.312 0.002 0.077 0.513
15471 38.14.11 0.718 0.401 0.595 1.125 -0.654 -0.231 -0.058 0.358
15473 38.14.13 0.583 0.487 -0.431 0.963 1.647 1.007 1.191 0.996
15599 40.15.19 -0.202 0.032 -0.344 -0.929 -0.455 -1.161 -0.636 0.442
15633 38.16.13 0.380 0.264 0.021 0.317 0.046 -0.341 -0.248 -0.472
15831 40.18.11 -0.286 -0.436 -0.658 -0.557 0.125 -0.168 0.004 -0.320
16022 42.1.2 0.476 0.672 0.875 0.817 0.383 0.183 0.368 0.488
16054 43.1.14 -0.806 -0.665 0.227 0.263 -0.269 0.786 -0.167 -0.590
16088 41.2.8 -0.208 0.198 -0.038 -0.537 -0.682 -0.184 -0.245 -0.624
16138 43.2.18 -0.500 -0.473 -0.145 0.419 -0.770 -0.591 -0.273 -0.002
16145 44.2.5 -0.081 0.222 0.391 0.589 0.129 0.369 0.636 0.724
16173 41.3.13 -0.179 0.301 0.252 0.340 0.353 0.400 0.616 0.664
16177 41.3.17 -0.054 0.363 0.171 0.594 0.861 0.970 1.330 1.117
16182 42.3.2 -3.586 -1.109 -0.342 -0.812 -2.463 1.239 0.554 0.216
16213 43.3.13 0.343 0.203 -0.023 0.155 0.132 -0.328 -0.269 -0.478
16234 44.3.14 -0.386 0.244 -0.085 -0.843 -1.038 -0.278 -0.430 -0.905
16255 41.4.15 -0.366 -0.355 -0.232 0.281 0.052 0.480 0.032 -0.164
16294 43.4.14 -4.189 -1.489 -0.357 -2.370 -3.373 0.972 0.542 -0.261
16296 43.4.16 -0.453 -0.321 -0.790 -0.180 -0.229 -0.009 -0.166 -0.015
16323 41.5.3 0.306 -0.332 -0.520 -0.235 1.110 0.237 0.189 -0.444
16376 43.5.16 0.453 0.617 1.162 0.739 0.326 0.562 0.430 0.361
16383 44.5.3 0.363 -0.152 0.439 1.214 0.189 1.366 0.629 0.133
16400 44.5.20 0.333 0.312 -0.084 0.191 0.295 -0.417 -0.294 -0.252
16413 41.6.13 0.477 0.550 0.355 0.398 -0.367 0.080 0.099 0.643
16482 41.7.2 -0.618 -0.462 -0.187 0.126 0.001 0.428 -0.239 -0.411
16488 41.7.8 -1.127 -0.539 -0.325 -0.348 -1.007 0.408 0.083 -0.051
16502 42.7.2 0.554 0.115 0.118 -0.082 0.924 0.239 1.130 2.028
16579 41.8.19 1.091 0.617 0.582 0.403 0.585 0.576 0.221 0.388
16632 44.8.12 0.184 -0.579 -0.253 -0.178 0.333 -0.078 -0.008 0.190
16638 44.8.18 -0.202 0.127 0.235 0.480 0.502 0.464 0.484 0.590
16722 41.10.2 0.775 -0.048 0.745 0.025 0.012 -0.005 -0.007 -0.045
16935 43.12.15 -0.416 -0.339 -0.356 -0.253 -0.075 -0.482 -0.123 0.267
16939 43.12.19 0.221 0.918 0.822 0.663 0.255 0.461 0.385 0.617




no. Lean 1 Lean 3 Lean 5 Lean 7 Fat 1 Fat 3 Fat 5 Fat 7
17076 42.14.16 1.012 1.428 -0.149 0.145 0.189 -0.536 0.165 2.235
17103 44.14.3 -0.241 -0.039 0.029 0.356 0.213 0.359 0.614 0.371
17128 41.15.8 0.613 1.108 0.909 2.642 0.973 1.466 1.259 0.123
17186 44.15.6 0.715 0.566 0.344 0.205 0.592 0.426 0.235 -0.001
17319 42.17.19 -0.174 -0.439 -0.281 0.101 0.196 -0.138 0.028 0.301
17419 43.18.19 1.265 0.772 0.456 0.923 4.589 2.132 0.681 3.966
17438 44.18.18 0.267 0.316 0.695 0.479 -0.068 0.109 0.346 0.366
17440 44.18.20 -0.022 0.111 0.517 0.230 -0.367 -0.204 0.035 0.196
17454 41.19.14 1.617 1.064 1.231 0.892 1.429 1.892 1.678 2.510
17622 46.1.2 -0.132 0.274 0.496 0.331 -0.392 0.047 0.139 0.290
17651 47.1.11 0.093 -0.011 0.674 0.229 0.303 0.776 1.057 0.326
17746 48.2.6 -0.903 -0.642 -0.434 0.130 0.037 0.249 0.212 -0.040
17981 48.5.1 -3.005 -1.109 -0.655 -1.528 -2.757 0.873 0.185 -0.096
17984 48.5.4 0.336 0.659 1.456 0.554 0.452 1.387 0.477 0.777
18016 45.6.16 0.286 0.569 0.193 2.057 0.415 2.282 2.020 4.044
18020 45.6.20 -0.175 0.404 0.264 -0.157 -0.599 0.011 -0.079 -0.274
18126 47.7.6 -0.590 0.406 -1.064 0.402 0.296 1.378 0.272 1.529
18215 47.8.15 0.839 0.577 0.589 0.424 0.374 0.369 0.136 0.298
18264 46.9.4 0.653 0.407 0.416 0.283 0.580 0.302 -0.053 -0.073
18295 47.9.15 -0.463 -0.129 0.030 0.353 0.183 0.361 0.319 0.227
18331 45.10.11 0.104 -0.379 -0.160 0.009 1.654 1.705 0.223 0.461
18439 46.11.19 0.598 0.370 0.074 -0.087 0.652 0.845 0.232 0.643
18472 48.11.12 0.273 0.318 -0.096 0.255 0.967 1.863 0.179 0.595
18476 48.11.16 0.300 0.647 0.192 0.689 1.449 1.106 1.488 1.531
18511 46.12.11 0.879 0.691 0.542 0.357 0.629 0.623 0.468 0.169
18522 47.12.2 0.294 0.238 0.065 0.418 0.605 0.765 0.689 0.326
18533 47.12.13 0.255 1.054 0.918 0.311 0.683 0.877 0.270 0.377
18589 46.13.9 0.771 0.703 1.429 0.671 0.808 1.597 2.237 2.374
18615 47.13.15 0.119 0.366 0.132 0.758 0.403 0.816 0.955 0.997
18634 48.13.14 0.341 0.608 0.502 0.892 1.251 0.715 1.153 0.875
18786 48.15.6 0.344 0.604 0.674 0.444 0.356 0.407 -0.306 0.170
18823 46.16.3 -0.236 -0.055 0.250 -0.006 -0.548 -0.269 -0.188 -0.094
18850 47.16.10 -1.262 -0.424 -0.442 -0.232 -0.850 1.046 0.496 0.361
18991 46.18.11 -0.166 0.331 0.322 -0.068 0.810 0.660 0.623 0.670
19041 45.19.1 0.469 0.485 0.196 0.198 0.904 1.067 0.595 1.143
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Table 6. Results of ANOVA.  387 genes were significantly different by line or for the 
line-by-age interaction and had at least a 0.68-fold difference in their log2 ratios between 
lines.  Spot is the Del-Mar 14K Chicken Integrated Systems microarray individual spot 
number; GEO no. is the GEO accession no. GPL1731 ID; BlastX is the highest scoring 
translated BLAST hit; line, age, interaction are the ANOVA probility values; and Fold 
diff is the difference between the highest and lowest log2 means.
Spot
GEO 
no. BlastX line age interaction
Fold 
diff
35 2.1.15 gamma-immunoglobulin heavy chain (504 AA) [Gallus gallus] 0.002 0.004 0.723 1.891
43 3.1.3 immunoglobulin J chain [Gallus gallus] 0.003 0.006 0.444 1.435
159 4.2.19 No Hits Found 0.000 0.700 0.477 0.995
224 4.3.4 hypothetical protein BC013949 [Homo sapiens] 0.452 0.483 0.036 0.694
238 4.3.18 TUC-4b [Rattus norvegicus] 0.004 0.377 0.607 1.022
264 2.4.4 unnamed protein product [Mus musculus] 0.020 0.178 0.895 1.365
284 3.4.4 hypothetical protein MGC10731 [Homo sapiens] 0.028 0.014 0.880 1.096
292 3.4.12 Slit1 protein [Gallus gallus] 0.036 0.042 0.079 1.184
310 4.4.10 No Hits Found 0.029 0.036 0.723 0.794
321 1.5.1 No Hits Found 0.009 0.000 0.220 1.139
333 1.5.13 Skin secretory protein XP2 precursor (APEG protein) 0.001 0.021 0.647 1.808
343 2.5.3 No Hits Found 0.044 0.297 0.687 0.806
408 1.6.8
serologically defined colon cancer antigen 28; 
phosphatidylcholinetransfer protein-like [Mus musculus] 0.015 0.001 0.389 1.320
413 1.6.13 Unknown (protein for MGC:10089) [Homo sapiens] 0.002 0.249 0.774 1.744
422 2.6.2 similar to The KIAA0150 gene product is novel. [Homo sapiens] 0.099 0.127 0.045 1.172
455 3.6.15 No Hits Found 0.000 0.183 0.468 1.483
501 2.7.1 KIAA0789 protein [Homo sapiens] 0.049 0.024 0.985 0.948
608 3.8.8
similar to dJ475N16.3 (novel protein similar to RPL7A (60Sribosomal 
protein L7A)) [Homo sapiens] 0.006 0.835 0.175 0.833
650 1.9.10 No Hits Found 0.005 0.001 0.236 0.983
689 3.9.9 gag/env fusion protein [Gallus gallus] 0.025 0.207 0.699 1.705
701 4.9.1 prolyl 4-hydroxylase, alpha subunit (EC 1.14.11.2) 0.012 0.884 0.820 1.323
730 1.10.10 No Hits Found 0.003 0.491 0.565 2.634
744 2.10.4 deoxyribonuclease gamma [Xenopus laevis] 0.026 0.503 0.137 0.748
746 2.10.6 lacZ alpha peptide 0.001 0.065 0.015 0.933
771 3.10.11
expressed sequence AA408877; hypothetical protein MGC38511 
[Musmusculus] 0.022 0.816 0.286 1.193
887 1.12.7 gene_id:F1D9.26~unknown protein [Arabidopsis thaliana] 0.757 0.009 0.017 1.146
1017 3.13.17 hypothetical protein XP_148064 [Mus musculus] 0.899 0.260 0.025 1.278
1018 3.13.18 No Hits Found 0.024 0.259 0.607 1.193
1037 4.13.17 dJ604K5.1 (15 kDa selenoprotein) [Homo sapiens] 0.050 0.290 0.622 0.696
1089 3.14.9 unnamed protein product [Homo sapiens] 0.050 0.004 0.285 1.050
1123 1.15.3
NADH-ubiquinone oxidoreductase 19 kDa subunit (Complex I-
19KD)(CI-19KD) (Complex I-PGIV) (CI-PGIV) 0.006 0.003 0.912 0.741
1185 4.15.5 gene 17.5 protein - chicken 0.002 0.902 0.350 1.029
1187 4.15.7 Frizzled-1 [Gallus gallus] 0.040 0.050 0.880 0.944
1319 2.17.19 EH-domain containing 3; EH domain containing 3 [Homo sapiens] 0.001 0.002 0.708 1.338
1337 3.17.17 similar to hypothetical protein [Homo sapiens] [Mus musculus] 0.010 0.241 0.371 1.145
1507 4.19.7 No Hits Found 0.022 0.776 0.484 0.886
1602 5.1.2
ADP-ribosylation factor 1 GTPase activating protein 
[Rattusnorvegicus] 0.002 0.001 0.309 1.005
1639 6.1.19 similar to FLJ00237 protein [Homo sapiens] 0.010 0.001 0.689 1.348








transmembrane 4 superfamily member 2; membrane component, 
xchromosome, surface marker 1; T-cell acute lymphoblasticleukemia 
associated antigen 1; transmembrane proteinA15; tetraspanin protein; 
cell surface glycoprotein A15;CD231 antigen; transmembrane 4 
superfamily 2b [Homosapiens] 0.000 0.008 0.163 1.380
1666 8.1.6 MAPK-interacting and spindle-stabilizing protein [Homo sapiens] 0.034 0.711 0.944 1.039
1687 5.2.7 No Hits Found 0.013 0.306 0.087 1.504
1696 5.2.16 CD63 antigen 0.000 0.491 0.568 1.042
1712 6.2.12 No Hits Found 0.041 0.509 0.438 0.720
1757 8.2.17 gene_id:F1D9.26~unknown protein [Arabidopsis thaliana] 0.003 0.020 0.573 0.725
1764 5.3.4 unnamed protein product [Homo sapiens] 0.006 0.021 0.407 1.273
1806 7.3.6 Similar to butyrate-induced transcript 1 [Mus musculus] 0.003 0.001 0.272 1.634
1832 8.3.12 Cathepsin D precursor 0.040 0.880 0.257 1.877
1846 5.4.6 No Hits Found 0.009 0.055 0.200 0.741
1900 7.4.20
similar to Amyloid beta A4 precursor protein-binding family B 
member 2 (Fe65-like protein) [Homo sapiens] 0.837 0.211 0.037 0.946
1977 7.5.17 No Hits Found 0.022 0.005 0.988 0.783
2035 6.6.15
Beta-neoendorphin-dynorphin precursor (Proenkephalin 
B)(Preprodynorphin) [Contains: Beta-neoendorphin;Dynorphin; Leu-
Enkephalin; Rimorphin; Leumorphin] 0.021 0.015 0.292 1.387
2054 7.6.14 hypothetical protein [Homo sapiens] 0.044 0.012 0.747 1.378
2101 6.7.1 DKFZP586B1621 protein [Homo sapiens] 0.013 0.004 0.792 1.510
2141 8.7.1
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 1; beta-3-
galt1[Homo sapiens] 0.032 0.538 0.044 1.803
2145 8.7.5 OSJNBa0029H02.25 [Oryza sativa (japonica cultivar-group)] 0.035 0.584 0.055 1.322
2296 7.9.16
3-oxoacid CoA transferase precursor; Succinyl CoA:3-oxoacid CoA 
transferase; succinyl-CoA:3-ketoacid-CoA transferase precursor 
[Homo sapiens] 0.068 0.119 0.040 0.732
2350 6.10.10 Neuropeptide Y precursor (NPY) 0.047 0.034 0.066 2.115
2368 7.10.8 No Hits Found 0.021 0.881 0.180 0.822
2413 5.11.13 No Hits Found 0.355 0.295 0.048 1.639
2533 7.12.13
ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC 
(OXALOSUCCINATE DECARBOXYLASE) (IDH) (NADP+-
SPECIFIC ICDH) (IDP) 0.136 0.534 0.031 1.315
2567 5.13.7 chromodomain helicase DNA binding protein 2 [Homo sapiens] 0.087 0.425 0.049 3.113
2569 5.13.9 E74-like factor 1 (ets domain transcription factor) [Rattus norvegicus] 0.047 0.217 0.716 0.882
2600 6.13.20 hypothetical protein MGC10485 [Homo sapiens] 0.022 0.566 0.518 0.793
2621 8.13.1 No Hits Found 0.760 0.114 0.016 0.851
2694 7.14.14
putative protein; protein id: At5g12470.1, supported by 
cDNA:gi_20268751, supported by cDNA: gi_21281148 
[Arabidopsisthaliana] 0.021 0.081 0.871 0.717
2706 8.14.6 No Hits Found 0.002 0.695 0.306 2.606
2745 6.15.5
RIKEN cDNA 1810046J19; expressed sequence AI463380 [Mus 
musculus] 0.003 0.041 0.643 1.304
2815 5.16.15 No Hits Found 0.031 0.757 0.694 0.719
2851 7.16.11
hypothetical protein; extensin-like; with SH3 Src homology domain 
[Schizosaccharomyces pombe] 0.027 0.544 0.689 1.146
2854 7.16.14 dJ259A10.1 (ssDNA binding protein (SEB4D)) [Homo sapiens] 0.022 0.138 0.694 3.165
2858 7.16.18 similar to K02B2.3.p [Homo sapiens] 0.024 0.000 0.278 1.194
2889 5.17.9 aldo-keto reductase [Gallus gallus] 0.001 0.566 0.231 0.985
2968 5.18.8 suppressor of fused [Gallus gallus] 0.000 0.355 0.691 2.650
3033 8.18.13 fragile X mental retardation protein 0.644 0.085 0.043 3.071
3221 10.1.1 Ig light chain precursor 0.003 0.000 0.726 4.738
3236 10.1.16 similar to serum amyloid A-activating factor SAF-8 [Homo sapiens] 0.019 0.524 0.570 0.896
3241 11.1.1
adenylate cyclase 2; adenylyl cyclase 2; adenylate cyclase II; adenylyl 
cyclase; ATP pyrophosphate-lyase; type II adenylate cyclase; 3',5'-
cyclic AMP synthetase [Homo sapiens] 0.040 0.449 0.570 1.191
3242 11.1.2
chromosome 11 open reading frame2; chromosome  11 open 
readingframe2 [Homo sapiens] 0.012 0.001 0.573 1.404
3260 11.1.20 ATP-binding cassette, sub-family B, member 6 [Homo sapiens] 0.028 0.421 0.573 0.715
3270 12.1.10
similar to vesicle-associated calmodulin-binding protein 
[Musmusculus] 0.024 0.532 0.753 0.712
3274 12.1.14
mel transforming oncogene; ras-associated protein RAB8 [Homo 
sapiens] 0.013 0.450 0.621 0.806




no. BlastX line age interaction
Fold 
diff
3284 9.2.4 No Hits Found 0.008 0.002 0.633 0.891
3291 9.2.11 PEROXISOMAL FARNESYLATED PROTEIN 0.015 0.001 0.463 1.106
3293 9.2.13 No Hits Found 0.018 0.002 0.568 0.954
3341 12.2.1 superoxide dismutase 3, extracellular [Homo sapiens] 0.002 0.001 0.276 1.257
3399 10.3.19
Dynactin 1 (150 kDa dynein-associated polypeptide) (DP-150) (DAP-
150) (p150-glued) 0.041 0.589 0.490 1.189
3404 11.3.4 unnamed protein product [Homo sapiens] 0.007 0.001 0.573 1.568
3413 11.3.13 No Hits Found 0.048 0.127 0.584 0.692
3428 12.3.8 No Hits Found 0.014 0.236 0.236 0.944
3441 9.4.1
Gamma-interferon inducible lysosomal thiol reductase 
precursor(Gamma-interferon-inducible protein IP-30) 0.021 0.333 0.097 0.833
3451 9.4.11 alpha-2-antiplasmin precursor 0.003 0.002 0.838 0.862
3549 10.5.9 gene 17.5 protein - chicken 0.000 0.587 0.472 1.143
3550 10.5.10
hepatocyte growth factor activator inhibitor precursor; 
hepatocytegrowth factor activator inhibitor [Homo sapiens] 0.038 0.072 0.233 1.566
3623 10.6.3 2',5'-oligo adenylate synthetase A [Gallus gallus] 0.018 0.086 0.992 0.726
3642 11.6.2 No Hits Found 0.027 0.466 0.372 0.719
3645 11.6.5 LH-beta 0.024 0.000 0.024 2.837
3677 12.6.17 gastrin-releasing peptide precursor splice form III - human 0.014 0.017 0.683 2.104
3759 12.7.19 succinate dehydrogenase Ip subunit [Gallus gallus] 0.022 0.394 0.619 0.761
3818 11.8.18
hepatitis B virus x-interacting protein; hepatitis B virusx-interacting 
protein (9.6kD); HBx-interacting protein[Homo sapiens] 0.007 0.054 0.168 0.874
3831 12.8.11
sequestosome 1; UBIQUITIN-BINDING PROTEIN P62; 
phosphotyrosineindependent ligand for the Lck SH2 domain p62 
[Homosapiens] 0.023 0.000 0.613 0.734
3869 10.9.9 SH2 domain protein 1A; Duncan disease homolog [Mus musculus] 0.045 0.622 0.979 1.037
3883 11.9.3
DIHYDROPYRIMIDINASE RELATED PROTEIN-2 (DRP-2) 
(COLLAPSIN RESPONSE MEDIATOR PROTEIN CRMP-62) 0.011 0.137 0.833 0.781
3940 9.10.20 similar to expressed sequence AI649009 [Homo sapiens] 0.014 0.490 0.906 0.880
4127 11.12.7 No Hits Found 0.008 0.274 0.786 0.913
4170 9.13.10 catalase [Canis familiaris] 0.043 0.130 0.293 0.926
4200 10.13.20 No Hits Found 0.221 0.388 0.049 0.853
4247 9.14.7 No Hits Found 0.009 0.124 0.220 1.519
4311 12.14.11 Thymosin beta 0.010 0.120 0.278 2.019
4352 10.15.12 similar to kinesin superfamily protein 1C [Mus musculus] 0.683 0.285 0.029 1.155
4354 10.15.14
NADH-ubiquinone oxidoreductase SGDH subunit, 
mitochondrialprecursor (Complex I-SGDH) (CI-SGDH) 0.041 0.338 0.439 1.151
4413 9.16.13 No Hits Found 0.023 0.000 0.037 1.169
4433 10.16.13 No Hits Found 0.015 0.351 0.420 0.762
4481 9.17.1 No Hits Found 0.004 0.001 0.265 0.892
4649 9.19.9
DNA mismatch repair protein MSH6 (MutS-alpha 160 kDa subunit) 
(G/T mismatch binding protein) (GTBP) (GTMBP) (P160) 0.037 0.255 0.258 1.102
4713 12.19.13 similar to RAB7, member RAS oncogene family [Mus musculus] 0.015 0.154 0.775 0.694
4811 13.1.11 Zinc finger protein CKR1 0.017 0.157 0.066 1.886
4817 13.1.17 unnamed protein product [Mus musculus] 0.017 0.623 0.900 0.739
4849 15.1.9 60S RIBOSOMAL PROTEIN L3 (L4) 0.987 0.867 0.046 0.732
4880 16.1.20 Regulator of G-protein signaling 5 0.000 0.004 0.127 1.278
4938 15.2.18
Similar to neural proliferation, differentiation and control gene 1[Mus 
musculus] 0.032 0.259 0.958 1.325
4989 14.3.9
endothelial differentiation, lysophosphatidic acidG-protein-coupled 
receptor, 2 [Rattus norvegicus] 0.037 0.688 0.225 1.073
5005 15.3.5 ubiquitin fusion-degradation 1-like protein [Gallus gallus] 0.007 0.035 0.337 0.903
5006 15.3.6 OB-receptor gene related protein [Rattus norvegicus] 0.017 0.566 0.592 0.883
5007 15.3.7 ELL gene (11-19 lysine-rich leukemia gene) [Homo sapiens] 0.013 0.236 0.860 0.806
5050 13.4.10 scavenger-receptor protein [Sus scrofa] 0.032 0.006 0.487 3.463
5073 14.4.13
solute carrier family 29 (nucleoside transporters), member 1 
[Homosapiens] 0.032 0.251 0.609 1.711
5114 16.4.14
mixed lineage kinase-related kinase MRK-beta; mixed lineage 
kinasewith a leucine zipper and a sterile alpha motif; mixedlineage 
kinase-related kinase [Homo sapiens] 0.003 0.023 0.235 0.729
5132 13.5.12 Unknown (protein for MGC:25768) [Mus musculus] 0.042 0.280 0.158 0.811
5140 13.5.20
aristaless related homeobox; aristaless-related homeobox, X-
linked[Homo sapiens] 0.703 0.001 0.024 0.753
5155 14.5.15 No Hits Found 0.019 0.035 0.314 4.271




no. BlastX line age interaction
Fold 
diff
5208 13.6.8 hypothetical protein [Rhodopseudomonas palustris] 0.044 0.171 0.519 0.748
5283 13.7.3 carbamoyl-phosphate synthetase (E.C.6.3.5.5) 0.000 0.725 0.767 1.066
5285 13.7.5 bone morphogenetic protein 1 [Gallus gallus] 0.048 0.544 0.322 2.203
5331 15.7.11 CD47 antigen [Bos taurus] 0.010 0.318 0.544 1.134
5353 16.7.13 unnamed protein product [Mus musculus] 0.033 0.785 0.024 1.800
5430 16.8.10 No Hits Found 0.047 0.424 0.588 3.188
5456 13.9.16 CD63 antigen 0.007 0.033 0.230 1.327
5479 14.9.19 Ig light chain precursor 0.050 0.528 0.449 0.968
5495 15.9.15 prosaposin [Gallus gallus] 0.014 0.004 0.959 0.946
5499 15.9.19 multiple exostoses type II protein EXT2.I [Homo sapiens] 0.033 0.740 0.241 1.635
5532 13.10.12 immunoglobulin-like receptor CHIR-A [Gallus gallus] 0.031 0.118 0.895 0.916
5579 15.10.19 nectin-lke 1 [Mus musculus] 0.003 0.018 0.103 1.072
5691 13.12.11 MHC class II-associated invariant chain [Gallus gallus] 0.001 0.144 0.094 1.088
5732 15.12.12 No Hits Found 0.029 0.750 0.322 1.768
5781 14.13.1 aldose reductase 0.003 0.007 0.854 1.046
5845 13.14.5 No Hits Found 0.030 0.049 0.568 1.228
5846 13.14.6
similar to dJ886K2.3(GALE (UDP-galactose-4-epimerase)) 
[Homosapiens] 0.018 0.867 0.442 0.828
5855 13.14.15 growth hormone receptor [Gallus gallus] 0.002 0.026 0.291 1.657
5862 14.14.2 Similar to RIKEN cDNA 0610013D04 gene [Homo sapiens] 0.023 0.029 0.557 0.728
6021 14.16.1 RIKEN cDNA 2610034N24 [Mus musculus] 0.028 0.496 0.903 0.772
6074 16.16.14 hypothetical protein XP_148705 [Mus musculus] 0.009 0.126 0.835 1.180
6401 17.1.1 No Hits Found 0.048 0.419 0.339 1.262
6438 18.1.18 D15Wsu75e protein [Mus musculus] 0.372 0.313 0.006 0.714
6447 19.1.7 histocompatibility 13 [Mus musculus] 0.040 0.006 0.962 2.499
6480 20.1.20 stathmin [Gallus gallus] 0.037 0.000 0.644 1.261
6495 17.2.15
leucine-rich, glioma inactivated 1 precursor; epilepsy, partial[Homo 
sapiens] 0.004 0.061 0.345 0.876
6503 18.2.3 No Hits Found 0.044 0.000 0.219 1.024
6507 18.2.7
translocase of inner mitochondrial membrane 8 homolog 
A;deafness/dystonia peptide; translocase of innermitochondrial 
membrane 8 (yeast) homolog A [Homosapiens] 0.001 0.797 0.011 0.682
6511 18.2.11 claudin 10 [Homo sapiens] 0.018 0.001 0.866 1.321
6533 19.2.13 MHC class II-associated invariant chain [Gallus gallus] 0.002 0.057 0.114 1.414
6545 20.2.5 hypothetical protein [Macaca fascicularis] 0.010 0.509 0.735 0.765
6629 20.3.9 No Hits Found 0.231 0.379 0.044 1.349
6690 19.4.10
Transcript Antisense to Ribosomal RNA; Tar1p 
[Saccharomycescerevisiae] 0.049 0.016 0.843 0.980
6745 18.5.5 No Hits Found 0.014 0.002 0.839 0.735
6768 19.5.8 dJ963K23.4 (continues in dJ1041C10 (AL162615)) [Homo sapiens] 0.036 0.464 0.353 1.688
6794 20.5.14 No Hits Found 0.020 0.011 0.699 0.942
6840 18.6.20
Glycylpeptide N-tetradecanoyltransferase 2 (PeptideN-
myristoyltransferase 2) (Myristoyl-CoA:proteinN-myristoyltransferase 
2) (NMT 2) (Type IIN-myristoyltransferase) 0.000 0.155 0.470 1.135
6849 19.6.9 KIAA0872 protein [Homo sapiens] 0.422 0.433 0.034 0.964
6947 20.7.7 No Hits Found 0.008 0.002 0.750 1.096
7037 20.8.17 clusterin [Gallus gallus] 0.010 0.817 0.048 1.217
7110 20.9.10 Glutathione reductase, mitochondrial precursor (GR) (GRase) 0.000 0.064 0.924 0.720
7147 18.10.7 gene 17.5 protein - chicken 0.000 0.910 0.232 2.423
7157 18.10.17 No Hits Found 0.018 0.815 0.580 2.092
7333 19.12.13 unnamed protein product [Mus musculus] 0.016 0.624 0.826 2.340
7349 20.12.9 No Hits Found 0.026 0.028 0.106 1.370
7376 17.13.16 No Hits Found 0.125 0.160 0.036 0.803
7388 18.13.8 No Hits Found 0.019 0.272 0.086 0.774
7423 20.13.3 unnamed protein product [Homo sapiens] 0.048 0.443 0.332 1.020
7428 20.13.8 No Hits Found 0.045 0.221 0.268 0.885
7501 20.14.1 3-mercaptopyruvate sulfurtransferase [Homo sapiens] 0.036 0.184 0.796 0.772
7517 20.14.17
serine (or cysteine) proteinase inhibitor, clade F, member 2;plasmin 
inhibitor alpha 2; alpha 2 antiplasmin; serine(or cysteine) proteinase 
inhibitor, clade F (alpha-2antiplasmin, pigment epithelium derived 
factor), member2 [Mus musculus] 0.010 0.005 0.278 0.825
7570 19.15.10 unnamed protein product [Mus musculus] 0.004 0.252 0.261 0.706
7639 18.16.19 CCCH zinc finger protein C3H-3 [Xenopus laevis] 0.345 0.724 0.023 0.794
7702 18.17.2
peptidyl-glycine alpha-amidating monooxygenase precursor (EC 




no. BlastX line age interaction
Fold 
diff
8048 23.1.8 ionized calcium binding adapter molecule 2 [Mus musculus] 0.023 0.047 0.608 0.961
8138 23.2.18 EWS [Homo sapiens] 0.017 0.469 0.537 1.125
8169 21.3.9 hyaluronoglucosaminidase 3 [Homo sapiens] 0.024 0.005 0.709 1.685
8207 23.3.7 unnamed protein product [Mus musculus] 0.950 0.003 0.035 0.733
8257 21.4.17 proline rich protein 2 [Mus musculus] 0.001 0.000 0.402 0.748
8418 21.6.18 calreticulin [Mus musculus] 0.002 0.756 0.143 1.013
8433 22.6.13 No Hits Found 0.020 0.009 0.546 1.530
8438 22.6.18
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A 
dehydrogenase[Homo sapiens] 0.039 0.091 0.258 0.966
8479 24.6.19
pleiotrophin; osteoblastic cell factor; heparin-binding brainmitogen; 
heparin-binding growth factor 8; heparin affinregulatory peptide; 
heparin-binding neurotorphic factor;heparin-binding neurite promoting 
factor;heparin-binding growth-associated molecule [Musmusculus] 0.043 0.040 0.557 4.215
8555 24.7.15 FLJ00239 protein [Homo sapiens] 0.002 0.268 0.211 1.020
8655 21.9.15 MHC class I antigen [Gallus gallus] 0.342 0.565 0.014 1.519
8673 22.9.13 tetranectin [Gallus gallus] 0.000 0.550 0.326 1.475
8703 24.9.3
basic leucine zipper and W2 domains 1; KIAA0005 gene product; 
basic leucine-zipper protein BZAP45 [Homo sapiens] 0.076 0.292 0.030 0.720
8851 23.11.11 proline rich protein 2 [Mus musculus] 0.007 0.012 0.287 2.187
8866 24.11.6 syndecan 0.012 0.094 0.169 2.489
8876 24.11.16 No Hits Found 0.059 0.172 0.031 0.694
8919 22.12.19 calcium binding protein P22; Sid470p [Mus musculus] 0.143 0.076 0.031 1.126
8961 21.13.1
proteasome 26S ATPase subunit 4 isoform 1; protease 26S subunit 
6;Tat-binding protein 7; MB67 interacting protein [Homosapiens] 0.006 0.990 0.871 0.728
8984 22.13.4 No Hits Found 0.015 0.155 0.219 1.126
8989 22.13.9 No Hits Found 0.048 0.533 0.940 1.338
9001 23.13.1 kelch domain containing 1 [Homo sapiens] 0.046 0.562 0.943 1.601
9071 22.14.11 No Hits Found 0.041 0.296 0.057 2.779
9090 23.14.10 No Hits Found 0.006 0.003 0.495 1.964
9447 21.19.7 Wnt-5a [Gallus gallus] 0.015 0.064 0.144 1.836
9635 26.1.15
similar to hypothetical protein similar to RNA-binding protein 
lark[Homo sapiens] [Rattus norvegicus] 0.010 0.013 0.409 1.442
9659 27.1.19 hypothetical protein [Rhodobacter sphaeroides] 0.045 0.201 0.937 1.705
9713 26.2.13 No Hits Found 0.024 0.493 0.735 0.854
9743 28.2.3
Cytokine-inducible SH2-containing protein (CIS) (CIS-1) (Suppressor 
of cytokine signaling) (SOCS) 0.763 0.481 0.033 0.755
9781 26.3.1
probable translational initiation factor; putative translationinitiation 
factor IF-2(fragment) [Streptomycescoelicolor A3(2)] 0.016 0.008 0.821 1.098
9843 25.4.3 immunoglobulin alpha heavy chain [Gallus gallus] 0.004 0.008 0.670 2.456
9878 26.4.18 PTD009 protein [Homo sapiens] 0.036 0.098 0.687 1.011
10038 26.6.18 No Hits Found 0.042 0.325 0.599 1.472
10040 26.6.20 UV radiation resistance associated gene [Homo sapiens] 0.016 0.003 0.457 1.542
10070 28.6.10 glypican 3 [Homo sapiens] 0.003 0.000 0.099 2.420
10098 25.7.18 No Hits Found 0.000 0.513 0.653 1.806
10099 25.7.19 No Hits Found 0.041 0.053 0.409 2.443
10168 25.8.8 syndecan-2 variant 1 [Gallus gallus] 0.002 0.349 0.089 0.826
10231 28.8.11 laminin, gamma 1 precursor; formerly LAMB2 [Homo sapiens] 0.022 0.041 0.585 0.819
10287 27.9.7 aspartyl aminopeptidase [Homo sapiens] 0.027 0.029 0.811 0.762
10322 25.10.2
Similar to gene trap ROSA 26 antisense, Philippe Soriano [Mus 
musculus] 0.040 0.216 0.952 0.858
10345 26.10.5
active breakpoint cluster region-related  protein isoform a 
[Homosapiens] 0.011 0.078 0.970 1.288
10348 26.10.8
chromosome 6 open reading frame 4 isoform 1; chromosome 6 open 
reading frame 6; chromosome 6 open reading frame 5; connection to 
IKK and SAPK/JNK; NFkB-activating protein ACT1 [Homo sapiens] 0.181 0.149 0.047 2.096
10350 26.10.10 RIKEN cDNA 1200015A22 [Mus musculus] 0.009 0.043 0.478 1.204
10438 26.11.18
ATPase, H+ transporting, lysosomal V0 subunit a isoform 4; 
vacuolarproton pump 116 kDa accessory subunit; vacuolar 
protonpump, subunit 2; H(+)-transporting two-sector 
ATPase,noncatalytic accessory protein 1B; ATPase, H+transporting, 
lysosomal (vacuolar proton pump)non-catalytic accessory protein 1B; 
renal tubularacidosis; ATPase, H+ transporting, lysosomal 
(vacuolarproton pump) non-catalytic accessory protein 2 (38kD)[Homo 
sapiens] 0.685 0.140 0.030 3.228








Predicted CDS, cuticle collagen family member [Caenorhabditis 
elegans] 0.011 0.605 0.731 0.986
10667 26.14.7 No Hits Found 0.038 0.001 0.085 1.254
10675 26.14.15 alpha-1-antiproteinase [Xenopus laevis] 0.037 0.156 0.229 2.165
10702 28.14.2 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase [Gallus gallus] 0.002 0.039 0.056 1.248
10767 27.15.7 LYSYL-TRNA SYNTHETASE (LYSINE --TRNA LIGASE) (LYSRS) 0.189 0.048 0.042 0.690
10888 25.17.8 similar to smoothelin isoform c [Homo sapiens] [Mus musculus] 0.011 0.342 0.672 1.793
10937 27.17.17 lysyl oxidase-like 2 [Homo sapiens] 0.000 0.000 0.563 2.540
10954 28.17.14 No Hits Found 0.030 0.002 0.617 0.710
11262 32.1.2
vesicular membrane protein p24; vesicular membrain protein 
p24[Homo sapiens] 0.002 0.000 0.988 0.825
11265 32.1.5
Platelet-endothelial tetraspan antigen 3 (PETA-3) (GP27) (Membrane 
glycoprotein SFA-1) (CD151 antigen) 0.003 0.000 0.410 0.934
11292 29.2.12 RNA polymerase II largest subunit 0.199 0.089 0.012 0.854
11305 30.2.5 hypothetical protein MGC4293 [Homo sapiens] 0.016 0.002 0.512 0.794
11309 30.2.9 No Hits Found 0.001 0.820 0.858 1.069
11313 30.2.13 cited2/melanocyte specific gene-related gene 1 MRG1 [Gallus gallus] 0.002 0.001 0.124 2.847
11345 32.2.5 aldo-keto reductase [Gallus gallus] 0.000 0.807 0.504 0.913
11363 29.3.3 ADP-ribosylation factor-like 1 [Rattus norvegicus] 0.019 0.000 0.293 1.111
11494 31.4.14 unnamed protein product [Homo sapiens] 0.024 0.004 0.419 0.692
11515 32.4.15
RIKEN cDNA 1810046J19; expressed sequence AI463380 [Mus 
musculus] 0.001 0.015 0.583 0.814
11523 29.5.3 unnamed protein product [Mus musculus] 0.011 0.633 0.798 0.773
11530 29.5.10
similar to cytoplasmic cysteine conjugate-beta lyase;glutamine-
phenylpyruvate aminotransferase [Homo sapiens][Mus musculus] 0.000 0.254 0.438 0.779
11560 30.5.20 No Hits Found 0.660 0.264 0.027 0.995
11610 29.6.10 No Hits Found 0.473 0.592 0.031 1.075
11622 30.6.2 skeletrophin; dystrophin-like [Mus musculus] 0.037 0.002 0.428 1.435
11649 31.6.9 No Hits Found 0.002 0.000 0.296 0.771
11797 30.8.17 Unknown (protein for IMAGE:3507673) [Homo sapiens] 0.000 0.001 0.370 0.943
11963 31.10.3 similar to ZK792.1b.p [Homo sapiens] 0.046 0.117 0.202 0.955
12097 29.12.17 stromal cell-derived factor 2-like 1 [Mus musculus] 0.041 0.199 0.292 0.997
12199 30.13.19 No Hits Found 0.037 0.595 0.148 1.280
12217 31.13.17 catecholamine-O-methyltransferase [Rattus norvegicus] 0.001 0.011 0.076 0.966
12255 29.14.15 No Hits Found 0.020 0.000 0.062 1.331
12314 32.14.14 No Hits Found 0.004 0.018 0.525 0.962
12350 30.15.10 L-lactate dehydrogenase A chain (LDH-A) 0.003 0.024 0.123 1.492
12915 34.2.15 ADP-ribosylation factor 1 [Homo sapiens] 0.027 0.007 0.652 0.777
12945 36.2.5
Fc fragment of IgG binding protein; IgG Fc binding protein [Homo 
sapiens] 0.009 0.001 0.512 1.062
12970 33.3.10 RIKEN cDNA 1200007O21 [Mus musculus] 0.019 0.002 0.626 1.194
12975 33.3.15 No Hits Found 0.038 0.013 0.889 1.177
12976 33.3.16 UV radiation resistance associated gene [Homo sapiens] 0.011 0.003 0.578 1.154
13006 35.3.6 unnamed protein product [Mus musculus] 0.030 0.021 0.348 1.229
13019 35.3.19
proteasome (prosome, macropain) 28 subunit, alpha; protease(prosome, 
macropain) 28 subunit, alpha [Mus musculus] 0.019 0.257 0.303 0.796
13057 33.4.17 hypothetical protein MGC32124 [Homo sapiens] 0.050 0.022 0.037 1.364
13108 36.4.8
complement component factor h; complement factor H related protein 
3A4/5G4 [Mus musculus] 0.000 0.438 0.051 0.829
13203 33.6.3 glucosamine-6-phosphate isomerase [Homo sapiens] 0.032 0.004 0.667 1.048
13212 33.6.12
major histocompatibility complex class II beta chain; B-L betachain 
[Gallus gallus] 0.003 0.160 0.048 0.981
13227 34.6.7 No Hits Found 0.039 0.662 0.599 0.701
13304 34.7.4 rhomboid-related protein [Homo sapiens] 0.217 0.082 0.013 1.783
13578 35.10.18 No Hits Found 0.043 0.644 0.553 0.867
13779 33.13.19 CGI-133 protein [Homo sapiens] 0.002 0.365 0.958 0.867
13876 34.14.16
ALCOHOL DEHYDROGENASE CLASS III (GLUTATHIONE-
DEPENDENT FORMALDEHYDE DEHYDROGENASE) (FDH) 0.061 0.043 0.044 1.005
14002 33.16.2 carbonic anhydrase [Mus musculus] 0.011 0.150 0.547 0.753
14052 35.16.12
ADENYLATE KINASE ISOENZYME 1 (ATP-AMP 
TRANSPHOSPHORYLASE) (AK1)(MYOKINASE) 0.016 0.332 0.579 0.809
14080 36.16.20 No Hits Found 0.007 0.588 0.889 0.817
14091 33.17.11
SEC24 (S. cerevisiae) homolog B; secretory protein 24; Sec24-related 
protein B; protein transport protein Sec24B [Homo sapiens] 0.994 0.327 0.047 0.902




no. BlastX line age interaction
Fold 
diff
14157 36.17.17 Cog4S [Homo sapiens] 0.004 0.068 0.695 0.960
14236 36.18.16 No Hits Found 0.019 0.501 0.991 0.898
14275 34.19.15 No Hits Found 0.026 0.277 0.246 1.122
14490 37.2.10 No Hits Found 0.029 0.003 0.641 1.125
14515 38.2.15 MHC class I histocompatibility antigen B-F alpha chain 2 - chicken 0.086 0.542 0.019 1.386
14541 40.2.1 Protein CGI-100 precursor 0.012 0.157 0.907 0.779
14563 37.3.3
bA207C16.3 (novel protein similar to predicted yeast, plant andworm 
proteins) [Homo sapiens] 0.006 0.005 0.664 0.829
14571 37.3.11 No Hits Found 0.006 0.021 0.091 2.119
14589 38.3.9 No Hits Found 0.038 0.000 0.688 1.069
14596 38.3.16 No Hits Found 0.008 0.010 0.639 1.039
14623 40.3.3
Lysosomal alpha-mannosidase precursor (Mannosidase, alpha B) 
(Lysosomal acid alpha-mannosidase) (Laman) (Mannosidase alpha 
class 2B member 1) 0.029 0.489 0.024 1.873
14625 40.3.5 unnamed protein product [Mus musculus] 0.001 0.016 0.056 0.852
14643 37.4.3
similar to hypothetical protein FLJ20225 [Homo sapiens] 
[Musmusculus] 0.025 0.012 0.787 0.946
14688 39.4.8 beta-xylosidase B [Clostridium stercorarium] 0.039 0.000 0.261 1.194
14690 39.4.10 type I hair keratin 6; keratin, hair, acidic, 6 [Homo sapiens] 0.012 0.055 0.226 0.697
14816 37.6.16
polymerase (DNA directed), delta 2, regulatory subunit 50kDa; 
polymerase (DNA directed), delta 2, regulatory subunit (50kD) [Homo 
sapiens] 0.013 0.137 0.778 0.784
14839 38.6.19 No Hits Found 0.984 0.247 0.024 1.280
14871 40.6.11 procKr2 - chicken (fragment) 0.021 0.070 0.588 1.729
14944 40.7.4 Unknown (protein for MGC:26097) [Homo sapiens] 0.034 0.022 0.637 0.729
14955 40.7.15 attractin [Mesocricetus auratus] 0.013 0.343 0.647 3.522
15001 39.8.1 dJ761I2.1 (enhancer of filamentation (HEF1)) [Homo sapiens] 0.049 0.223 0.959 1.035
15027 40.8.7
solute carrier family 21 (organic anion transporter), member 11 [Homo 
sapiens] 0.038 0.232 0.031 2.002
15125 37.10.5 repressor protein [Homo sapiens] 0.039 0.100 0.283 0.904
15165 39.10.5 neurofascin - chicken 0.000 0.077 0.702 0.871
15188 40.10.8
similar to latent transforming growth factor beta binding protein 1; 
latent TGF beta binding protein [Mus musculus] 0.040 0.173 0.421 0.774
15228 38.11.8 Salivary gland secretion 1 [Drosophila melanogaster] 0.004 0.637 0.259 1.366
15285 37.12.5 No Hits Found 0.017 0.088 0.077 0.883
15370 37.13.10
small integral membrane protein of lysosome/late endosome 
[Gallusgallus] 0.025 0.421 0.609 1.108
15379 37.13.19 lecithin cholesterol acyltransferase [Anas platyrhynchos] 0.025 0.419 0.097 1.265
15429 40.13.9 hypothetical protein [Rhodopseudomonas palustris] 0.027 0.110 0.032 1.274
15432 40.13.12 No Hits Found 0.022 0.485 0.633 1.556
15436 40.13.16
blood plasma glutamate carboxypeptidase precursor;prostate-specific 
membrane antigen (PSMA) [Homo sapiens] 0.000 0.018 0.599 1.226
15439 40.13.19
serine/threonine kinase 25 (yeast); Ste20-like kinase;serine/threonine 
kinase 25 (Ste20, yeast homolog); YeastSps1/Ste20-related kinase 1 
[Mus musculus] 0.028 0.848 0.376 0.730
15471 38.14.11 No Hits Found 0.007 0.274 0.760 1.779
15473 38.14.13 Similar to Human C219-reactive peptide (L34688) [Homo sapiens] 0.050 0.542 0.490 2.078
15599 40.15.19 GTP-binding protein Rab0 [Rattus norvegicus] 0.734 0.812 0.015 1.603
15633 38.16.13 talin [Gallus gallus] 0.004 0.462 0.625 0.851
15831 40.18.11 No Hits Found 0.006 0.278 0.673 0.784
16022 42.1.2 hypothetical protein XP_161952 [Mus musculus] 0.018 0.519 0.695 0.692
16054 43.1.14 MHC Rfp-Y class I alpha chain [Gallus gallus] 0.525 0.448 0.043 1.592
16088 41.2.8 No Hits Found 0.018 0.004 0.630 0.880
16138 43.2.18 unnamed protein product [Mus musculus] 0.037 0.000 0.719 1.189
16145 44.2.5 No Hits Found 0.012 0.000 0.933 0.804
16173 41.3.13 No Hits Found 0.000 0.003 0.259 0.843
16177 41.3.17
blood plasma glutamate carboxypeptidase precursor;prostate-specific 
membrane antigen (PSMA) [Homo sapiens] 0.000 0.268 0.507 1.385
16182 42.3.2 Ig light chain precursor 0.005 0.000 0.617 4.824
16213 43.3.13 KIAA1627 protein [Homo sapiens] 0.010 0.206 0.673 0.821
16234 44.3.14
similar to Putative ubiquinone biosynthesis monooxgenase COQ6 
(CGI-10) [Mus musculus] 0.030 0.006 0.650 1.283
16255 41.4.15 MHC class I antigen [Gallus gallus] 0.066 0.597 0.027 0.847
16294 43.4.14 Ig gamma chain (clone 36) - chicken (fragment) 0.022 0.002 0.730 5.161




no. BlastX line age interaction
Fold 
diff
16323 41.5.3 neuromedin U [Homo sapiens] 0.043 0.013 0.365 1.631
16376 43.5.16 Unknown (protein for IMAGE:3659371) [Homo sapiens] 0.048 0.362 0.442 0.836
16383 44.5.3 No Hits Found 0.594 0.536 0.006 1.518
16400 44.5.20 DEAD-box protein abstrakt; putative RNA helicase [Homo sapiens] 0.026 0.146 0.417 0.750
16413 41.6.13 NIP1 [Homo sapiens] 0.027 0.144 0.067 1.011
16482 41.7.2 MHC class I [Gallus gallus] 0.189 0.672 0.028 1.046
16488 41.7.8 REST corepressor; KIAA0071 protein [Homo sapiens] 0.042 0.006 0.559 1.535
16502 42.7.2 hypothetical protein FLJ11198 [Homo sapiens] 0.047 0.581 0.400 2.111
16579 41.8.19 hypothetical protein MGC2494 [Homo sapiens] 0.036 0.017 0.259 0.869
16632 44.8.12
mitogen-activated protein kinase kinase 1 interacting protein 1;MEK 
partner 1; MEK binding partner 1 [Homo sapiens] 0.041 0.034 0.797 0.912
16638 44.8.18 No Hits Found 0.021 0.292 0.489 0.792
16722 41.10.2 androgen induced protein [Homo sapiens] 0.045 0.215 0.267 0.823
16935 43.12.15 No Hits Found 0.030 0.056 0.153 0.749
16939 43.12.19
GROWTH HORMONE RECEPTOR PRECURSOR (GH 
RECEPTOR) (SERUM BINDING PROTEIN) 0.031 0.012 0.191 0.698
17004 43.13.4 Lamin A 0.046 0.304 0.786 0.700
17076 42.14.16 Serum albumin precursor 0.829 0.314 0.035 2.771
17103 44.14.3 NADH dehydrogenase subunit 6 [Gallus gallus] 0.002 0.050 0.236 0.856
17128 41.15.8
similar to hypothetical protein MGC30022 [Homo sapiens] 
[Musmusculus] 0.360 0.702 0.032 2.519
17186 44.15.6 NONHISTONE CHROMOSOMAL PROTEIN HMG-14A 0.025 0.000 0.945 0.716
17319 42.17.19 No Hits Found 0.010 0.019 0.952 0.739
17419 43.18.19 KIAA1784 protein [Homo sapiens] 0.020 0.165 0.441 4.134
17438 44.18.18 No Hits Found 0.024 0.033 0.830 0.763
17440 44.18.20 Nd1 [Mus musculus] 0.011 0.015 0.522 0.884
17454 41.19.14 hypothetical protein FLJ33903 [Homo sapiens] 0.004 0.815 0.028 1.618
17622 46.1.2 SH3-containing protein SH3GLB2 [Mus musculus] 0.008 0.000 0.530 0.887
17651 47.1.11 KIAA1184 protein [Homo sapiens] 0.022 0.028 0.367 1.068
17746 48.2.6 Similar to guanylate cyclase 1, soluble, alpha 3 [Homo sapiens] 0.000 0.110 0.025 1.153
17981 48.5.1 p57kip2 0.016 0.000 0.525 3.878
17984 48.5.4
similar to Ca<2+>dependent activator protein for secretion; Ca2+-
dependent activator protein for secretion [Homo sapiens] 0.899 0.063 0.016 1.120
18016 45.6.16
PROTEIN-TYROSINE PHOSPHATASE X PRECURSOR (R-PTP-X) 
(M1851) 0.006 0.009 0.402 3.851
18020 45.6.20 RIKEN cDNA 1200007O21 [Mus musculus] 0.000 0.000 0.521 1.003
18126 47.7.6 mitochondrial carrier homolog 1 isoform a [Mus musculus domesticus] 0.023 0.087 0.983 2.593
18215 47.8.15
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3;procollagen-lysine, 
2-oxoglutarate 5-dioxygenase 3v;lysyl hydroxylase 3 [Homo sapiens] 0.038 0.574 0.775 0.703
18264 46.9.4 hypothetical protein MGC19606 [Homo sapiens] 0.040 0.020 0.571 0.726
18295 47.9.15 MHC class II-associated invariant chain [Gallus gallus] 0.012 0.091 0.133 0.824
18331 45.10.11 keratin 18 [Homo sapiens] 0.000 0.012 0.007 2.084
18439 46.11.19 No Hits Found 0.043 0.132 0.480 0.932
18472 48.11.12 tumor necrosis factor receptor 0.020 0.095 0.355 1.959
18476 48.11.16 No Hits Found 0.040 0.970 0.882 1.339
18511 46.12.11 No Hits Found 0.040 0.000 0.719 0.709
18522 47.12.2 CD48 antigen; expressed sequence AI449234 [Mus musculus] 0.008 0.843 0.154 0.699
18533 47.12.13 No Hits Found 0.408 0.001 0.007 0.798
18589 46.13.9
CD38 antigen; CD38 antigen (ADP-ribosyl cyclase / cyclic ADP-
ribose hydrolase) [Rattus norvegicus] 0.007 0.079 0.246 1.702
18615 47.13.15 No Hits Found 0.003 0.031 0.468 0.878
18634 48.13.14 No Hits Found 0.018 0.782 0.152 0.910
18786 48.15.6
nucleotide binding protein 2 (MinD homolog, E. coli); 
nucleotidebinding protein 2 (E.coli MinD like) [Homo sapiens] 0.045 0.630 0.262 0.980
18823 46.16.3
similar to Kelch motif containing protein~data source:Pfam, 
sourcekey:PF01344, evidence:ISS~putative [Homo sapiens] 0.017 0.040 0.666 0.798
18850 47.16.10 Ig light chain precursor 0.001 0.001 0.370 2.308
18991 46.18.11 unnamed protein product [Mus musculus] 0.035 0.919 0.725 0.976
19041 45.19.1
amyotrophic lateral sclerosis 2 (juvenile) chromosome region,candidate 
19; partitioning-defective 3-like [Homosapiens] 0.040 0.786 0.874 0.947
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Table 7. Up-regulated genes in the Lean line at 1-week of age.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number;  BlastX is the highest 
scoring translated BLAST hit; Lean 1 and Fat 1 are the normalized log2 ratios for each 
line at 1-week of age; Fold diff is the fold change between the Lean and Fat log2 means.  
Bolded and italicized Spot numbers are genes that were chosen as potential candidate 
genes for further investigation.
Spot BlastX Lean 1 Fat 1
Fold 
diff
2706 No Hits Found 1.386 -1.220 2.606
7147 gene 17.5 protein - chicken 1.437 -0.986 2.423
3645 LH-beta -0.643 -2.594 1.952
730 No Hits Found 0.492 -1.444 1.936
11313
cited2/melanocyte specific gene-related gene 1 MRG1 [Gallus 
gallus] -0.629 -2.536 1.907
2968 suppressor of fused [Gallus gallus] 1.108 -0.504 1.612
15471 No Hits Found 0.718 -0.654 1.372
10098 No Hits Found 0.708 -0.637 1.345
2350 Neuropeptide Y precursor (NPY) 1.795 0.553 1.242
7037 clusterin [Gallus gallus] 0.299 -0.918 1.217
413 Unknown (protein for MGC:10089) [Homo sapiens] 0.769 -0.391 1.160
2035
Beta-neoendorphin-dynorphin precursor (Proenkephalin 
B)(Preprodynorphin) [Contains: Beta-neoendorphin;Dynorphin; 
Leu-Enkephalin; Rimorphin; Leumorphin] -0.159 -1.316 1.157
8433 No Hits Found 0.019 -1.075 1.095
4352 similar to kinesin superfamily protein 1C [Mus musculus] 0.894 -0.169 1.063
4989
endothelial differentiation, lysophosphatidic acidG-protein-coupled 
receptor, 2 [Rattus norvegicus] 0.947 -0.102 1.049
4247 No Hits Found 1.080 0.051 1.028
5430 No Hits Found 1.171 0.151 1.020
9090 No Hits Found 0.220 -0.800 1.019
8418 calreticulin [Mus musculus] 0.693 -0.320 1.013
1764 unnamed protein product [Homo sapiens] 0.028 -0.985 1.013
1806 Similar to butyrate-induced transcript 1 [Mus musculus] -0.201 -1.198 0.997
3677 gastrin-releasing peptide precursor splice form III - human -0.632 -1.628 0.996
8989 No Hits Found 0.972 0.023 0.950
1018 No Hits Found 0.642 -0.303 0.945
8169 hyaluronoglucosaminidase 3 [Homo sapiens] -0.341 -1.278 0.937
8866 syndecan 0.723 -0.207 0.930
10038 No Hits Found 0.510 -0.406 0.916
292 Slit1 protein [Gallus gallus] 0.856 -0.046 0.901
1696 CD63 antigen 0.296 -0.588 0.884
6447 histocompatibility 13 [Mus musculus] -0.504 -1.381 0.876
5331 CD47 antigen [Bos taurus] 1.574 0.702 0.872
2745
RIKEN cDNA 1810046J19; expressed sequence AI463380 [Mus 
musculus] 1.053 0.185 0.868
12199 No Hits Found 0.803 -0.061 0.864
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5579 nectin-lke 1 [Mus musculus] 0.932 0.083 0.849
16413 NIP1 [Homo sapiens] 0.477 -0.367 0.845
6840
Glycylpeptide N-tetradecanoyltransferase 2 (PeptideN-
myristoyltransferase 2) (Myristoyl-CoA:proteinN-
myristoyltransferase 2) (NMT 2) (Type IIN-myristoyltransferase) 0.218 -0.622 0.840
10040 UV radiation resistance associated gene [Homo sapiens] -0.329 -1.166 0.838
264 unnamed protein product [Mus musculus] -0.099 -0.934 0.836
3549 gene 17.5 protein - chicken 0.615 -0.220 0.835
5283 carbamoyl-phosphate synthetase (E.C.6.3.5.5) 0.162 -0.673 0.834
17076 Serum albumin precursor 1.012 0.189 0.823
11345 aldo-keto reductase [Gallus gallus] 0.393 -0.428 0.821
3404 unnamed protein product [Homo sapiens] -0.215 -1.033 0.818
2141
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 1; beta-3-
galt1[Homo sapiens] 0.429 -0.386 0.814
1666 MAPK-interacting and spindle-stabilizing protein [Homo sapiens] 1.197 0.399 0.798
1832 Cathepsin D precursor 0.935 0.144 0.791
2889 aldo-keto reductase [Gallus gallus] 0.568 -0.221 0.789
11963 similar to ZK792.1b.p [Homo sapiens] 1.359 0.575 0.785
16722 androgen induced protein [Homo sapiens] 0.775 0.012 0.763
238 TUC-4b [Rattus norvegicus] 0.892 0.139 0.753
3242
chromosome 11 open reading frame2; chromosome  11 open 
readingframe2 [Homo sapiens] -0.281 -1.032 0.751
2101 DKFZP586B1621 protein [Homo sapiens] 0.528 -0.214 0.742
1652
transmembrane 4 superfamily member 2; membrane component, 
xchromosome, surface marker 1; T-cell acute 
lymphoblasticleukemia associated antigen 1; transmembrane 
proteinA15; tetraspanin protein; cell surface glycoprotein 
A15;CD231 antigen; transmembrane 4 superfamily 2b 
[Homosapiens] 0.059 -0.673 0.732
11610 No Hits Found -0.042 -0.754 0.712
1185 gene 17.5 protein - chicken 0.600 -0.104 0.704
13006 unnamed protein product [Mus musculus] -0.346 -1.045 0.699
1639 similar to FLJ00237 protein [Homo sapiens] -0.280 -0.978 0.698
408
serologically defined colon cancer antigen 28; 
phosphatidylcholinetransfer protein-like [Mus musculus] -0.300 -0.995 0.694
10667 No Hits Found -0.075 -0.761 0.686
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Table 8. Up-regulated genes in the Fat line at 1-week of age.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number;  BlastX is the highest 
scoring translated BLAST hit; Lean 1 and Fat 1 are the normalized log2 ratios for each 
line at 1-week of age; Fold diff is the fold change between the Lean and Fat log2 means.  
Bolded and italicized Spot numbers are genes that were chosen as potential candidate 
genes for further investigation.
Spot BlastX Lean 1 Fat 1
Fold 
diff
17419 KIAA1784 protein [Homo sapiens] 1.265 4.589 3.325
10438
ATPase, H+ transporting, lysosomal V0 subunit a isoform 4; 
vacuolarproton pump 116 kDa accessory subunit; vacuolar 
protonpump, subunit 2; H(+)-transporting two-sector 
ATPase,noncatalytic accessory protein 1B; ATPase, 
H+transporting, lysosomal (vacuolar proton pump)non-catalytic 
accessory protein 1B; renal tubularacidosis; ATPase, H+ 
transporting, lysosomal (vacuolarproton pump) non-catalytic 
accessory protein 2 (38kD)[Homo sapiens] 0.959 3.850 2.892
15027
solute carrier family 21 (organic anion transporter), member 11 
[Homo sapiens] 0.538 2.534 1.996
14955 attractin [Mesocricetus auratus] 1.431 3.412 1.980
5155 No Hits Found -0.146 1.653 1.798
5732 No Hits Found 0.072 1.840 1.768
8479
pleiotrophin; osteoblastic cell factor; heparin-binding brainmitogen; 
heparin-binding growth factor 8; heparin affinregulatory peptide; 
heparin-binding neurotorphic factor;heparin-binding neurite 
promoting factor;heparin-binding growth-associated molecule 
[Musmusculus] -1.871 -0.169 1.702
3221 Ig light chain precursor -3.625 -1.963 1.662
18331 keratin 18 [Homo sapiens] 0.104 1.654 1.550
8851 proline rich protein 2 [Mus musculus] 1.040 2.510 1.469
2413 No Hits Found 0.573 2.020 1.447
2567 chromodomain helicase DNA binding protein 2 [Homo sapiens] 0.388 1.752 1.365
4311 Thymosin beta -0.955 0.243 1.199
18476 No Hits Found 0.300 1.449 1.149
16182 Ig light chain precursor -3.586 -2.463 1.122
3241
adenylate cyclase 2; adenylyl cyclase 2; adenylate cyclase II; 
adenylyl cyclase; ATP pyrophosphate-lyase; type II adenylate 
cyclase; 3',5'-cyclic AMP synthetase [Homo sapiens] -1.285 -0.174 1.110
8673 tetranectin [Gallus gallus] -0.535 0.550 1.085
9071 No Hits Found 0.408 1.480 1.071
15473 Similar to Human C219-reactive peptide (L34688) [Homo sapiens] 0.583 1.647 1.064
8655 MHC class I antigen [Gallus gallus] -1.092 -0.034 1.058
11309 No Hits Found -0.018 1.036 1.054
15228 Salivary gland secretion 1 [Drosophila melanogaster] -0.370 0.652 1.023
4880 Regulator of G-protein signaling 5 -0.658 0.362 1.020
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expressed sequence AA408877; hypothetical protein MGC38511 
[Musmusculus] -0.810 0.201 1.011
18991 unnamed protein product [Mus musculus] -0.166 0.810 0.976
6533 MHC class II-associated invariant chain [Gallus gallus] -0.774 0.191 0.965
17746 Similar to guanylate cyclase 1, soluble, alpha 3 [Homo sapiens] -0.903 0.037 0.940
9001 kelch domain containing 1 [Homo sapiens] 0.048 0.987 0.939
16177
blood plasma glutamate carboxypeptidase precursor;prostate-
specific membrane antigen (PSMA) [Homo sapiens] -0.054 0.861 0.915
18634 No Hits Found 0.341 1.251 0.910
18126
mitochondrial carrier homolog 1 isoform a [Mus musculus 
domesticus] -0.590 0.296 0.886
1507 No Hits Found -0.650 0.236 0.886
3033 fragile X mental retardation protein 0.623 1.509 0.886
4200 No Hits Found 0.277 1.130 0.853
15436
blood plasma glutamate carboxypeptidase precursor;prostate-
specific membrane antigen (PSMA) [Homo sapiens] -0.341 0.502 0.843
12350 L-lactate dehydrogenase A chain (LDH-A) -0.545 0.295 0.840
15432 No Hits Found 0.020 0.846 0.826
13876
ALCOHOL DEHYDROGENASE CLASS III (GLUTATHIONE-
DEPENDENT FORMALDEHYDE DEHYDROGENASE) (FDH) -0.124 0.695 0.819
16294 Ig gamma chain (clone 36) - chicken (fragment) -4.189 -3.373 0.816
10702
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase [Gallus 
gallus] -0.696 0.112 0.808
16323 neuromedin U [Homo sapiens] 0.306 1.110 0.805
4170 catalase [Canis familiaris] 0.093 0.892 0.799
5691 MHC class II-associated invariant chain [Gallus gallus] -0.592 0.202 0.795
14515 MHC class I histocompatibility antigen B-F alpha chain 2 - chicken -0.805 -0.021 0.783
10350 RIKEN cDNA 1200015A22 [Mus musculus] -0.255 0.526 0.781
13108
complement component factor h; complement factor H related 
protein 3A4/5G4 [Mus musculus] -0.490 0.266 0.757
1017 hypothetical protein XP_148064 [Mus musculus] 0.717 1.473 0.756
4811 Zinc finger protein CKR1 -0.460 0.287 0.747
4127 No Hits Found -0.223 0.513 0.736
2600 hypothetical protein MGC10485 [Homo sapiens] -0.479 0.251 0.730
7639 CCCH zinc finger protein C3H-3 [Xenopus laevis] 0.256 0.984 0.728
9878 PTD009 protein [Homo sapiens] 0.271 0.992 0.721
12217 catecholamine-O-methyltransferase [Rattus norvegicus] -0.093 0.622 0.716
16638 No Hits Found -0.202 0.502 0.704
9659 hypothetical protein [Rhodobacter sphaeroides] -0.637 0.060 0.697
8555 FLJ00239 protein [Homo sapiens] -0.230 0.465 0.695
18472 tumor necrosis factor receptor 0.273 0.967 0.694
10675 alpha-1-antiproteinase [Xenopus laevis] -0.455 0.237 0.692
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Table 9. Up-regulated genes in the Lean line at 3-weeks of age.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number;  BlastX is the highest 
scoring translated BLAST hit; Lean 3 and Fat 3 are the normalized log2 ratios for each 
line at 3-weeks of age; Fold diff is the fold change between the Lean and Fat log2 means.  
Bolded and italicized Spot numbers are genes that were chosen as potential candidate 
genes for further investigation.
Spot BlastX Lean 3 Fat 3
Fold 
diff
5285 bone morphogenetic protein 1 [Gallus gallus] 1.345 -0.858 2.20
7157 No Hits Found 1.375 -0.717 2.09
17076 Serum albumin precursor 1.428 -0.536 1.96
2968 suppressor of fused [Gallus gallus] 1.238 -0.612 1.85
9447 Wnt-5a [Gallus gallus] 0.377 -1.178 1.56
10098 No Hits Found 0.477 -0.967 1.44
455 No Hits Found 0.348 -0.949 1.30
2706 No Hits Found 0.314 -0.975 1.29
1650 cell division cycle control protein 37 1.333 0.079 1.25
2854 dJ259A10.1 (ssDNA binding protein (SEB4D)) [Homo sapiens] 0.236 -0.973 1.21
15599 GTP-binding protein Rab0 [Rattus norvegicus] 0.032 -1.161 1.19
9090 No Hits Found 0.691 -0.500 1.19
5456 CD63 antigen 0.376 -0.732 1.11
10038 No Hits Found 0.912 -0.161 1.07
730 No Hits Found 0.701 -0.345 1.05
701 prolyl 4-hydroxylase, alpha subunit (EC 1.14.11.2) 1.422 0.382 1.04
1696 CD63 antigen 0.444 -0.595 1.04
1185 gene 17.5 protein - chicken 0.879 -0.149 1.03
2889 aldo-keto reductase [Gallus gallus] 0.671 -0.314 0.98
8866 syndecan 0.743 -0.239 0.98
5283 carbamoyl-phosphate synthetase (E.C.6.3.5.5) 0.289 -0.689 0.98
6447 histocompatibility 13 [Mus musculus] 0.621 -0.357 0.98
1652
transmembrane 4 superfamily member 2; membrane component, 
xchromosome, surface marker 1; T-cell acute 
lymphoblasticleukemia associated antigen 1; transmembrane 
proteinA15; tetraspanin protein; cell surface glycoprotein 
A15;CD231 antigen; transmembrane 4 superfamily 2b 
[Homosapiens] 0.707 -0.263 0.97
6840
Glycylpeptide N-tetradecanoyltransferase 2 (PeptideN-
myristoyltransferase 2) (Myristoyl-CoA:proteinN-
myristoyltransferase 2) (NMT 2) (Type IIN-myristoyltransferase) 0.278 -0.691 0.97
14839 No Hits Found 0.097 -0.857 0.95
1017 hypothetical protein XP_148064 [Mus musculus] 1.342 0.404 0.94
3677 gastrin-releasing peptide precursor splice form III - human -0.248 -1.137 0.89
11345 aldo-keto reductase [Gallus gallus] 0.485 -0.369 0.85
5331 CD47 antigen [Bos taurus] 1.807 0.980 0.83
9635
similar to hypothetical protein similar to RNA-binding protein 
lark[Homo sapiens] [Rattus norvegicus] 0.759 -0.068 0.83
95




Predicted CDS, cuticle collagen family member [Caenorhabditis 
elegans] 0.557 -0.265 0.82
11313
cited2/melanocyte specific gene-related gene 1 MRG1 [Gallus 
gallus] 0.311 -0.477 0.79
6074 hypothetical protein XP_148705 [Mus musculus] 0.122 -0.643 0.77
13578 No Hits Found 1.203 0.439 0.76
8919 calcium binding protein P22; Sid470p [Mus musculus] 0.700 -0.035 0.73
15439
serine/threonine kinase 25 (yeast); Ste20-like 
kinase;serine/threonine kinase 25 (Ste20, yeast homolog);
YeastSps1/Ste20-related kinase 1 [Mus musculus] 0.731 0.002 0.73
16400
DEAD-box protein abstrakt; putative RNA helicase [Homo 
sapiens] 0.312 -0.417 0.73
10345
active breakpoint cluster region-related  protein isoform a 
[Homosapiens] 0.772 0.063 0.71
7147 gene 17.5 protein - chicken 0.951 0.245 0.71
5006 OB-receptor gene related protein [Rattus norvegicus] 0.361 -0.336 0.70
2851
hypothetical protein; extensin-like; with SH3 Src homology 
domain [Schizosaccharomyces pombe] 0.521 -0.175 0.70
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Table 10. Up-regulated genes in the Fat line at 3-weeks of age.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number;  BlastX is the highest 
scoring translated BLAST hit; Lean 3 and Fat 3 are the normalized log2 ratios for each 
line at 3-weeks of age; Fold diff is the fold change between the Lean and Fat log2 means.  
Bolded and italicized Spot numbers are genes that were chosen as potential candidate 
genes for further investigation.
Spot BlastX Lean 3 Fat 3
Fold 
diff
2567 chromodomain helicase DNA binding protein 2 [Homo sapiens] 0.751 3.500 2.75
3033 fragile X mental retardation protein 0.892 3.610 2.72
16294 Ig gamma chain (clone 36) - chicken (fragment) -1.489 0.972 2.46
9071 No Hits Found 0.746 3.187 2.44
16182 Ig light chain precursor -1.109 1.239 2.35
3221 Ig light chain precursor -1.127 1.114 2.24
8479
pleiotrophin; osteoblastic cell factor; heparin-binding 
brainmitogen; heparin-binding growth factor 8; heparin 
affinregulatory peptide; heparin-binding neurotorphic 
factor;heparin-binding neurite promoting factor;heparin-binding 
growth-associated molecule [Musmusculus] -0.943 1.221 2.16
18331 keratin 18 [Homo sapiens] -0.379 1.705 2.08
17981 p57kip2 -1.109 0.873 1.98
7333 unnamed protein product [Mus musculus] 0.554 2.337 1.78
18016
PROTEIN-TYROSINE PHOSPHATASE X PRECURSOR (R-
PTP-X) (M1851) 0.569 2.282 1.71
6768
dJ963K23.4 (continues in dJ1041C10 (AL162615)) [Homo 
sapiens] 0.702 2.390 1.69
5193 RIKEN cDNA 1110063G11 [Mus musculus] -0.577 1.049 1.63
18472 tumor necrosis factor receptor 0.318 1.863 1.54
8655 MHC class I antigen [Gallus gallus] -1.167 0.352 1.52
16383 No Hits Found -0.152 1.366 1.52
10937 lysyl oxidase-like 2 [Homo sapiens] -0.489 0.991 1.48
18850 Ig light chain precursor -0.424 1.046 1.47
16054 MHC Rfp-Y class I alpha chain [Gallus gallus] -0.665 0.786 1.45
9843 immunoglobulin alpha heavy chain [Gallus gallus] -0.727 0.724 1.45
17419 KIAA1784 protein [Homo sapiens] 0.772 2.132 1.36
6629 No Hits Found -0.801 0.548 1.35
5073
solute carrier family 29 (nucleoside transporters), member 1 
[Homosapiens] 0.605 1.945 1.34
14515
MHC class I histocompatibility antigen B-F alpha chain 2 -
chicken -0.649 0.582 1.23
333 Skin secretory protein XP2 precursor (APEG protein) -0.414 0.802 1.22
4811 Zinc finger protein CKR1 -0.561 0.560 1.12
12350 L-lactate dehydrogenase A chain (LDH-A) -0.171 0.947 1.12
15370
small integral membrane protein of lysosome/late endosome 
[Gallusgallus] -0.264 0.844 1.11
14871 procKr2 - chicken (fragment) 0.611 1.678 1.07
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Spot BlastX Lean 3 Fat 3
Fold 
diff
15429 hypothetical protein [Rhodopseudomonas palustris] 0.620 1.674 1.05
15228 Salivary gland secretion 1 [Drosophila melanogaster] -0.052 0.995 1.05
9659 hypothetical protein [Rhodobacter sphaeroides] -0.224 0.815 1.04
771
expressed sequence AA408877; hypothetical protein MGC38511 
[Musmusculus] -0.992 0.021 1.01
15027
solute carrier family 21 (organic anion transporter), member 11 
[Homo sapiens] 0.633 1.636 1.00
5855 growth hormone receptor [Gallus gallus] -1.358 -0.372 0.99
5155 No Hits Found 0.397 1.378 0.98
18126
mitochondrial carrier homolog 1 isoform a [Mus musculus 
domesticus] 0.406 1.378 0.97
1337 similar to hypothetical protein [Homo sapiens] [Mus musculus] -1.337 -0.376 0.96
8673 tetranectin [Gallus gallus] -0.339 0.610 0.95
16488 REST corepressor; KIAA0071 protein [Homo sapiens] -0.539 0.408 0.95
35 gamma-immunoglobulin heavy chain (504 AA) [Gallus gallus] -0.502 0.421 0.92
689 gag/env fusion protein [Gallus gallus] 0.558 1.458 0.90
18589
CD38 antigen; CD38 antigen (ADP-ribosyl cyclase / cyclic ADP-
ribose hydrolase) [Rattus norvegicus] 0.703 1.597 0.89
14955 attractin [Mesocricetus auratus] 1.533 2.425 0.89
17746 Similar to guanylate cyclase 1, soluble, alpha 3 [Homo sapiens] -0.642 0.249 0.89
16482 MHC class I [Gallus gallus] -0.462 0.428 0.89
10070 glypican 3 [Homo sapiens] -1.429 -0.543 0.89
7349 No Hits Found -1.368 -0.498 0.87
11622 skeletrophin; dystrophin-like [Mus musculus] -0.034 0.810 0.84
10888 similar to smoothelin isoform c [Homo sapiens] [Mus musculus] -0.487 0.355 0.84
16255 MHC class I antigen [Gallus gallus] -0.355 0.480 0.84
17454 hypothetical protein FLJ33903 [Homo sapiens] 1.064 1.892 0.83
43 immunoglobulin J chain [Gallus gallus] -0.475 0.352 0.83
6533 MHC class II-associated invariant chain [Gallus gallus] -0.314 0.491 0.81
10350 RIKEN cDNA 1200015A22 [Mus musculus] -0.047 0.754 0.80
17651 KIAA1184 protein [Homo sapiens] -0.011 0.776 0.79
1687 No Hits Found 0.390 1.165 0.78
11309 No Hits Found 0.093 0.866 0.77
1319 EH-domain containing 3; EH domain containing 3 [Homo sapiens] -0.376 0.392 0.77
744 deoxyribonuclease gamma [Xenopus laevis] -0.427 0.321 0.75
17984
similar to Ca<2+>dependent activator protein for secretion; Ca2+-
dependent activator protein for secretion [Homo sapiens] 0.659 1.387 0.73
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Table 11. Up-regulated genes in the Lean line at 5-weeks of age.  Spot is the Del-Mar 
14K Chicken Integrated Systems microarray individual spot number;  BlastX is the 
highest scoring translated BLAST hit; Lean 5 and Fat 5 are the normalized log2 ratios for 
each line at 5-weeks of age; Fold diff is the fold change between the Lean and Fat log2
means.  Bolded and italicized Spot numbers are genes that were chosen as potential 
candidate genes for further investigation.
Spot BlastX Lean 5 Fat 5
Fold 
diff
3033 fragile X mental retardation protein 3.684 1.115 2.570
2854 dJ259A10.1 (ssDNA binding protein (SEB4D)) [Homo sapiens] 2.191 0.111 2.081
10348
chromosome 6 open reading frame 4 isoform 1; chromosome 6 
open reading frame 6; chromosome 6 open reading frame 5; 
connection to IKK and SAPK/JNK; NFkB-activating protein 
ACT1 [Homo sapiens] 2.768 0.694 2.074
2968 suppressor of fused [Gallus gallus] 2.038 0.005 2.033
7147 gene 17.5 protein - chicken 1.411 -0.559 1.970
2350 Neuropeptide Y precursor (NPY) 1.739 -0.224 1.964
8866 syndecan 2.250 0.328 1.922
2706 No Hits Found 1.085 -0.798 1.883
1832 Cathepsin D precursor 1.719 -0.157 1.877
5430 No Hits Found 2.544 0.709 1.835
5353 unnamed protein product [Mus musculus] 1.645 -0.155 1.800
10099 No Hits Found 1.702 -0.061 1.763
2141
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 1; beta-3-
galt1[Homo sapiens] 1.417 -0.286 1.703
730 No Hits Found 1.190 -0.486 1.676
5499 multiple exostoses type II protein EXT2.I [Homo sapiens] 1.628 -0.007 1.635
2533
ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC 
(OXALOSUCCINATE DECARBOXYLASE) (IDH) (NADP+-
SPECIFIC ICDH) (IDP) 0.485 -0.830 1.315
4247 No Hits Found 0.848 -0.440 1.288
7157 No Hits Found 0.945 -0.269 1.214
422 similar to The KIAA0150 gene product is novel. [Homo sapiens] 0.951 -0.221 1.172
413 Unknown (protein for MGC:10089) [Homo sapiens] 1.353 0.190 1.164
701 prolyl 4-hydroxylase, alpha subunit (EC 1.14.11.2) 1.355 0.251 1.104
4649
DNA mismatch repair protein MSH6 (MutS-alpha 160 kDa 
subunit) (G/T mismatch binding protein) (GTBP) (GTMBP) 
(P160) 1.266 0.164 1.102
3550
hepatocyte growth factor activator inhibitor precursor; 
hepatocytegrowth factor activator inhibitor [Homo sapiens] 0.922 -0.177 1.099
4989
endothelial differentiation, lysophosphatidic acidG-protein-coupled 
receptor, 2 [Rattus norvegicus] 0.971 -0.090 1.061
10098 No Hits Found 0.839 -0.220 1.059
18786
nucleotide binding protein 2 (MinD homolog, E. coli); 
nucleotidebinding protein 2 (E.coli MinD like) [Homo sapiens] 0.674 -0.306 0.980
17984 similar to Ca<2+>dependent activator protein for secretion; Ca2+- 1.456 0.477 0.979
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Spot BlastX Lean 5 Fat 5
Fold 
diff
dependent activator protein for secretion [Homo sapiens]
10633
Predicted CDS, cuticle collagen family member [Caenorhabditis 
elegans] 0.636 -0.342 0.978
6849 KIAA0872 protein [Homo sapiens] 1.265 0.301 0.964
1185 gene 17.5 protein - chicken 0.872 -0.087 0.960
7423 unnamed protein product [Homo sapiens] 0.674 -0.284 0.958
11560 No Hits Found 0.909 -0.047 0.956
4354
NADH-ubiquinone oxidoreductase SGDH subunit, 
mitochondrialprecursor (Complex I-SGDH) (CI-SGDH) 0.825 -0.129 0.954
3677 gastrin-releasing peptide precursor splice form III - human 0.476 -0.437 0.913
3549 gene 17.5 protein - chicken 0.923 0.011 0.912
12199 No Hits Found 0.952 0.077 0.875
1666 MAPK-interacting and spindle-stabilizing protein [Homo sapiens] 1.066 0.211 0.855
9447 Wnt-5a [Gallus gallus] 0.306 -0.534 0.841
608
similar to dJ475N16.3 (novel protein similar to RPL7A 
(60Sribosomal protein L7A)) [Homo sapiens] 0.922 0.088 0.833
5846
similar to dJ886K2.3(GALE (UDP-galactose-4-epimerase)) 
[Homosapiens] 1.116 0.288 0.828
10168 syndecan-2 variant 1 [Gallus gallus] 1.171 0.344 0.826
6495
leucine-rich, glioma inactivated 1 precursor; epilepsy, 
partial[Homo sapiens] 0.853 0.037 0.815
1652
transmembrane 4 superfamily member 2; membrane component, 
xchromosome, surface marker 1; T-cell acute 
lymphoblasticleukemia associated antigen 1; transmembrane 
proteinA15; tetraspanin protein; cell surface glycoprotein 
A15;CD231 antigen; transmembrane 4 superfamily 2b 
[Homosapiens] 0.697 -0.114 0.812
5845 No Hits Found 1.229 0.427 0.802
5283 carbamoyl-phosphate synthetase (E.C.6.3.5.5) 0.377 -0.415 0.792
15285 No Hits Found 1.447 0.661 0.787
7428 No Hits Found 1.164 0.384 0.781
7702
peptidyl-glycine alpha-amidating monooxygenase precursor (EC 
1.14.17.3) 0.895 0.120 0.775
5132 Unknown (protein for MGC:25768) [Mus musculus] 0.939 0.177 0.762
14091
SEC24 (S. cerevisiae) homolog B; secretory protein 24; Sec24-
related protein B; protein transport protein Sec24B [Homo sapiens] 0.241 -0.514 0.754
16722 androgen induced protein [Homo sapiens] 0.745 -0.007 0.752
2851
hypothetical protein; extensin-like; with SH3 Src homology 
domain [Schizosaccharomyces pombe] 0.971 0.234 0.738
16376 Unknown (protein for IMAGE:3659371) [Homo sapiens] 1.162 0.430 0.733
8919 calcium binding protein P22; Sid470p [Mus musculus] 0.781 0.049 0.732
9090 No Hits Found 1.165 0.432 0.732
455 No Hits Found 0.533 -0.197 0.730
13019
proteasome (prosome, macropain) 28 subunit, alpha; 
protease(prosome, macropain) 28 subunit, alpha [Mus musculus] 0.323 -0.398 0.721
8703
basic leucine zipper and W2 domains 1; KIAA0005 gene product; 
basic leucine-zipper protein BZAP45 [Homo sapiens] 0.923 0.203 0.720
343 No Hits Found 1.294 0.577 0.716
6947 No Hits Found 0.862 0.168 0.694
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Table 12. Up-regulated genes in the Fat line at 5-weeks of age.  Spot is the Del-Mar 14K 
Chicken Integrated Systems microarray individual spot number;  BlastX is the highest 
scoring translated BLAST hit; Lean 5 and Fat 5 are the normalized log2 ratios for each 
line at 5-weeks of age; Fold diff is the fold change between the Lean and Fat log2 means.  
Bolded and italicized Spot numbers are genes that were chosen as potential candidate 
genes for further investigation.
Spot BlastX Lean 5 Fat 5
Fold 
diff
14955 attractin [Mesocricetus auratus] 1.954 4.907 2.954
5155 No Hits Found 1.729 4.125 2.397
5050 scavenger-receptor protein [Sus scrofa] -1.967 0.076 2.043
14623
Lysosomal alpha-mannosidase precursor (Mannosidase, alpha B) 
(Lysosomal acid alpha-mannosidase) (Laman) (Mannosidase alpha 
class 2B member 1) -0.756 1.117 1.873
18016
PROTEIN-TYROSINE PHOSPHATASE X PRECURSOR (R-
PTP-X) (M1851) 0.193 2.020 1.827
10675 alpha-1-antiproteinase [Xenopus laevis] -1.928 -0.155 1.773
7333 unnamed protein product [Mus musculus] 0.628 2.284 1.656
15473 Similar to Human C219-reactive peptide (L34688) [Homo sapiens] -0.431 1.191 1.622
14571 No Hits Found 0.604 2.083 1.479
15432 No Hits Found 0.182 1.576 1.394
4811 Zinc finger protein CKR1 -0.031 1.326 1.356
18126
mitochondrial carrier homolog 1 isoform a [Mus musculus 
domesticus] -1.064 0.272 1.335
2145 OSJNBa0029H02.25 [Oryza sativa (japonica cultivar-group)] -0.359 0.964 1.322
18476 No Hits Found 0.192 1.488 1.296
15379 lecithin cholesterol acyltransferase [Anas platyrhynchos] -0.510 0.755 1.265
14839 No Hits Found -0.807 0.378 1.186
8673 tetranectin [Gallus gallus] -0.864 0.311 1.175
2567 chromodomain helicase DNA binding protein 2 [Homo sapiens] 0.420 1.595 1.174
1687 No Hits Found -0.340 0.824 1.164
16177
blood plasma glutamate carboxypeptidase precursor;prostate-
specific membrane antigen (PSMA) [Homo sapiens] 0.171 1.330 1.159
5073
solute carrier family 29 (nucleoside transporters), member 1 
[Homosapiens] 0.440 1.584 1.143
5193 RIKEN cDNA 1110063G11 [Mus musculus] -0.674 0.465 1.139
4311 Thymosin beta -0.043 1.063 1.106
9843 immunoglobulin alpha heavy chain [Gallus gallus] -0.922 0.148 1.070
333 Skin secretory protein XP2 precursor (APEG protein) -0.193 0.876 1.070
11610 No Hits Found -0.744 0.308 1.052
35 gamma-immunoglobulin heavy chain (504 AA) [Gallus gallus] -1.002 0.039 1.041
16502 hypothetical protein FLJ11198 [Homo sapiens] 0.118 1.130 1.012
8984 No Hits Found 0.049 1.057 1.008
3221 Ig light chain precursor -0.637 0.369 1.005
159 No Hits Found -0.307 0.688 0.995
5732 No Hits Found 0.184 1.160 0.976
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Spot BlastX Lean 5 Fat 5
Fold 
diff
8851 proline rich protein 2 [Mus musculus] 0.619 1.592 0.973
9001 kelch domain containing 1 [Homo sapiens] 0.695 1.648 0.954
18850 Ig light chain precursor -0.442 0.496 0.939
16294 Ig gamma chain (clone 36) - chicken (fragment) -0.357 0.542 0.900
16182 Ig light chain precursor -0.342 0.554 0.896
5855 growth hormone receptor [Gallus gallus] -0.790 0.104 0.894
14871 procKr2 - chicken (fragment) 1.458 2.339 0.881
43 immunoglobulin J chain [Gallus gallus] -0.755 0.113 0.868
17981 p57kip2 -0.655 0.185 0.841
18615 No Hits Found 0.132 0.955 0.823
689 gag/env fusion protein [Gallus gallus] -0.165 0.658 0.823
2368 No Hits Found -0.863 -0.041 0.822
18589
CD38 antigen; CD38 antigen (ADP-ribosyl cyclase / cyclic ADP-
ribose hydrolase) [Rattus norvegicus] 1.429 2.237 0.808
5479 Ig light chain precursor -0.736 0.067 0.804
8438
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A 
dehydrogenase[Homo sapiens] 0.030 0.825 0.795
10937 lysyl oxidase-like 2 [Homo sapiens] -0.393 0.401 0.794
13212
major histocompatibility complex class II beta chain; B-L betachain 
[Gallus gallus] -0.324 0.469 0.793
4413 No Hits Found -0.129 0.663 0.793
3441
Gamma-interferon inducible lysosomal thiol reductase 
precursor(Gamma-interferon-inducible protein IP-30) -1.092 -0.301 0.791
3341 superoxide dismutase 3, extracellular [Homo sapiens] -0.012 0.738 0.750
11292 RNA polymerase II largest subunit -0.332 0.406 0.739
15228 Salivary gland secretion 1 [Drosophila melanogaster] -0.120 0.615 0.735
4849 60S RIBOSOMAL PROTEIN L3 (L4) -0.581 0.151 0.732
14157 Cog4S [Homo sapiens] -0.509 0.217 0.726
7349 No Hits Found -0.716 0.002 0.718
10702
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase [Gallus 
gallus] -0.161 0.552 0.713
11309 No Hits Found -0.033 0.680 0.713
1017 hypothetical protein XP_148064 [Mus musculus] 0.969 1.681 0.712
16323 neuromedin U [Homo sapiens] -0.520 0.189 0.710
1319 EH-domain containing 3; EH domain containing 3 [Homo sapiens] -0.473 0.227 0.700
224 hypothetical protein BC013949 [Homo sapiens] -0.300 0.394 0.694
8876 No Hits Found -0.604 0.090 0.694
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Table 13. The 25 genes with the highest correlation with the Lean line at 1-week of age.  
Signal-to-noise genes are on the left; t-test is on the right (see materials and methods 
details).  Genes are ranked by correlation.  Spot Chromosome is the microarray spot 
number and the chicken chromosomal location of the gene on which the gene has been 
located.  Gene is the highest scoring BLAST hit.  Bolded and italicized Spot numbers are 
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Table 14. The 25 genes with the highest correlation with the Fat line at 1-week of age.  
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Table 15. The 25 genes with the highest correlation with the Lean line at 3-weeks of age.  
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2817501 stathmin [Gallus gallus] 23
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Table 16. The 25 genes with the highest correlation with the Fat line at 3-weeks of age.  
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Table 17. The 25 genes with the highest correlation with the Lean line at 5-weeks of age.  
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Table 18. The 25 genes with the highest correlation with the Fat line at 5-weeks of age.  













-142055069 No Hits Found 1
4413 
chr2:142050069-






































































translocase of inner 
mitochondrial 































-39208353 No Hits Found 8
11649 
chrUn:39203353-
39208353 No Hits Found
9 8257
proline rich protein 
2 [Mus musculus] 9
8257
chr unknown




















chr unknown lacZ alpha peptide
11
746























































































Similar to guanylate 
cyclase 1, soluble, 



































component factor h; 
































9361312 No Hits Found 23
6503 
chr20:9356312-



























heavy chain (504 
AA) [Gallus gallus]
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Immunoglobulin J polypeptide, linker protein for immunoglobulin 
alpha and mu polypeptides
2889 5.17.9 aldo-keto reductase
3341 12.2.1
Extracellular superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1) 
(EC-SOD)
4880 16.1.20 Regulator of G-protein signaling 5
4989 14.3.9 Lysophosphatidic acid receptor Edg-2 (LPA receptor 1) (LPA-1)
5006 15.3.6 leptin receptor overlapping transcript
7037 20.8.17
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 
2, testosterone-repressed prostate message 2, apolipoprotein J)
7147 18.10.6
Early activation antigen CD69 (Early T-cell activation antigen p60) 
(GP32/28) (Leu-23) (MLR-3) (EA1) (BL-AC/P26) (Activation 
inducer molecule) (AIM)
8866 24.11.6 Syndecan-1 precursor (SYND1) (CD138 antigen)
10070 28.6.10 Glypican-3 precursor (Intestinal protein OCI-5) (GTR2-2) (MXR7)
16177 41.3.17 Plasma glutamate carboxypeptidase
16234 44.3.14 Ubiquinone biosynthesis monooxgenase COQ6
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Table 20. Identification of SNPs in candidate genes.  Spot is the microarray spot ID, 
Gene is the gene name of highest scoring BLASTX hit. Sequence identifies the SNP, 

































































to 99791115 5G:6A 11G:0A
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Table 21.  SNP-specific genotypes of the F0 birds.  Bird ID no., Line, Sex, and Genotype 
are given.
Bird no. Line Sex Genotype
472 Lean Male C/T
573 Lean Female C/C
649 Lean Female T/T
655 Lean Female C/C
656 Lean Male C/C
681 Lean Female C/C
695 Lean Female C/C
697 Lean Male C/C
712 Lean Male C/T
717 Lean Female T/T
732 Lean Female T/T
763 Fat Female T/T
778 Fat Female T/T
814 Fat Male T/T
826 Fat Female T/T
847 Fat Female T/T
869 Fat Male T/T
901 Fat Female T/T
919 Fat Female T/T
946 Fat Male T/T
980 Fat Male T/T
982 Fat Female T/T
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Table 22.  Genotypes of the animals in the tails of the body fat percentage distribution.  
Bird ID, genotype as determine by LNA PCR, sex, tail, body weight at sacrifice, weight 
of abdominal fat pad, body fat percentage.
Bird 
no. Genotype Sex Tail






1292 CT Male Lean 2388 12.16 0.509
1916 TT Male Lean 2191 15.73 0.718
1764 TT Male Lean 1855 17.25 0.930
1190 CT Male Lean 2237 22.90 1.024
1302 CC Male Lean 2135 27.19 1.274
1535 CC Female Lean 1912 26.43 1.382
1202 TT Male Lean 2323 32.49 1.399
1864 CC Male Lean 2427 35.32 1.455
1531 TT Male Lean 2314 34.12 1.475
1193 TT Female Lean 1726 25.57 1.481
1547 CC Male Lean 2307 35.38 1.534
51986 CT Male Lean 1958 30.57 1.561
51896 TT Male Lean 3089 48.39 1.567
51970 CT Male Lean 2133 33.60 1.575
1663 CT Male Lean 1996 31.52 1.579
1739 TT Female Lean 1559 24.73 1.586
1743 CT Male Lean 2396 38.33 1.600
1430 TT Male Lean 2263 36.52 1.614
1815 TT Female Lean 1943 32.40 1.668
1359 TT Male Lean 2143 35.80 1.671
51981 CT Male Lean 2755 46.39 1.684
1465 TT Male Lean 2420 41.16 1.701
1963 CC Male Lean 2531 43.24 1.708
1194 TT Female Lean 1696 29.03 1.712
1549 CC Male Lean 2563 44.34 1.730
51997 CT Male Lean 2358 41.62 1.765
1662 CT Male Lean 2851 50.96 1.787
1551 TT Female Lean 1948 35.61 1.828
1962 CT Male Lean 2546 46.80 1.838
1423 CT Male Lean 2346 43.28 1.845
1650 CT Male Lean 2420 44.82 1.852
1504 TT Male Lean 2580 48.25 1.870
1530 CT Male Lean 2344 44.22 1.887
1568 CC Male Lean 2314 43.66 1.887
51977 CC Female Lean 1874 35.37 1.887
1753 CT Male Lean 2685 50.74 1.890
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Bird 
no. Genotype Sex Tail






1539 TT Female Lean 2018 38.17 1.891
1639 TT Male Lean 2704 51.29 1.897
1495 TT Male Lean 2189 41.78 1.909
1528 CC Female Lean 1309 25.03 1.912
1543 CC Female Lean 2033 38.91 1.914
1942 TT Male Lean 2374 45.55 1.919
1494 TT Female Lean 1651 31.68 1.919
1757 CT Male Lean 2604 50.50 1.939
1678 CC Male Lean 2180 42.67 1.957
1164 TT Male Lean 2448 48.24 1.971
1500 TT Male Lean 2329 46.08 1.979
1859 CC Male Lean 2452 48.52 1.979
1399 TT Male Lean 1938 38.44 1.983
1401 TT Male Lean 1892 37.63 1.989
1571 CC Male Lean 2569 51.39 2.000
1973 CC Male Lean 1928 38.57 2.001
1965 TT Female Lean 1857 37.39 2.013
1805 TT Male Lean 2450 49.39 2.016
1200 TT Male Lean 2276 46.55 2.045
1924 TT Male Lean 2430 49.92 2.054
51987 CC Female Lean 2085 42.92 2.059
1715 CT Male Lean 2426 50.10 2.065
1589 CC Male Lean 2550 52.95 2.076
1869 CC Male Lean 2234 46.42 2.078
1703 TT Female Lean 1525 31.80 2.085
1282 CC Male Lean 2596 54.17 2.087
1582 TT Female Lean 1817 39.22 2.159
1544 CC Female Lean 2084 44.99 2.159
1668 CC Female Lean 1863 40.74 2.187
1676 CC Female Lean 1872 41.22 2.202
1802 TT Female Lean 1322 29.84 2.257
1675 CC Female Lean 1477 33.52 2.269
1971 TT Female Lean 1748 39.73 2.273
51933 TT Female Lean 2289 52.96 2.314
1348 TT Female Lean 1683 39.14 2.326
51916 TT Female Lean 1846 43.17 2.339
1346 TT Female Lean 1718 40.58 2.362
1384 TT Female Lean 1679 39.66 2.362
1115 CT Female Lean 2349 55.59 2.367
1221 TT Female Lean 1953 46.40 2.376
1163 TT Female Lean 1639 39.10 2.386
1677 TT Female Lean 1921 45.99 2.394
1457 TT Female Lean 2139 53.38 2.496
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Bird 
no. Genotype Sex Tail






1950 TT Female Lean 1833 46.13 2.517
1533 TT Female Lean 1792 45.42 2.535
1964 TT Female Lean 2166 54.96 2.537
1553 TT Female Lean 1893 48.24 2.548
1161 TT Female Lean 1790 46.08 2.574
1588 . Female Lean 1790 46.39 2.592
1470 TT Female Lean 1398 36.33 2.599
1310 CC Female Lean 1409 36.68 2.603
1959 TT Female Lean 1699 44.29 2.607
1987 TT Female Lean 1715 45.05 2.627
1651 . Female Lean 1754 46.25 2.637
1199 CC Female Lean 2083 55.17 2.649
1156 TT Female Lean 1724 45.77 2.655
1824 CC Female Lean 2007 53.49 2.665
51950 TT Female Lean 1943 52.13 2.683
1649 TT Female Lean 1925 51.73 2.687
1212 CC Female Lean 1774 47.81 2.695
51886 TT Male Fat 2719 95.43 3.510
1503 TT Male Fat 2092 73.64 3.520
1667 CT Male Fat 2290 80.85 3.531
1814 TT Male Fat 2659 94.49 3.554
1511 TT Male Fat 2498 89.66 3.589
1852 CC Male Fat 2796 100.65 3.600
1480 TT Male Fat 2541 91.71 3.609
1449 CT Male Fat 2508 90.83 3.622
1940 TT Male Fat 2070 75.35 3.640
1762 CC Male Fat 2967 108.10 3.643
1467 CT Male Fat 2540 92.76 3.652
1437 TT Male Fat 2475 90.46 3.655
51893 TT Male Fat 2779 101.65 3.658
51888 TT Male Fat 2832 104.20 3.679
1801 TT Male Fat 2332 86.59 3.713
1182 CC Male Fat 2222 83.10 3.740
1779 TT Male Fat 2790 104.95 3.762
1055 TT Male Fat 2549 95.89 3.762
1958 TT Male Fat 1801 68.65 3.812
51877 CT Male Fat 2876 110.23 3.833
1821 TT Male Fat 2602 101.08 3.885
1478 TT Male Fat 2573 100.28 3.897
1429 CC Male Fat 2478 97.05 3.916
1914 TT Male Fat 2539 99.47 3.918
1045 TT Male Fat 2606 103.48 3.971
1358 TT Male Fat 2380 95.65 4.019
126
Bird 
no. Genotype Sex Tail






51900 TT Male Fat 2840 114.47 4.031
1464 TT Male Fat 2549 103.49 4.060
1825 CC Male Fat 2466 100.87 4.090
1696 TT Male Fat 2604 106.59 4.093
51879 CT Male Fat 2956 121.96 4.126
1717 CT Male Fat 2546 105.24 4.134
51942 CT Male Fat 3022 125.34 4.148
1823 CC Male Fat 2099 87.80 4.183
51982 CC Male Fat 2815 118.13 4.196
1169 TT Male Fat 1957 82.24 4.202
51946 TT Male Fat 3021 127.47 4.219
1096 TT Male Fat 2301 98.37 4.275
1217 CC Male Fat 2046 87.83 4.293
1862 CC Male Fat 2424 105.21 4.340
1440 TT Male Fat 2101 91.99 4.378
1923 TT Male Fat 1990 88.15 4.430
1442 TT Male Fat 2543 117.87 4.635
1466 CT Male Fat 2668 125.05 4.687
1172 TT Female Fat 1926 90.44 4.696
1585 TT Female Fat 2024 95.55 4.721
1101 TT Female Fat 1764 83.35 4.725
1778 TT Female Fat 1987 93.95 4.728
1718 TT Female Fat 1922 91.08 4.739
1364 . Female Fat 2176 103.12 4.739
51940 CC Female Fat 2299 109.03 4.742
51954 CC Female Fat 2233 106.10 4.751
1139 TT Female Fat 1933 92.69 4.795
1436 CT Male Fat 2894 139.46 4.819
1927 TT Female Fat 1929 93.02 4.822
1137 TT Female Fat 2066 99.87 4.834
1949 TT Female Fat 1762 85.50 4.852
1912 CC Female Fat 1947 94.55 4.856
1438 CT Male Fat 2361 114.78 4.861
1796 TT Female Fat 2211 107.70 4.871
1443 TT Female Fat 2125 103.57 4.874
51889 TT Female Fat 2208 107.76 4.880
1167 TT Female Fat 2149 105.14 4.893
51880 CC Female Fat 2230 109.37 4.904
51911 TT Male Fat 2970 146.64 4.937
51910 TT Female Fat 2213 109.61 4.953
1697 TT Female Fat 2045 101.39 4.958
1756 CC Female Fat 2321 115.22 4.964
1656 TT Female Fat 2219 110.38 4.974
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Bird 
no. Genotype Sex Tail






1352 TT Female Fat 1903 94.92 4.988
1141 TT Female Fat 2069 103.40 4.998
51901 TT Female Fat 1841 92.47 5.023
51985 TT Female Fat 2265 114.28 5.045
51904 TT Female Fat 2062 104.79 5.082
1413 TT Female Fat 2262 115.45 5.104
1724 TT Female Fat 1990 101.71 5.111
1768 TT Female Fat 2192 112.12 5.115
51913 TT Female Fat 2183 111.93 5.127
51891 TT Female Fat 2227 114.32 5.133
1979 TT Female Fat 1790 92.49 5.167
1693 TT Female Fat 1928 101.90 5.285
1694 TT Female Fat 2316 122.64 5.295
1166 TT Female Fat 2095 111.14 5.305
1340 TT Female Fat 1955 103.77 5.308
1357 TT Male Fat 2713 148.87 5.487
1560 CC Female Fat 2121 117.22 5.527
1103 CC Female Fat 2044 113.01 5.529
51960 CC Female Fat 2278 127.43 5.594
1863 TT Female Fat 1634 91.69 5.611
1933 TT Female Fat 2072 116.39 5.617
51927 TT Female Fat 2283 128.62 5.634
1713 CC Female Fat 2086 117.72 5.643
51871 CC Female Fat 2122 120.38 5.673
1812 TT Female Fat 2154 123.81 5.748
51968 TT Female Fat 2138 136.25 6.373
1695 TT Female Fat 2278 145.27 6.377
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Table 23. Number of animals from the tails of the abdominal body fat percentage.  The 
CC/CT genotypes contain the GATA transcription factor binding site.
Genotype CC/CT TT
Lean tail animals 43 51
Fat tail animals 29 66
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